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This study addresses the problem of asphyxia neonatorum 
in a developing African community in the Mdantsane 
region of Ciskei. It also documents asphyxia as a 
prominent cause 




a regimen of 
handicap, examines 
and evaluates the 
phenobarbitone and 
dexamethasone in limiting subsequent 
deficit in asphyxiated neonates. 
neurological 
Analysis of neonatal deaths at Cecilia Makiwane Hospital 
over an 18 month period showed that aspyhxia accounted 
for one third of all neonatal deaths. In particular, 
asphyxia caused two thirds of deaths in infants over 2 
Kg birth weight. 
From a hospital register of handicapped children, 211 
had cerebral palsy. Asphyxia was the cause of cerebral 
palsy in 33X of these children. Spastic quadriplegia, 
the type of cerebral palsy most often resulting from the 
cerebral damage associated with asphyxia! hypoxic-
ischaemic insults, was by far the largest diagnostic 
category (57X>. Asphyxia therefore appears to be the 
single largest cause of significant handicap in Ciskei. 
In view of the underdeveloped support services to 
parents in most developing areas, the problem of 
asphyxia is of considerable importance. 
In the study of the epidemiology of asphyxia , details 
j 
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of pregnancy and labour were obtained for 163 
asphyxiated term inf ants and 2758 non asphyxiated term 
infants whose mothers had delivered in the hospital. The 
factors positively associated with asphyxia were : low 
gravidity and parity, failure to book for antenatal 
care, the occurence of antenatal disorders, the 
occurence of fetal distress, a prolonged first stage of 
labour and delivery by caesarian section or vacuum 
extraction. Maternal age and the actual number of 
antenatal vists were not associated with asphyxia. The 
causes of asphyxia assigned by the specialist 
obstetrician in charge were cephalopelvic 
disproportion <CPD> <39X>, utero-placental pathologies 
<22X>, other (8X>, and "unknown" where he could find no 
abnormality in pregnancy and labour <27Y.). 
From these findings it appears that the steps that need 
to he taken for prevention include : active recruitment 
of patients to book for antenatal care, more active 
detection and management of cephalopelvic 
and basic research to elucidate the 
disproportion 
causes of the 





therapy trial 116 term infants were selected as 
asphyxiated on the basis of having a 5 minute 
score of < 7 and/or having had signs of fetal 
distress in labour and having a placental arterial base 
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excess of > - 11. Patients were randomly assigned as 
cases or controls. Therapy was identical for both groups 
except that the cases received phenobarbitone and 
dexamethasone. At 48-72 hours of age blood was taken for 
electrolytes, urea and creatinine. In addition the 
neurological state was assessed. Infants were monitored 
in the nursery and then followed at home with visits at 
6 weeks, 3, 6 and 9 months. At these visits they were 
weighed, measured and items of the Denver Developmental 
Screening Test <DOST> administered. At 12 months the 
infants were seen in hospital where DOST items plus a 
formal neurological assessment were carried out. 
Taken as a single group the infants defined as being 
asphyxiated by these criteria experienced the following 
outcome : In the neonatal period 4/116 (3.4Y.> died. Of 
the 88 who completed follow-up to 12 months 21 <23.8Y.) 
children had some detectable neurodevelopmental 
problem, of whom 12 <13.6Y.> had significant neurological 
deficits, 9 of which were spastic quadriplegia. 
The cases were significantly different to controls in 
the following respects : Lower neonatal mortality (0/64 
vs 4/52>, greater neurological depression at 48-72 hours 
of age, less neonatal jaundice and minor biochemical 
differences at 48-72 hours. There were no significant 
differences with respect to growth, items on the DOST or 
the occurence of neurological deficit. 
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It is concluded that the therapy regimen probably has 
some survival advantage to asphyxiated infants but it 
does not limit handicap in survivors. The supposition 
that spastic quadriparesis is the main form of cerebral 
palsy following asphyxia is supported. 
ACKNOWLEDGEMENTS Page v 
In the preparation of this thesis I was assisted and 
supported by many people. I would like to acknowledge 
and thank them at the outset. They includ• 
The board of Trustees of the Stella and Paul Loewnstein 
Trust for awarding me the Loewenstein Research 
Scholarship for two years thus providing the necessary 
financial support. 
The medical superintendent of Cecilia Makiwane Hospital 
for allowing this work to be conducted. 
My colleague Dr.Joan Warren for assistance with 
compiling the register of handicapped children and for 
carrying out many of their neurological assessments. 
Sisters N. Lupondwana and H.Tshandu who carried out the 
home visits on both the handicapped children and the 
infants in the therapy trial. These were carried out 
cheerfully despite often unfavourable conditions. 
Cheryl Nagel for her help in many different ways in 
keeping track of the patients and organising the 
follow-up visits. 
My obstetric colleague Dr.Rob Jones for access to 
information about the mothers and for his help in 
assesing the aetiology of asphyxia in each case. 
Dr. Felicity Goosen for her help with the 
encephalopathic inf ants and for a good deal of the care 
ACKNOWLEDGEMENTS Page vi 
provided to the patients in the nursery. 
The medical officers and interns of the Paediatric 
department who carried out the routine care and 
investigations of the infants in the nursery. 
The sisters and nurses of the Nursery <Ward 17) who 
cared for the inf ants studied and assisted me during 
examination of the inf ants. 
Prof. Peter Folb and Dr.J.S.Cridland of the Department 
of Clinical Pharmacology at the University of Cape Town 
for carrying out the phenobarbitone estimations. 
My paediatric colleagues Drs. Gerry Boon, Felicity 
Goosen and George Swingler for supporting me in so many 
ways during both the execution and writing of this 
thesis. 
Prof. D.L.Woods and Prof A.F.Malan both of the neonatal 
service of the Department of Paediatrics and Child 
Health of the University of Cape Town for discussions 
about many aspects of the therapy trial. Prof. Woods 
very kindly also read the manuscript and made many 
helpful suggestions. 
Dr.Chris Molteno for his help in reading the manuscript 
and providing much useful comment. 
Dr.Lilian Dubowitz for reading part of the manuscript 
ACKNOWLEDGEMENTS Page vii 
during her recent visit and providing helpful 
suggest.ions. 
The librarians of the Medical Library of the University 
of Cape Town for their expert help in retrieving 
references. 
Judy Katzenellenbogen of the Institute of Biostatistics 
of the Medical Research Council for doing the Fisher's 
Exact Tests. 
The Director General of the Department of Health, 
Ciskei for allowing me to carry out. this work. 
Prof .H.deV.Heese Head of the Department of Paediatrics 
and Child Health at the University of Cape Town for the 
constant encouragement to complete this work and for 
his valued support over many years. 
j 




LIST OF TABLES xii 
CHAPTER 1 INTRODUCTION 1 
1. 1. The Hypotheses. 1 
1. 2. Definition of asphyxia neonatorum. 1 
1. 3 The setting. 1 
1. 4 The problems initiating the study. 4 
1. 5 Aims of the study. 8 
1.6 Outline of the thesis. 8 
CHAPTER 2 HANDICAP IN CISKEI 10 
2. 1 Introduction. 10 
2.2 Patients and methods. 12 
2.3 Results. 16 
2.4 Discussion. 23 
2.5 Conclusions. 34 
CHAPTER 3 ASPHYXIA AND CEREBRAL INJURY 35 
3.1 Introduction. 35 
3.2 Effect of cerebral blood flow and 
metabolism on injury pattern. 35 
3.3 Neuropathological appearances of 
hypoxic ischaemic cerebral injury. 43 
CONTENTS Page ix 
3.4. Pathological appearances of 
neonatal hypoxic-ischaemic brain 






CHAPTER 4 CLINICAL CRITERIA OF ASPHYXIA 58 
58 4.1 Changing concepts of asphyxia. 
4.2 Pathophysiology of fetal hypoxia-
ischaemia. 59 
4.3 Evaluation of parameters currently 
used in the definition of asphyxia. 66 
4.4 Conclusions. 85 
CHAPTER 5 EPIDEMIOLOGY OF ASPHYXIA NEONATORUM 87 
5. 1 Incidence. 87 
5.2 Antecedent factors in pregnancy and 
labour. 91 
5.3 Role of asphyxia in cerebral palsy. 94 
5.4 Summary. 100 
CHAPTER 6 EPIDEMIOLOGY STUDY 103 
6. 1 Introduction. 103 
6.2 Patients and methods. 104 
6.3 Results. 107 
6.4 Discussion. 124 
6.5 Conclusions. 133 
CONTENTS Page x 
CHAPTER 7 TREATMENT OF ASPHYXIA NEONATORUM 136 
CHAPTER 8 
7.1 Introduction. 136 
7.2 General management of the 
asphyxiated infant. 
7.3 Posible mechanisms of barbiturate 
protection. 
7.4 Protective effect of barbiturates 
in animal models of hypoxic-
ischaemic cerebral injury. 
7.5 The dosage of phenobarbitone in 
neonates. 
7.6 The role of corticosteroids in the 
treament of hypoxic-ischaemic brain 
injury. 
7.7 Trials on the protective effect of 

























CONTENTS Page xi 
CHAPTER 9. FINAL CONCLUSIONS 239 
9.1 First hypothesis 239 
9.2 Second hypothesis 240 
9.3 Third hypothesis 242 
REFERENCES 243 
APPENDICES 270 
APPENDIX I SCHEMES FOR GRADING HYPOXIC-
ISCHAENIC ENCEPHALOPATHY. 270 
APPENDIX II COMBINATION SCHEMES FOR DEFINITION 
OF ASPHYXIA. 273 
APPENDIX III CRITERIA FOR REFERRAL OF OBSTETRIC 
PATIENTS FOR HOSPITAL DELIVERY. 275 
APPENDIX IV IDENTITY OF PATIENTS WITH ABNORMAL 
NEURODEVELOPMENTAL OUTCOMES AT 12 
MONTHS. 277 
APPENDIX V COMPOSITION OF .. NEONATALYTE" SABAX 278 
APPENDIX VI RANGES OF DATA IN THERAPY TRIAL. 279 
APPENDIX VII TEST ITEMS COMPLETED AT FOLLOW UP 
VISITS. 282 
APPENDIX VIII PROFORMAS FOR NURSERY. 284 
APPENDIX IX PROFORMAS FOR FOLLOW UP. 296 
LIST OF TABLES Page xii 
CHAPTER 1 INTRODUCTION 
1.4.1 Deliveries and early neonatal deaths 
: Cecilia Makiwane Hospital. 6 
CHAPTER 2 HANDICAP IN CISKEI 
CHAPTER 
CHAPTER 






2.3.2 Aetiology of Cerebral palsy by type. 17 
2.3.3 Cerebral palsy : Coincidental mental 
retardation. 18 
2.3.4 Degree of mental retardation in non-
cerebral palsy cases. 18 
2.3.5 Seizures by type of cerebral palsy. 20 
2.3.6 Patients assessed as needing 
institutional care. 21 
2.3.7 Provision of day training for 
suitable mentally retarded children. 22 
2.4.1 Types of cerebral palsy in published 
studies. 25 
2.4.2 Type of cerebral palsy after 
documented hypoxic-ischaemic 
encephalopathy. 28 
2.4.3 Comparative aetiology of cerebral 
palsy. 32 
3 ASPHYXIA AND CEREBRAL INJURY 
4 CLINICAL CRITERIA OF ASPHYXIA 
4. 3. 1 Studies using Apgar as only 
criterion of asphyxia. 69 
4.3.2 Studies using time to spontaneous 
respiration as criterion for 
asphyxia. 72 
4.3.3 Studies using HIE plus other factors 
as criteria for asphyxia. 74 
4.3.4 Studies relating grade of severity 
of HIE t.o outcome. 76 
LIST OF TABLES Page xiii 
4.3.5 Pooled data from 3 studies using 
Sarnat scheme. 77 
4.3.6 Metabolic acidosis as sole criterion 
of asphyxia. 78 
4.3.7 CT and US scanning in asphyxia. 84 
CHAPTER 5 EPIDEMIOLOGY OF ASPHYXIA NEONATORUM 
5.1.1 Studies 
asphyxia. 
of the incidence of 
5.1.2 Causes of neonatal deaths in 
88 
Southern African neonatal Units. 90 
5. 2. 1 Controlled studies 
antenatal factors to 
asphyxia and/or HIE. 
relating 
incidence of 
5.2.2 Studies relating antenatal events to 
92 
incidence of asphyxia and/or HIE. 93 
5.3.1 Obstetric antecedents of cerebral 
palsy. 96 

















6.3.4.1.1. Weeks at first booking. 111 
6.3.4.1.2. Weeks at first booking 
6.3.4.2.1. 
6.3.4.2.2. 
- percent.ages. 111 
Number of antenatal visits 
Number of antenatal visits 
112 
- percent.ages. 112 
6.3.5.1 Antenatal disorders. 114 
6.3.5.2. Antenatal disorders - percentages. 114 
LIST OF TABLES Page xiv 
6.3.6.1. Evidence of fetal distress. 115 
6.3.6.2. Evidence of fetal distress 
- percentages. 116 
6.3.7.1. Method of delivery. 117 
6.3.7.2. Method of delivery - percentages. 117 
6.3.8.1. Duration of first stage of labour. 118 
6.3.8.2. Duration of first stage of labour 
- percentages. 118 
6.3.9.1. Method of resuscitation. 119 
6.3.9.2. Method of resuscitation 
- percentages. 119 
6.3.10. Birth Weights in study groups. 120 
6.3.11. Apgar scores in HIE group. 121 
6.3.12.1. Obstetricians cause of asphyxia. 123 
6.3.12.2. Obstetricians cause of asphyxia 
- percentages. 123 
CHAPTER 7 TREATMENT OF ASPHYXIA NEONATORUM 
7.4.1 Studies on protective effect of 
barbiturates on neonatal animals. 153 
7.6.1 Comparison of vasogenic and 
cytotoxic cerebral oedema. 162 
7.7.1 Occurence of seizures in 
experimental and control groups. 171 
CHAPTER 8 THERAPY TRIAL 
8. 3.1.1. Gravida. 
8.3.1.2. Gravida - percentages. 
8.3.2.1. Parity. 
8.3.2.2. Parity - percentages. 






8.3.4.1. Complications of pregnancy. 191 
8.3.4.2. Complications of pregnancy 
- percentages. 191 
8.3.5.1. Presentation. 192 
8.3.5.2. Presentation - percentages. 192 
8.3.6.1. Evidence for fetal distress. 192 
8.3.6.2. Evidence for fetal distress. 
- percentages. 193 
LIST OF TABLES Page xv 
8.3.7.1. Complications of labour. 193 
8.3.7.2. Complications of labour 
- percentages. 194 
8.3.8.1. Method of delivery. 194 
8.3.8.2. Method of delivery 
- percentages. 195 
8.3.9.1. Indications for operative delivery. 196 
8.3.9.2. Indications for operative delivery 
- percentages. 196 
8.3.10.1. Maternal sedation. 197 
8.3.10.2. Maternal sedation 
- percentages. 197 
8.3.11.1. Obstetricians cause of asphyxia. 198 
8.3.11.2. Obstetricians cause of asphyxia 
- percentages. 198 
8.3.12.1. Resuscitation. 199 




8. 3. 16 
8.3.17 
Sex of infants. 200 
Birth weight and gestational age. 200 
Placental arterial blood gas 
determinations. 
Details of deaths in the neonatal 
period. 




8.3.18.1. Neurological state at 48-72 hours 204 
8.3.18.2. Neurological state at 48-72 hours 
- percentages. 204 
8.3.19 Biochemical results. 205 
8.3.20.1. Concurrent illness in neonatal 
period. 205 
8.3.20.2. Concurrent illness in neonatal 
period - percentages. 206 
8.3.21.1. Seizures in the nursery. 206 
8.3.21.2. Seizures in the nursery 
- percentages. 207 
8.3.22.1. Neonatal jaundice. 




LIST OF TABLES Page xvi 
8.3.23.1. Age at independent feeding. 208 
8.3.23.2. Age at independent feeding 
- percentages. 209 
8.3.24.1. Fate of patients entering trial. 210 












Age at followup visits. 211 
Developmental scores at follow-up. 212 
Weight at follow-up visits. 213 
Head circumference at follow-up. 213 
Cases : Neurological and develop-
mental outcome at 1 year. 214 
Controls : Neurological and develop-
mental outcome at 1 year. 215 
All patients : neurological and 
developmental outcome at 1 year. 215 
Neurological outcomes. 216 
Developmental outcomes. 216 
All neurodevelopmental outcomes. 217 
Details of patients with abnormal 
neurological outcome at 1 year. 218 
8.3.36.1. Hearing at 1 year. 219 
8.3.36.2. Hearing at 1 year - percentages. 219 
8.3.37.1. Seizures over 1 year. 220 
8.3.37.2. Seizures over 1 year - percentages.220 
LIST OF TABLES Page xvii 
APPENDICES 
Ax.I.1. Sarnat scheme for grading hypoxic-
ischaemic encephalopathy. 270 
Ax.I.2. Special investigations associated 
with grades of encephalopathy. 271 
Ax.I.3 Fenichiel scheme for 
encephalopathy. 
Ax.I.4 Brown scheme for 
encephalopathy. 








defining asphyxia. 274 
Ax.IV.1 Cases: Abnormal neurological and/or 
developmental outcome. Trial 
identity numbers. 277 
Ax.IV.2 Controls: Abnormal neurological 
and/or developmental outcome. Trial 
identity numbers. 277 
Ax. VI. 1. Ranges for Antenatal Care Use. 279 
Ax. VI. 2. Ranges for birth weight and 
Gestational Age. 279 
Ax. VI. 3. Ranges for placental chorionic 
arterial blood gas determinations. 279 
Ax. VI. 4. Ranges for Prechtl test. scores. 279 
Ax. VI. 5. Ranges for biochemical results. 280 
Ax. VI. 6. Ranges for ages at. follow up 
visits. 280 
Ax. VI. 7. Ranges for scores at follow up 
visits. 280 
Ax. VI. 8. Ranges for weight. at follow up 
visits. 281 
Ax.VI.9. Ranges for head circumference at 
follow up visits. 281 
• 
LIST OF TABLES Page xviii 
Ax. VI I. 1. Six weeks follow up Test Items 
completed. 282 
Ax. VI I. 2. Three months follow up Test 
Items completed. 282 
Ax. VI I. 3. Six months follow up Test Items 
completed. 283 
Ax. VI I. 4. Nine months follow up Test Items 
completed. 283 
Ax. VI I. 5. Twelve months follow up Test 
Items completed. 283 
CHAPTER 1 
INTRODUCTION 
CHAPTER 1 INTRODUCTION Page 1 
1.1 THE HYPOTHESES. 
The hypotheses advanced in this work are that 
neonatorum is the leading ascertainable 
asphyxia 
cause of 
cerebral palsy among handicapped children in developing 
communities in Southern Africa. Furthermore that data 
on the epidemiology of asphyxia neonatorum and on the 
efficacy of treatment regimens for the condition will 
be helpful in limiting the unduely harmful effects 
that it is having in such communities at present. 
1.2. DEFINITION OF ASPHYXIA NEONATORUM. 
In this 
asphyxia) 
study the term asphyxia neonatorum (or 
will be used to indicate the failure of 
adequate oxygenation of the fetus as reflected by 
clinical signs and biochemical abnormalities. 
1.3. THE SETTING. 
The work reported here was carried out in Mdantsane, 
the main urban area of the Ciskei which is one of the 
independent homelands in Southern Africa. 
The Ciskei is located between the Transkei and the 
Eastern Cape border region and consists of 8 small 
towns and one major conurbation. In the rural areas the 
population is chiefly engaged in subsistence farming 
but the main economic support is from relatives working 
in the cities. The population of the Ciskei is 
appoxirnately 1 million of whom about 400,000 live in 
Mdantsane. 
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The people of the Ciskei are of Xhosa lineage. The 
Xhosa people traditionally occupied an area comprising 
the Ciskei and Transkei for several hundred years. With 
the advent industrialisation at the turn of the century 
many people left the Ciskei to seek work in cities such 
as Johannesberg and Cape Town. Subsequently in the 60's 
and 70's many ex-Ciskeians were forcebly returned to 
the Ciskei from the Western Cape and were resettled in 
Mdantsane. 
Mdantsane is located some 25 kilometers inland from 
East London to which it is connected by rail and bus 
transport services. The building of Mdantsane began in 
the 60's and continues today. It is a township of small 
but well built houses, each with a municipal water 
supply and water borne sewerage. There are 
neighbourhood shops and schools as well a small 
downtown area but most people go to nearby East London 
for more sophisicated shopping or service .requirements. 
The majority of people in employment in Mdantsane 
commute to East London to work in factories, service 
industries and domestic service. There is a rapidly 
growing industrial area in Mdantsane itself. Despite 
this, unemployment is prevalent and the standard of 
living of most people is that of a poor working class. 
The possesion of consumer goods such as television 
sets, washing machines and motor cars are the privelige 
of a relatively small middle class. 
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1.3.1. Health Services. 
The Ciskei has a health service infrastructure which 
divides the country into 6 health regions each with its 
own general hosptial. Each hospital is responsible for 
a network of clinics in its region. Each clinic is 
staffed by at least 2 resident registered nurses plus 
assistant nurses, domestics and a gardener. The clinic 
nurses render a comprehensive primary care service 
involving basic preventive work such as antenatal care 
and immunization as well as consulting sick patients of 
all ages who are referred to hospital if necessary. The 
clinics have either a telephone or radio link with the 
base hospital. Clinics are equipped to carry out normal 
deliveries and to resuscitate and transport sick 
neonates. A primary care training programme has been 
running over the last 4 years and over 300 clinic 
sisters have been trained. In this structure there are 
6 hospitals and 109 permanent clinics as well as a 
large number of mobile clinic stops. 
The Mdantsane region is served by the Cecilia Makiwane 
Hospital and 9 clinics. The hospital was built in 1976 
and has 1400 beds. It is the only hospital in the 
Ciskei to have specialist departments and therefore is 
the hospital to which the other hospitals refer. 
Although provided with basic radiology and laboratory 
services, 
such as 
facilities for more advanced investigations 
computer assisted tomography <CT> and 
CHAPTER 1 INTRODUCTION Page 4 
electroencephalograms <EEG> are not available on the 
At the time of this study ultrasound premesis. 
facilities were also not available. Patients needing 
teaching tertiary care are usually referred to 
hospitals in Cape Town. 
1.3.2. Paediatric Service. 
the 
The hospital has 200 medical paediatric beds and a 50 
bed neonatal nursery. The paediatric staff at present 
consists of 4 specialist paediatricians, 9 medical 
officers, 1 registrar and 4 interns, although during 
the earlier part of the study there were only 2 
specialists. 
.. ~ .. 
The neonatal nursery is adjacent to the labour ward and 
caesarian theatre and is connected to them by an 
interleading door which makes communication very easy 
and quick. 
The author has held the position of head of the 
paediatric department at the hospital since 1980. 
1.4.THE PROBLEMS THAT INITIATED THE STUDY. 
A paediatrician arriving in a developing area is 
immediately impressed by obvious clinical problems such 
as malnutrition, gastroenteritis and tuberculosis, as 
well as by organisational problems such as the absence 
of clear routines, poorly trained paediatric nursing 
staff and a shortage of basic equipment. These problems 
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are pressing but the solutions are fairly obvious given 
the will to solve them. 
Two less immediately obvious problems were encountered 
by the author. These were handicap and the high 
mortality in term neonates from asphyxia. From the 
outset there was a strong suspicion that these 
phenomena were linked and it was the preliminary 
investigation of these two problems that. lead the 
author into this study. 
An investigation into the causes of death of neonates 
in the nursery for an 18 month period was carried out. 
The results are shown in Table 1.4.1. Of all neonatal 
deaths 34Y. could be attributed to asphyxia. Furthermore 
most of these deaths (83X) were in infants weighing 
>2000 Gm at birth .. Asphyxia was responsible for 65Y. of 
neonatal deaths in i.nfants of birth weight >2000 Gm. 
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TABLE 1.4.1. DELIVERIES AND EARLY NEONATAL DEATHS :CECILIA nAKIWANE HOSPITAL 
JULY 1981 - DECEnBER 1982 
BIRTH WEIGHT l61sl 
==================================================================================== 
l-1000 :-1250 l-1500 l-1750 1-2000 l>2000llTOTAL I 
-------------------------:------:------l------:------:------:-----::------: 
DISCHARGED NEONATES 8 I 31 I 52 I 87 : 180 l8140 ll8498 I I I I I 
-------------------------'------·------:------·------:----·-:-----::------:-------: 
DEATHS BY CAUSE : lXDEATHS I 
CONGENITAL ABNORnALITIES 1 1 11 : 13 7.6 
PREnATURITV 42 16 9 5 7 - : 79 46.1 
ASPHYXIA 3 2 1 4 48 : 58 33.9 
OTHER 5 15 I 21 12.3 
ALL 43 19 11 7 17 74 l 171 100.0 
=========================:======:======:======,======:======1=====::======:--------1 
TOTAL : 51 : 50 I 63 I 94 l 197 18214 ll8669 I 
=========================:======:======:======:======:======}=====::======:========: 
'Y.DEATHS : 25.ll 11.1: 6.4: 4.ll 9.91 43.2::100.0: 
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At the second conference on perinatal priorities in 
Southern Africa in 1983 the problem of asphyxia! deaths 
at Cecilia Makiwane Hospital was presented by the 
author and the data were compared to those from other 
units in Southern Africa. It was clear that in units 
serving the economically disadvantaged areas a similar 
picture was seen with 40-60Y. of the deaths in neonates 
over 2000 Gm being due to asphyxia. In units serving 
more affluent communities the percentage was much 
lower. The problem of a high neonatal mortality from 
asphyxia was thus not Just a local Ciskeian problem but 
a regional one as well. It was resolved that as much 
work as possible should be done by all units on this 
problem. The feeling was also expressed that if many 
inf ants were dying of asphyxia there would also be many 
handicapped survivors. 
The problem of handicap was important in that it was 
prevalent, tended to be severe and that the social 
welfare, educational and other community facilities to 
deal with it were very limited. This will be explored 
further in Chapter 2. 
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1.5. AIMS OF THE STUDY. 
1.5.1. To determine the aetiology of cerebral palsy as it 




To determine as far as possible, the 
epidemiolgical associations of asphyxia neonatorum 
in Ciskei with particular reference to factors in 
pregnancy and labour. 
To determine the efficacy or otherwise, of a 
regimen of phenobarbitone and dexamethasone on the 
survival and long term neurodevelopmental outcome 
of term asphyxiated neonates. 
By using data gathered in the above studies to 
make recommendations for limiting the 
harmful effects of asphyxia neonatorum 
children of Ciskei and similar areas. 
unduly 
on the 
1.6. OUTLINE OF THE THESIS. 
The investigation starts by reporting the results of a 
study of handicapped children with a view to 
elucidating the aetiology. This is followed by a review 
of the literature on the pathophysiology of asphyxia! 
cerebral injury in term infants. The next section deals 
with the problem as to which criterion or group of 
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criteria can reasonably be taken to indicate that a 
newborn infant has suffered a significant hypoxic-
ischaemic cerebral insult. This is followed by a review 
of the literature on the epidemiology of asphyxia 
neonatorum. Next is a report on a study of the 
epidemiology of asphyxia in the Mdantsane region of 
Ciskei. This is followed by a review of the literature 
relating to the therapy of hypoxic-ischaemic insults in 
the newborn and the work concludes with a report on a 
controlled trial of the possible long term 
neurodevelopmental benefits of a phenobarbitone and 
dexamethasone regimen in term asphyxiated inf ants. 
CHAPTER 2 
HANDICAP IN CISKEI 
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2.1. INTRODUCTION. 
A distressing feature of paediatrics in the developing 
world is the plight of handicapped children and their 
guardians. One gains the impression that there are many 
such children and further that they tend to be very 
severely affected. The doctor trying to assist their 
families quickly discovers that facilites in the 
community are inadequate and often simply non-existent. 
In Ciskei, residential care for the very severely 
affected children is not available and such children 
have to be cared for at home. Houses in the urban areas 
tend to be small and often overcrowded. The presence of 
a severely handicapped child is inevitably a great 
trial to the family. There may be loss of income as a 
result of the guardian having to stay at home to care 
for the child. The limited availability of appliances 
such as wheel chairs leads to hardship when the 
children become too heavy to carry on public transport. 
Some day training facilities for the mentally retarded 
are provided in the urban area of Mdantsane, but they 
are not enough. Physiotherapy and occupational therapy 
are available to a limited extent in Mdantsane, but not 
in the other urban and rural areas. The state assists 
by awarding sPngle care grants to the guardians of 
mentally retarded children over the age of 3 years who 
stay at home to care for the child. These grants are 
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subject to availability of state funds. 
Commentators from the developed world have suggested 
that the problem of handicap is less burdensome in 
underdeveloped communities because the "extended 
family" supports the parents. Trudy Thomas (1973) has 
pointed out that in the Ciskei, the family structure in 
both rural and urban areas has become disorganized as a 
result of the socially disruptive effects of 
urbanization and the migrant labour system. The result 
is that elderly grandparents (usually grandmothers) are 
to be found in the rural areas caring for children 
while the young adults go to town to seek work and to 
send money home on an irregular basis. Thus, a normal 
family structure, extended or otherwise, is absent and 
ecomomic support very tenous. In this environment it is 
difficult enough to care for a normal child let alone a 
severely handicapped one. 
The need to investigate this distressing problem was 
seen to be important. Effective prevention of the 
handicap is the most desirable approach, combined with 
efforts to improve the care and facilities for such 
children. A start has been made on the latter and will 
not be discussed further here. Before prevention can be 
embarked upon the problem needs to be clearly defined 
and the causes described as far as possible. It was for 
this reason that the following survey of handicapped 
children in the area was carried out. 
l 
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2.2. PATIENTS AND METHODS. 
During the period January 1981 to June 1986 a register 
was compiled of all handicapped children presenting to 
the paediatric department of the Cecilia Makiwane 
Hospital. 
On registration patients entering the register were 
referred to 2 specially orientated community health 
nurses 
carried 
who interviewed the parents or escort and 
out a home visit to find out more about 
later 
the 
social situation and the specific medical and social 
needs of the handicapped child. 
The patients were assessed medically either by the 
author or by a senior paediatric medical officer with 
an interest in handicap (J.W.>. A full paediatric 
history was taken and a physical examination with 
special emphasis on the neurological aspects was 
carried out by the same pair. 
case of an aetiology for the 
The assignment to 
handicap was in 
each 
the 
majority of cases done on the basis of the history. The 
perinatal records were available for relatively few. 
Where any doubt existed as to the intellectual or 
developmental level of the child a more formal 
developmental assessment was carried out by the same 
medical officer (J.W.>. The mental 
evaluations were carried out by the same 
and physical 
examiner at 
the same session. Every effort was made to prevent the 
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child's physical 
assessment of the 
state from influencing objective 
mental state. At the end of the 
evaluation each patient was categorised in terms of 
* Aetiology. 
* Type of cerebral palsy, if present. 
* Degree of mental retardation. 
* Presence of seizures. 
* Requirements for community facilities. 
2.2.1. Definition of Handicap. 
The handicapped child is one who suffers from any 
continuing disability of body, intellect or personality 
which is likely to interfere with normal growth, 
development and capacity to learn (Sheridan 1968). 
2.2.2. Definition and Classi£iction of Cerebral Palsy. 
Cerebral palsy is the result of a lesion or 
maldevelopment of the brain, non-progressive in 
character and existing from earliest childhood CBobath 
1966) . 
The classification used here is as follows 
Spastic, in which spasticity is the dominant motor 
pattern. 
Athetoid, in which dystonia and/or choreoathetosis 
predominate. 
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Mixed, in which spasticity and athetoid features are 
clearly found. 
Hypotonic, an undifferentiated form found most often in 
young infants in whom hypotonia is the dominant 
feature. 
Quadriparesis refers to the involvement of all four 
limbs with arms more affected than legs. In diplegia 
the legs are involved more than the arms which may be 
normal. In hemiplegia the motor disorder is limited to 
one side of the body. 
2.2.3. Categories of Mental Retardation. 
The following categories of mental retardation were 
used. <Steenkamp and Steenkamp 1981) : 
Mild : The child shows poor scholastic progress. IQ 84-
70. 
Moderate : The child needs special education to make any 
progress. IQ 69-50. 
Severe The child is able to cope with simple 
activities of daily living but unable to benefit from 
any form of academic schooling. IQ 49-25. 
Profound : Totally Dependent on others for most routine 
functions. IQ less than 25. 
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2.2.4. Community facilities for handicap. 
The following terms are used below and need some 
explanation in the local context 
Day Training This is form of care is provided at a 
suitable centre which the child attends on a daily 
basis. The programme involves activities of daily living 
and adaption to everyday life in the community. It does 
not involve academic work of any kind. Normally children 
in the severe category who are older than 5 years and 
who are largely "clean and dry" , are suitable for this 
type of care. 
In Ciskei there are at present no educational facilites 
for children in the the mild and moderate categories in 
the educational system. These children have either to 
attend a normal school which poses many difficulties 
for them socially and educationally or to attend a day 
training centre whose programme is also not suitable 
for them but less difficult socially. 
Institutional care This refers to residential, 
hospital type care which is suitable for those whose 
physical or mental state makes it impossible for the 
parents to care for them at home. It is also suitable 
for less severely handicapped children who have no-
one in the community to care for them. 
In this study the above local conditions as well as the 
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social position of the child were taken into account 
before deciding on which community facilites would be 
suitable for the child. 
2.3 RESULTS : 
2.3.1. CEREBRAL PALSY 
A total of 350 children were entered in the register at 
the time of analysis. Table 2.3.1. sets out the 
categories of cerebral palsy and mental retardation. 
TABLE 2.3.1. CEREBRAL PALSY AND MENTAL RETARDATION. 
FROM HANDICAP REGISTER. 
================================================== 
!NO MENTAL : MENTAL 




PALSY 10 129 139 
-----------:------------ -------------:----------
CEREBRAL 
PALSY 18 193 211 
===========!============ =============!==========· 
TOTAL 28 322 350 
================================================== 
2.3.2. CEREBRAL PALSY AETIOLOGY AND TYPES 
The aetiology of cerebral palsy by type is set out in 
Table 2.3.2. The spastic group is subdivided into 
quadriplegia, diplegia and hemiplegia. The other 
categories are athetoid, mixed <having features of both 
spasticity and choreoathetosis>, hypotonic and other, 
which consisted of patients difficult to categorise. 
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TABLE 2.3.2. AETIOLOGY OF CEREBRAL PALSY BY TYPE. 
================================================================ 
lPRE-NATALlPERI-NATAL l POST-NATAL lUKNlTOTl 
------------:---------:-----------:-------------------:---:---: 
TYPE lHYDl MS lASPlPRMlOTHlTB"lBC"lENClCYTIOTHl 
-------------:---:-----:---:---:---:---:---:---:---:---1 
SPASTIC 
QUADRIPLEGIA l 1 
DIPLEGIA . l 1 
HE"IPLEGIA l 1 
l52 7 7 l5 b 2 2 137 :120: 
:1 4 - :- 1 - 14 111 : 
:s 2 2 110 2 - 3 l16 : 45 : 
-------------:---------:-----------:-------------------:---:---: 
MIXED l - - 16 - 3 l- - - - - 16 115 l 
-------------:---------:-----------:-------------------:---1---: 
ATHETOID : - - :- 1 :1 - 1 - - 12 lb : 
-------------:---------:-----------1-------------------:---:---1 
HYPOTONIC : - 1 l3 1 - l- 1 2 2 - l1 112 l 
-------------:---------:-----------:-------------------:---:--~: 
OTHER : - - :- - - l- - - - - 12 12 l 
=============:=========:===========:===================:===:===: 
TOTAL : 3 l70 15 13 l16 9 5 B 2 169 l2111 
================================================================ 
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Key : HYD = Hydrocephalus 
ASP = Asphyxia 
"S = Morphological syndro1e 
PR" = Pre1aturity 
OTH = Other TBM = TB aeningitis 
BCM = Bacterial 1eningitis ENC = Encephalitis 
CYT = Cerebral vein thro1bosis UKN = Un kno1m 
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TABLE 2.3.3. CEREBRAL PALSY : COINCIDENTAL MENTAL RETARDATION. 
================================================================= 
MENTAL RETARDATION 




DIPLEGIA l 5 
HEtlI PLESIA : 4 
6 l 15 
l 4 
B :19 
136 :so 1120 : 94 
: 1 : 1 : 11 : 45 
: 10 l 3 I 44 I 9 
------------:-----,------:--------1------:--------:------1------: 
MIXED l - : - : 3 I B I 4 : 15 l100 
------------:-----:------:--------:------1--------:------:------1 
ATHETOID : 2 I - I 1 I 2 I 1 I 6 l 67 
------------:-----1------:--------:------:--------;------l------i 
HYPOTONIC l - : 2 I 1 : 6 l 3 l 12 1100 
------------~-----:------:--------:------:--------:------:------i 
OTHER ! - : 1 : - : - l 1 : 2 : 100 
============:=====:======:========:======:========:======:======: 
TOTAL :ta 111 :43 :63 : 69 l210 : 91 
============: =====: ======: ======== : ======: ========: =-=====:======I 
x :s.o :a.1 :20.5 :30.0 :32.s :100 : x 
================================================================= 
TABLE 2.3.4. DEGREE OF MENTAL RETARDATION IN NON- CEREBRAL PALSY 
CASES. 
============================================================= 
lNONE :MILD IMODERATE:SEVERElPROFOUND:UNKNONNlTOTAL: 
========:=====:======:========!======:========:=======:====== 
NO CP :10 :20 :49 :s2 : 1 : 1 1139 : 
============================================================= 
PASE 18 
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The aetiology is divided into pre-natal, peri-natal and 
post-natal. The various sub- headings are indicated in 
the table. 
The most noteworthy features are that spastic 
quadriplegia was by far the largest single group by 
type and that asphyxia is the dominant aetiological 
category. Fifty two cases <2SX> were spastic 
quadriplegics caused by asphyxia. The next largest 
aetiological category was TB meningitis which is less 
than a quarter of the number in the asphyxia category. 
2.3.3. MENTAL RETARDATION. 
The distribution of mental retardation among 
cerebral palsy patients is set out in TABLE 2.3.3. 






category <33X> was "profound". It is 
modal category of retardation for 
of note 
spastic 
quadriplegics was "profound" whereas that for 
hemiplegics was "moderate". Further the largest single 
cell in the table is that of profoudly retarded spastic 
quadriplegia. The spastic quadriplegics tend to be the 
most severely retarded. 
The degree of mental retardation in non-cerebral palsy 
cases is set out in Table 2.3.4. 
2.3.4. CEREBRAL PALSY AND SEIZURES. 
The proportions of each category of cerebral palsy 
experiencing seizures is set out in TABLE 2.3.5. The 
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overall rate of occurence was 35Y. with the athetoid 
group having the highest rate (66Y.) although the 
numbers in this category are small. 
2.3.5. 
TABLE 2.3.5. SEIZURES BY TYPE OF CEREBRAL PALSY 
=============================================== 











WITH : WITH 













: 65 -------------- ----- ------:-------:----------: 
MIXED 15 5 : 33 : 80 
-------------- ----- ------:-------:----------: 
ATHETOID 6 4 : 66 I 50 
-------------- ----- ------:------- ----------
HYPOTONIC 12 7 : 54 58 ,, ------.-------
OTHER 2 
============== =====:======!======= ========== 
TOTALS : 211 : 74 : 35Y. 69Y. 
=============================================== 
PROVISION OF COMMUNITY FACILITIES FOR HANDICAP. 
2.3.5.1. Institutional Care 
Of the total of 350 patients in the handicap register 
136 (39Y.) were regarded by the medical assessor as being 
most suitably placed in residential institutional care 
which is felt to be appropriate for only the most 
severely affected patients taking the social 
circumstances into account. To indicate the severity of 
those considered suitable, the percentage of those in 
each age category who were both non-ambulant and 
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incontinent is set out in TABLE 2.3.6. It must be noted 
that in the situation studied no child was actually in 
institutional care as no such facility is provided in 
the region. 
TABLE 2.3.6. PATIENTS ASSESSED AS NEEDING INSTITUTIONAL 
CARE. 
==~==================================== 
ALL IN : X NON AMBULANT : 
AGE GROUP : & INCONTINENT ----------- =========='================: 
UNDER 6 
YEARS 80 87 
----------- ---------- ----------~-----: 
6-10 
YEARS 33 79 
----------- ----------,----------------: 
10 + 




2.3.5.2. Day Care for Suitable Children with Mental 
retardation. 
In the group of handicapped children studied 124 were 
assessed as being best placed in day training taking 
local conditions and their social position into account. 
The extent to which they were receiving it are set out 
in TABLE 2.3.7. Only 49X of children qualifying for such 
day care were actually receiving it. This was because 
either the parents were working and so could not take a 
child to a centre every day or that the 2 centres 
providing such care were too far away from their place 
of residence. 
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TABLE 2.3.7. PROVISION OF DAY TRAINING FOR 
SUITABLE MENTALLY RETARDED CHILDREN. 
================================================ 














DAY CARE 40 23 63 
============== =========~ ==========:========== 
TOTAL 95 29 124 
================================================ 
( > = Those mentally retarded children suitable for day 
care but attending normal schools. 
2.3.6. SUMMARY OF RESULTS 
2.3.6.1 Spastic quadriplegia is the commonest category of 
cerebral palsy encountered. 
2.3.6.2. Asphyxia is the major acertainable cause of 
spastic quadriplegia. 
2.3.6.3. Severe and profound mental retardation and 
seizures are frequent accompaniments of spastic 
quadriplegia. 
2.3.6.4. In a developing world setting the facilities for 
coping with the problem of severe handicap are 
very inadequate. 
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2.4. DISCUSSION. 
2.4.1.Type of Cerebral palsy 
The distribution of the types of cerebral palsy in this 
survey was very striking with 83Y. being spastic of which 
57Y. were quadriplegics. Less common were the hemiplegics 
C21Y.> with the diplegic C5Y.) and athetoid C3Y.) groups 
being surprisingly small. 
The difficulties inherent in this type of study have 
been emphasised by Pharoah and McKinlay (1986). They 
note that even in developed countries the detection or 
ascertainment of cases of cerebral palsy is often 
incomplete. This is evidenced by the apparent increase 
in prevalence with age. This occurs because with time 
more handicapped children come forward for help and are 
so identifi~d. 
A lack of uniformity in classifying types of cerebral 
palsy also leads to difficulties in maki~g comparisons. 
These problems are compounded by the frequent difficulty 
in making a clear clinical distincton between 
quadriplegia and diplegia. This subjectivity has been 
emphasised by Jarvis et al (1985). In a study of 
cerebral palsy in Newcastle they avoid the term diplegia 
and use quadriplegia when all 4 limbs are affected and 
paraplegia when only the legs are affected. Rantakillio 
and Von Wendt (1986) also avoid the term diplegia. 
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The types of cerebral palsy from a number of published 
studies including the present report are compared in 
Table 2.4.1. 
The present study is striking in having the highest 
proportion of spastic quadriplegia (57Y.) of these 
studies. The reports from Nigeria (lzuora and Oroko 
1981> , Newcastle (Jarvis et al 1985) and Finland 
<Rantakillio and Von Wendt 1986) also have relatively 
high proportions of quadriplegics. However both 
Rantakillio and Jarvis avoid using the category diplegia 
and in doing so possibly overload the quadriplegic 
group. Furthermore Rantakillio and Von Wendt used small 
numbers <47). Although the study from Tanzania has a 
particularly low percentage of quadriplegics, it has the 
highest proportion <74Y.) of diplegics and quadriplegics 
combined of any study. This may reflect the diagnostic 
difficulty referred to above. 
There are possible explanations for the high proportion 
of quadriplegia in the present study. Diagnostic error 
may have occured with some diplegics being assigned as 
quadriplegics. The level of experience and expertise of 
the two doctors carrying out the assessments would make 
large scale errors of this sort unlikely. Furthermore 
wrong assignment of dyskinetics as spastic quadriplegics 
is extremely unlikely due to the striking clinical 
features. 
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TABLE 2.4.1. TYPES OF CEREBRAL PALSY IN PUBLISHED STUDIES 
TYPES OF CEREBRAL PALSY : COMPARATIVE STUDIES. 
============================================================================================================= 
Place IPRESENT lFINLND lSEATTLE ISWEDEN :CAPE TOWN IFINLND lW.AUSTRALIA lNISERIA :TANZANIA lNEWCASTLE l 
Date l81-B6 l 05 l 82 154-70 : BO 166-83 : I 78-79 l 83 : 60-75 
No. : 1. : 2. I 3. : 4. : 5. : 6. : 7. 8. 9. 10. 
============:========1=======1========:=======:==========:=======:============:========1=========:==========: 
SPASTIC x x x x x x x x x x 
QUADRPLEGIA : 57 36 17 3 14 40 24 37 10 52 
DIPLEGIA I 5 16 19 33 25 II 25 11 64 I- II 
HEl'IIPLEGIA I 21 30 17 36 29 : : 34 24 20 6 32 I 
------------:--------:-------i--------:-------1----------:-------:------------:--------1---------:----------: 
MIXED 7 I 11 10 I - s I 16 4 2 I I I 
------------:--------:-------:--------1-------:----------:-------:------------:--------:---------:----------: 
ATHETOID 3 : 12 : 10 4 18 I 26 s 2 : 12 4 
------------~--------~-------:--------:-------:----------:-------:------------:--------:---------:----------1 
HYPOTONIC 6 l 16 6 : - 7 I 13 4 
------------:--------:-------:--------:-------:----------:-------:------------:--------1---------1----------: 
OTHER 7 3 8 3 : - 10 10 
============:========:=======:========i=======:==========:=======:============:========l=========l==========l 
N = : 211 I 69 l 142 l 560 309 I 47 899 I 104 I 50 : 325 
============================================================================================================= 
l<ey~ 
1. Present Study 
3. Holi 1982 
5. "olteno & Arens 1980 
7. Blair & Stanley 1982 
9. Makwabe and "gone 1984 
2. Von Wendt et al 1985 
4. Hagberg et al 1975 
6. Rantakillio & Von Wendt 1996 
8. Izuora & Oroko 1981 
10. Jarvis et al 1985 
----------------------------~--------------------
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With such a hospital based survey a certain bias could 
operate in selecting more severely affected cases. The 
disproportionate number of mentally retarded children 
amongst the cerebral palsy patients is very suggestive 
of this bias. The parents of handicapped children attend 
hospital in order to receive physical therapy and to be 
put in touch with social services, particularly single 
care grants. Spastic quadriplegics tend to be much more 
disabled than diplegics or dyskinetics and as such are 
more likely to attend hospital and so be over-
represented. On the other hand the organisation of 
health and welfare services in the area is such that 
the hospital is the only satisfactory point of first 
contact with the supporting services. Parents in seeking 
help for their handicapped child, will first attend 
hospital and then be referred to other health and 
welfare services as necessary. Thus a hospital survey 
should identify most handicapped children who seek help 
and only miss those who need no help. Studies from 
developed countries rely on domicilliary follow up which 
excludes this type of bias. The clinical impression of 
the author is that spastic quadriparesis is very 
strongly represented amongst the handicapped children 
attending the health services. 
It remains a strong possibility that together with 
Nigeria and possibly Tanzania the study area does in 
fact have an unusually high prevalence of spastic 
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quadriplegia. 
A further perspective on this problem is to be gained 
from Table 2.4.2. which summarises the types of 
cerebral palsy diagnosed at follow up in studies of 
the neurodevelopmental sequelae of asphyxia associated 
with consequent hypoxic-ischaemic encephalopathy <HIE>. 
The leading category was spastic quadriparesis with 
others being much smaller. This high ratio is to be 
compared to the much smaller proportion in the general 
cerebral palsy population as set out in Table 2.4.1. 
Thus it might be expected that in a community where 
asphyxia is prevalent the pattern of cerebral palsy 
would be biased toward spastic quadriparesis. 
CHAPTER 2 HANDICAP IN CISKEI PAGE 28 
TABLE 2.4.2. TYPE OF CEREBRAL PALSY AFTER DOCUMENTED HYPOXIC-ISCHAE"IC ENCEPHALOPATHY 
================================================================================================= 
AUTHORS I GA I N TYPES OF CP I X ) 
SPASTIC lATHETOID IMIXED IATAXIC 
!Quadriplegia IDiplegia IHe1iplegia I 
=========================:====:======'=============:=========:===========:=========:======·====== 
Brown el al 1974 I Alll 22 36 22 18 9 l 14 
Mulligan et al 1980 : All: 10 20 30 10 10 : 30 
Ziegler et al 1976 136+NI 13 30.5 7.7 15.4 15.4 I 7.7 15.4 
Robertson ~ Finer 1985 ITersl 20 70 15 5 10 
Levene et al 1986 ITerml 6 50 33 lb 
Fitzhardinge et al 1981 lTerel 26 65 3.8 27 4 
"ulligan et al 1980 1Ter1I 5 40 20 20 : 20 
===================================================-============================================= 
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2.4.2. Aetiology of Cerebral Palsy 
It is recognised that the method of determining the 
aetiology by history, used in this study cannot be as 
accurate as the perusal of detailed perinatal records. 
Due to the situation in which this study was conducted 
this was not at all possible. Nevertheless it was 
usually possible to piece together the broad nature of 
the perinatal or post natal insult. 
The leading aetiological category in the present survey 
was asphyxia C33X>, the second, a large "unknown" 
category (32X>, the third TB meningitis <7.6X) and 
close thereafter prematurity (7.lY.) followed by lesser 
perinatal and postnatal causes. The presence of a large 
"unknown" category may be attributed to two factors. 
Firstly, the guardian of the child was sometimes not 
the mother, as in rural Xhosa society young children 
left in the care of elderly are frequently 
grandmothers. Very of ten these caretakers knew about 
the perinatal events, having been present themselves at 
delivery, but this was not always so. Their knowlege of 
postnatal events on the other hand was nearly always 
very good. The second possibility is that the cause is 
truly occult. 
Despite these possible sources of error the broad 
picture emerges that asphyxia is the leading cause of 
cerebral palsy in the survey area. 
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In this discussion it is freely assumed that the 
connection between perinatal asphyxia and later cerebral 
palsy is very frequently causative. It is however 
possible that infants with congenital cerebral 
abnormalities oould suffer both perinatal asphyxia and 
later cerebral palsy as parallel features rather than 
one being causative of the other. Nevertheless the 
review of the connection between asphyxia and cerebral 
injury in Chapter 3 provides evidence for a strong but 
not exclusive causative link between these two 
phenomena. 
It is of interest to speculate that the preconception of 
many health personnel as to the leading cause of severe 
handicap in such a developing community would be that TB 
meningitis, polio, cerebral vein thrombosis as result of 
dehydration and prematurity are the main culprits. 
Asphyxia in the term infant is unlikely to be perceived 
as a leading cause. 
Comparisons of causes of cerebral palsy from published 
studies are difficult in that diagnostic categories 
chosen by authors tend to be different. In Table 2.4.3. 
an attempt has been made to compare studies but some 
grouping of categories has had to be used. No other 
survey has shown such a high proportion of asphyxia 
(33%) as the present one. Izuora and Oroko (1981> from 
Nigeria report 31Y. and Makwabe and Mgone <1984) from 
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Tanzania state that 24Y. of cases of cerebral palsy were 
due to asphyxia. Their figures are unusual in that the 
proportion of post natal cases is much higher than in 
other studies which they attribute to prolonged 
seizues in children caused by cerebral malaria. If 
their postnatal group were excluded the proportion due 
to asphyxia would be large. Molteno et al <1980> in 
their report from Cape Town give a figure of 15Y. due to 
asphyxia but 
considerably 
the community served by their 
more affluent than that of the 
group is 
Ciskei. 
The large survey from Seattle by Holm <1982) used 
comparable diagnostic categories and found 
attributable to asphyxia. Noteworthy was 
only 13Y. 
the high 
proportion assigned by him to prenatal causes. 
There is a body of evidence and speculation that finds 
it difficult to accept asphyxia as a cause of cerebral 
palsy at all. This debate which is partly semantic will 
be reviewed in Chapter 5 (section 5.4.). 
The picture emerges in which asphyxia is an important 
association of cerebral palsy in Ciskei. Furthermore 
spastic quadriparesis is particularly common and is most 
usually caused by asphyxia. 
The implications of this are many. Firstly reference to 
Table 2.3.3. will show that the children with spastic 
quadriparesis tend to have the most severe degrees of 
associated mental retardation, with 47Y. being 
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TABLE 2.4.3. COMPARATIVE AETIOLOGY OF CEREBRAL PALSY. 
============================================================== 




l X I % % % X I X X X X % l Z l N 
1. CISKEI I 2 133 7 6 1 I 9 6 2 4 1 133 1211 
6. CAPE 
TOWN 
19 :15 19 3 : ------22-------- :20 1331 
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profoundly retarded. 
The community facilities available for such severely 
handicapped children and their parents in such a 
developing community are scanty. In the handicap survey 
136 children were assessed as being so severely 
physically, mentally and or socially disabled as to 
need residential care. None were in such care due to 
lack of facilities. Only 49Y. of those mentally 
handicapped children assessed as needing day care 
training were recieving it. 
Even in more affluent parts of the region, facilities 
may not be adequate. The author, in 2 studies of 
facilities in Cape Town for mentally retarded children 
found that while residential care was adequate that for 
day training was not. <Power 1977 and Friedlander and 
Power 1982>. It must be stated that the community 
surveyed in Cape Town was at a higher socioeconomic 
level than that in Ciskei. 








In a developing world situation handicap in 
children causes a disproportionate degree of 
distress to the guardians. 
The leading form of cerebral palsy is spastic 
quadriparesis with a high prevalence of coexisting 
mental retardation which tends to be profound. 
The social facilites to deal with the problem are 
scanty. 
The leading acertainable cause of cerebral palsy in 
this area is asphyxia. 
Efforts to prevent cerebral palsy in the developing 
world should centre on asphyxia. 
The relationship between asphyxia and cerebral 
palsy will be further explored in Chapter 3. 
CHAPTER 3 
ASPHYXIA AND CEREBRAL INJURY 
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3.1. INTRODUCTION. 
In the last chapter the importance of asphyxia as a 
cause of cerebral palsy in developing communities was 
noted. This chapter reviews the pathophysiological 
aspects of this association. The epidemiological 
aspects will be dealt with in Chapter 5. 
The distribution and type of cerebral injury after 
asphyxia! insults is reviewed starting with the effect 
of hypoxia on the rate and distribution of cerebral 
blood flow and how this may affect injury. Thereafter 
the possible effects of regional differences in 
cerebral metabolism on injury patterns are considered. 
Finally the actual patterns of cerebral injury as seen 
in both experimental animals and human asphyxiated 
infants will be reviewed. 
3.2. EFFECT OF CEREBRAL BLOOD FLOW AND METABOLISM ON 
INJURY PATTERNS. 
3.2.1. Hypoxia and cerebral blood flow 
Mild to moderate hypoxia is known to cause increased 
cerebral blood flow, possibly as a protective 
mechanism. This has been demonstrated in fetal lambs by 
Purves and James <1969) and in puppies by Duffy et al 
(1982). These changes were quantified in puppies by 
Casciotti et al (1979> who found that the increase 
began when arterial p02 fell below 35mm Hg. 
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More severe hypoxia causes myocardial depression with a 
consequent fall in cerebral blood flow. <Gardiner 
1980). As a result, ischaemia is added to hypoxia and 
the products of anaerobic metabolism accumulate rapidly 
in the form of brain adenosine monophosphate <AMP> and 
inorganic phosphate. This was shown by Lowry et al 
(1964) in mice after decapitation and by Hope et al 
(1984) and Younkin et al <1984> in asphyxiated human 









survival and adverse neurodevelopmental outcome. 
3.2.1.1. Failure of cerebral autoregulation. 




autoregulatory plateau of cerebral blood flow in 
newborn puppies in whom the cerebral blood flow remains 
fairly constant over a range of mean arterial blood 
pressures from 27 - 97 mm Hg. Lou et al <1979) and Lou 
(1980) carried out similar studies in human neonates and 
found that in the normal infant, as blood pressure falls 
cerebral arteriolar dilatation occurs maintaining 
cerebral perfusion. They found that in the asphyxiated 
infant this does not occur resulting in a situation 
where cerebral blood flow is directly dependant on blood 
pressure. The infant is thus prone to cerebral ischaemia 
with even small falls in blood pressure. 
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3,2.2. C@n§@quoneo~ of A §OY@roly roduood oorobr&l blood 
flow : 
3.2.2.2. Alteration in cerebral blood flow 
neurodevelopmental outcome. 
and 
Lou et al <1977, 1978, 1979> studied the cerebral blood 
flow of the human neonate using the 133-Xenon 
technique. They reported on 19 infants of whom 10 had 
been asphyxiated. The least severely affected inf ants 
had a mean cerebral blood flow of 40ml/100gm/min 
shortly after birth and the most severely affected had 
flows of < 20 ml/100gm/min. At follow up Lou et al 
(1979) found that 6 of the 10 infants who had had 
cerebral blood flows of less than 20 had cerebral 
atrophy on computed tomography <CT> scan or post 
mortem examination, whereas none of 9 infants who had 
had flows above 20 had cerebral atrophy. He found that 
only one infant who had a low flow developed normally 
while the majority of infants who had had higher flows 
were normal at follow up. He concluded that a cerebral 
blood flow of < 20 ml /100 gm /min places the infant at 
high risk of hypoxic-ischaemic brain damage. 
Skov, Lou and Pedersen (1984) re-evaluated the 15 
survivors of the above study at 4 years of age and 
found that the 5 survivors who had had low cerebral 
blood flow had significantly more abnormal neurological 
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signs as 
neonatal 
well as lower I.Q. They speculate that 
cerebral ischaemia may be the most important 
factor contributing to the development of single 
neurological handicap. 
Another study of cerebral blood flow on asphyxiated 
term inf ants showed a persistence of low cerebral blood 
flow for up to 4 days after the asphyxia! insult 
<Sankaran, Peters and Finer 1981). The method used was 
unusual in that cerebral blood flow was derived from 
data on the change in intra-cranial pressure and head 
circumference during a brief period of occlusion of 
both jugular veins. 
A fall in cerebral blood flow is a consistent finding 
in studies of severely asphyxiated human infants. With 
a falling cerebral blood flow the brain is likely to be 
injured and the pattern of injury will depend on the 
following factors 
3.2.2.2. Cerebral vascular anatomy. 
The anatomical development of the cerebral circulation 
in the fetus has been studied by Wigglesworth and Pape 
(1978). They studied cleared barium-gelatine injected 
preparations of fetal brains of various ages to 
establish the pattern of development of the cerebral 
vasculature. 














arrangement. The zone between the cortex, <supplied 
ventriculopetally by the cortical vessels>, and the 
underlying white matter, (supplied ventriculofugally>, 
remains as a boundary or watershed zone and as such is 
vulnerable to episodes of hypotension. During this same 
gestational period the degrees of anastomosis between 
the territories of supply of the 3 major cerebral 
arteries becomes more and more attenuated so that in 
the term fetus the vulnerable or .. watershed.. zones 
between their areas of supply are well established. 
Cerebral ischaemia will clearly exert its m~ximal 
adverse effect in these watershed zones. 
3.2.2.3. Areas of brain prone to reduction in blood 
flow in hypoxia-ischaemia. 
To study the pattern of alteration in cerebral blood 
flow in asphyxia, Vannucci and Duffy <1977) injected 
colloidal carbon black intravenously into neonatal dogs 
at various intervals after the onset of respiratory 
arrest. They found that the degree of reduction in 
cerebral blood flow increased with the duration of 
asphyxia and was greatest in the cerebral cortex and 
least in the brain stem. Myers <1972) in primate animal 
studies of prolonged partial asphyxia, using the 14c 
labelled antipyrine method of determining cerebral 
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blood flow, also found that the hemispheres of the 
brain rather than the brainstem structures, are more 
affected by alterations of blood flow. The areas of 
supply of the posterior cerebral arteries seem to be 
affected later and to a lesser extent than those 
supplied by the anterior and middle cerebral vessels. 
3.2.2.4. Differences in susceptibility to hypoxio-
ischaemic injury between gray and white matter. 
In the newborn infant the gray matter has a much higher 
blood flow than the white matter. In mild hypoxia 
Purvis and James (1969>, found that the increase in 
cerebral blood flow was much more marked in the gray as 
compared to the white matter. Not surprisingly, when 
cerebral blood flow falls in more severe hypoxia it is 
the white matter that suffers the more severe reduction 
in flow. Ment et al <1985) used the 14c iodoantipyrine 
method to asses cerebral blood flow in Beagle 
subjected to hypotension and found that the 




particularly of the parietal and temporal areas. 
The difference between white and gray matter in 
adaption of blood flow to hypoxia may partly explain 
the known susceptibility of white matter to hypoxic 
insult in the perinatal period. 
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3.2.2.5. Studies of human neonatal cerebral blood 
flow in response to hypoxia. 
There have been a number of studies trying to establish 
the pattern of alteration of cerebral blood flow in 
term asphyxiated human infants. Volpe et al (1985) used 
positron emission tomography which makes tomographic 
cuts after an I.V. bolus of radioisotopic <O 15) water. 
They found that in infants only very mildly affected, 
blood flow to the caudate nucleus and thalamus was 
similar to that to the cortical areas. Furthermore the 
blood flow to the gray matter of the cortex was double 
that to the white matter. The cortical area with the 
highest flow was the Sylvian area. In severely 
asphyxiated inf ants there was a decrease in the blood 
flow to the parasaggital regions of the cortex, which 
was usually symmetrical and more noticable posteriorly. 
The caudate nucleus, ventral pons and Purkinje cell 
layers of the cerebellar cortex were also markedly 
affected. One infant died and at post mortem 
examination showed a bilateral parasagital softening of 
the parietal lobes. These findings are similar to 
those of Amiel-Tison (1973) with regard to the 
distribution of the neuropathological lesions at post 
mortem. 
The balance of evidence from animal and human studies 
is that in hypoxic-ischaemic insults in the term infant 
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the areas of the brain that suffer the greatest 
reduction in blood flow are those of the cerebral 
cortex and particularly the associated white matter. 
3.2.3. The effect of regional differences in brain metabolism 
on the pattern of hypoxic ischaemic cerebral inJury. 
The distribution of asphyxia! injury to the neonatal 
brain is related not only to the pattern of blood 
supply but also to the pattern of metabolic activity of 
various parts of the brain. 
Hopkins et al <1980) in histochemical studies have 
demonstrated a lower density of the enzymes of 
oxidative phosphorylation, 
dehydrogenase, in immature as 
such as succinic 
compared to mature 
brains. They also showed that these enzymes display 
regional differences within the brain in that the 
phylogenetically older parts of the brain have higher 
levels than the phylogenetically newer parts. Thus the 
vermis of the cerebellum has higher levels than the 
lateral lobes and the basal ganglia have higher levels 
than the neocortex. 
Duffy et al (1982> have studied regional brain 
metabolism and found that gray matter consumes more 
glucose than white matter and that "caudal" <mainly 
basal ganglia) gray matter consumes more glucose than 
cortical gray matter. 
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It would be expected for example that the higher the 
glucose consumption of an area of the brain, the more 
vulnerable it would be to hypoxia-ischaemia in which 
the utilization of substrate is accelerated and its 
delivery curtailed. The pattern of injury that could 
be expected in hypoxia-ischaemia on the basis of these 
metabolic differences would mainly be to the gray 
matter of the basal ganglia and brain-stem rather than 
to the cortex, and different to that attributable to 
the accompanying reduction in cerebral blood flow. As 
will be seen in the next section the actual pattern of 
neuropathological injury is usually a combination of 
the patterns predictable from blood flow changes and 
from metabolic differences. 
3.3. NEUROPATHOLOGICAL APPEARANCES OF HYPOXIC-ISCHAEMIC 
CEREBRAL INJURY. 
The actual pattern of cerebral injury seen 
neuropathologically in neonates who have experienced 
asphyxia has been examined in a number of ways. Several 
primate models have been used by Myers and his co-
workers <Myers et al 1969, Myers 1972> while the 
clinical and neurohistological findings in human 
aphyxiated neonates have been examined by a number of 
authors. 
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3.3.1. Neuropathology in animal models of perinatal 
hypoxic-ischaemic injury. 
Myers (1972> compared two models of asphyxia, namely 
total aspyhyxia and prolonged partial asphyxia. In 
total asphyxia the cord of newborn monkeys was clamped 
and effective breathing prevented by placing a saline 
filled rubber hag over the infant's head. In prolonged. 
partial asphyxia the intrauterine fetus was subjected 
to hypoxia-ischaemia by obstructing the maternal 
arterial blood supply to the uterus and hence to the 
placenta by means of abdominal aortic banding. Further 
details of these models are given in Chapter 4. 
3.3.1.1. Total asphyxia. 
The pattern of neuropathological damage reported by 
Myers in fetuses which had experienced periods of total 
asphyxia was consistent. The following structures were 
involved in order of frequency after asphyxia! periods 
lasting from 10-13 minutes : 
Inferior colliculi. 
Superior olives. 
Sensory nuclei of V. 
Gracile and cuneate nuclei. 
Medial and spinal vestibular nuclei. 
Posterior and lateral ventral thalamic 
nuclei. 
When the asphyxia! period was greater than 16 minutes 
the neurohistological damage extended as follows : 
Thalamus. 
Lateral brainstem tegmentum. 
Brainstem motor nuclei. 
Spinal cord. 
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It is very striking that the cerebral cortex is 
virtually not involved in the damage caused by this 
type of asphyxia. 
He showed that the most vulnerable areas are those with 
the highest blood flow as determined by 14C antipyrine 
emission studies. 
3.3.1.2. Partial asphyxia. 
Myers found that partial asphyxia on the other hand 
produced a very different pattern of neuropathological 
damage. The brunt of damage fell on the cortex and 
basal ganglia and with very little brainstem 
involvement. 
He reported a spectrum of injury which ranged from 
total necrosis of both hemisheres to limi~ed damage of 
the middle third of the precentral gyrus. The former is 
usually associated with early death and the latter with 
adult survival and mild cerebral palsy. Involvement of 
the basal ganglia may occur alone or more usually 
together with cortical injury. Myers reports that the 
brain stem involvement is uncommon but may occur if 
episodes of total asphyxia are superimposed upon 
episodes of partial asphyxia. 
The group of Bondareff et al (1970> and Brann and Myers 
(1975> using a different model of prolonged partial 
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asphyxia produced asphyxia in 8 pregnant Rhesus monkeys 
at the 157-162 day stage of gestation. Maternal 
~ 
hypotension · of < 75 mm Hg was produced by means of 
halothane anaesthesia and maintained for 1-5 hours. The 
infants were then delivered by caesarian section. The 
infants required active resuscitation with artificial 
ventilation. They all developed evidence of 
encephalopathy and the mean survival time was 46.7 
hours. At post mortem they exhibited cerebral swelling 
of various degrees of severity. Six had areas of 
cortical softening which in every case involved the 
middle third of the paracentral region. Four 
additionally had softening in the posterior parietal 
and occipital regions. 
The basal ganglia, especially the head of the caudate 
nucleus, were affected in all cases, whilst the 
thalamus and cerebellum was affected in 5 of the 8 
infants. The brain stem, medial uncus and hippocampus 
and the medial portions of the temporal and occipital 
lobes were not affected. 
Conclusion Primate studies of asphyxia show two 
different patterns of brain injury depending on the 
type of insult. Total asphyxia produces injury mainly 
to the brain stem whilst prolonged partial asphyxia 
produces injury primarily to the cortex and basal 
ganglia. 
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3.3.2. Neuropathology after asphyxia! injury in human 
infants. : 
Amiel-Tison <1973) found that the gross pathological 
appearance of the brain after asphyxia! death in term 
neonates was of brain swelling with consequent 
flattening of the convolutions, narrowing of the sulci 
as well as uncal and tonsillar herniation. Pryse-Davies 
and Beard <1972) found similar gross appearances. 
Ami el-Tison <1973) noted that histologically the 
brainstem, basal ganglia and cerebellum were nearly 
always involved while the cortex was affected to a 
progressively greater degree with increasing severity. 
She noticed that cortical damage was worst in the 
depths of the sulci, that the hippocampal area was 
always the most severely affected part of the brain. 
The affected tissue showed swelling of the cytoplasm of 
the neurones with pyknosis and variable karyorrhexis. 
At later stages there was dissolution and glial 
replacement. 
Hill and Volpe <1981) have combined clinical, CT, 
isotope scan, and postmortem histological data from 
asphyxiated infants and suggest that the major cerebral 
lesions associated with hypoxic-ischaemic injury in the 
perinatal period are as follows : 
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3.3.2.1. Selective neuronal necrosis -
This involves the cerebral cortex, Purkinje cells of 
the cerebellar cortex, thalamus and brain stem. When 
examined some time after the acute episode, typically 
there is neuronal loss with astrocytosis and smooth 
gyral atrophy of the cortex <ulegyria). The long term 
clinical picture is of mental retardation, seizures, 
spastic motor defects and bulbar disorders such as poor 
sucking and difficulty with swallowing. Technetium 
brain scan shows increased uptake over the cerebral 
hemispheres. 
3.3.2.2. Parasaggital cerebral necrosis -
This involves necrosis of cerebral cortex and adjacent 
subcortical white matter in the parasaggital areas of 
the cortex. The lesion seen later involves cortical 
atrophy and gliosis in the affected area. These are 
thought to be watershed lesions as a result of severe 
systemic hypotension. Technetium scans in the neonatal 
period show increased uptake in the parasaggital areas. 
3.3.2.3. Status marmoratus 
This involves neuronal necrosis in the caudate nucleus, 
putamen and globus pallidus. The clinical picture is 
later development of rigidity and choreoathetosis. 
Technetium scan in the neonatal period shows increased 
uptake in the basal ganglia. 
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3.3.2.4. Periventriculal leukomalacia -
The lesion is in the white matter adjacent to the 
external angle of the lateral ventricles. There is 
variable atrophy of tissue lateral to the ventricles 
leading to an appearance of ventricular dilatation. The 
lesion is thought to be a watershed phenomenon between 
the penetrating branches of the anterior and middle 
cerebral arteries. Hypotension and impaired 
autoregulation 
the critical 
of the cerebral circulation seem to 
factors in its development. It is 
be 
a 
particular feature of asphyxia in the preterm infant in 
whom the overlying cortex tends to be spared. The 
clinical correlate is spastic diplegia with relative 
sparing of the intellect. This type of lesion is not 
frequently seen in the term infant. 
3.3.2.5. Focal ischaemic brain damage -
In term infants this involves the occlusion of single 
major arteries or their main branches with resulting 
cerebral infarction. The middle cerebral artery is most 
often involved. The common cause is embolization as a 
result of disseminated intravascular coagulation 
secondary to sepsis. The lesion seen later involves a 
focal cystic lesion with or without dilatation of the 
lateral ventricles. Porencephaly occurs if 
communication between a cyst and the lateral ventricle 
exists. Both the CT and Technetium scans show the 
lesions in the neonatal period. The late sequelae of 
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this type of lesion is mental retardation and/or focal 
motor defects such as hemiplegia. 
3.3.3. Unifying models of neuropathological injury. : 
Brann and Myers (1975) note the close similarity 
between the injury patterns in the brains of human 
infants dying of hypoxic-ischaemic injury and those of 
their primate model of prolonged partial asphyxia. They 
suggest it is likely that the pathogenetic mechanisms 
are similar. 
3.4. PATHOLOGICAL APPEARANCE OF NEONATAL HYPOXIC-ISCHAEMIC 
BRAIN INJURY AS REVEALED BY NEWER IMAGING TECHNIQUES. 
The new imaging techniques provide some information 
about pathological damage sustained by asphyxiated 
inf ants who do not come to post mortem. 
3.4.1. Computed tomographic appearances 
The computed tomographic <CT> appearances following 
perinatal asphyxia in term inf ants have been studied by 
a number of authors including Flodmark et al <1980>, 
Shewmon et al <1981>, Fitzhardinge et al (1981), 
Lutschg et al <1983>, Voorhies et al (1984) and more 
recently Lipp Zwahlen et al <1985). Initially the 
resolution of the instruments was poor and the 
importance of the timing of the scan was not fully 
appreciated. Once these problems were overcome a fairly 
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consistent pattern of CT appearances has been reported. 
In an affected infant, scans done in the first few days 
after delivery show compressed ventricles and 
widespread decreased brain tissue density typical of 
cerebral oedema. Haemorrhages are seen in a minority. 
Periventricular hypodensities are sometimes seen at 
this early stage. 
The greater value of scanning at 2-4 weeks after birth 
has been well demonstrated by Lipp Zwahlen et al 
(1985). They found that in infants later found to be 
neurologically normal, the periventricular densities of 
scans performed in the first few days cleared, whereas 
in those who were ultimately neurologically abnormal, 
the periventricular hypodensities became symmetrical in 
distribution and very clearly demarcated. The latter 
extended into the subdural white matter and often 
reached as far as the cortex. 
These authors report that when the scans are repeated 
at 3 or more months after birth, the hypodensities seen 
at 2-4 weeks had either disappeared due to glial 
proliferation or transformed into permanent cystic 
lesions. At this stage dilation of the ventricles is 
often seen. The cystic lesions may seem to communicate 
with the ventricles. This loss of periventricular 
tissue is felt by Lutschg (1983) to be the equivalent 
of the pathological finding of periventricular 
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leukomalacia. 
Earlier authors did not comment on basal ganglion or 
thalamic changes with CT scanning. However Lipp Zwahlen 
et al <1985) report that the basal ganglia may show 
areas of hypodensity in scans performed at 2-4 weeks of 
age. A scan done at 11 months of age showed high 
density in the thalamus which they felt was the 
radiographic equivalent of status marmoratus. 
3.4.2. Ultra-sound <US> appearances : 
Another recent tool for the assesment of brain injury 
in hypoxic-ischaemic encephalopa~hy is ultrasound <US>. 
This has great advantages over CT scanning in that it 
is less invasive, more portable, quicker to obtain, 
less disturbing for the infant and the cost of the 
equipment much lower. 
Siegel et al (1984), Martin <1983) and Slovis (1984) 
have reported consistent US appearances in aspyxiated 
infants. Firstly they report small or non-visualisable 
ventricles typical of cerebral oedema. Secondly they 
report diffuse cerebral echoes thought to be due to 
widespread ischaemic changes or cerebral oedema which 
US cannot easily discriminate. Thirdly they describe 
focal parenchymal echoes which are thought to be due to 
ischaemia resulting from single major vessel 
infarction. Fourthly they saw periventricular echoes. 
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Martin <1983) and Slovis <1984) found that over 2-4 
weeks these echogenic areas tend to develop a cystic 
appearance equivalent to periventricular leukomalacia. 
It is of note that the cystic lesions are not seen as 
such on CT scanning; their equivalent being the 
ventricular diatation seen at 2-4 weeks on CT scan. 
The US may have a disadvantage in that it tends to 
underestimate cerebral injury. The above authors report 
that in cases which later came to post mortem the US 
had underestimated the extent of cerebal damage. Siegel 
et al C1984) found that of 32 cases of hypoxic-
ischaemic encephalopathy, all but 2 showed small or 
non-visualised ventricles, but only 20 showed abnormal 
echoes. Ten out of the 32 cases died of whom all had 
had abnormal US scans and only 10 out of 22 survivors 
had abnormal echoes on scan. 
A further role for US scanning in asphyxia is to asses 
cerebral vessel pulsation in, and hence detect, 
infarcted areas of brain. Hill et al (1983) have 
described 4 asphyxiated infants with maJor focal 
ischaemic lesions on CT scan who had equivalent 
echodense areas on US performed at the same time. In 
these major lesions the pulsation of the major arteries 
could be seen and assesed in "real time". Within the 
echodense areas the vessel pulsation was visibly 
decreased. Voorhies et al (1984) also noted decreased 
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vessel pulsation bilaterally in the echodense areas 
associated with HIE. 
3.4.3. Digital intravenous angiography : 
Voorhies et al (1984) have described the use of digital 
intravenous angiography <DIVA> in the investigation of 
asphyxiated neonates. This is a new and relatively non-
invasive technique which involves an intravenous 
injection of a contrast medium and the taking of rapid 
serial radiographs which are later subjected to 
computer analysis to produce images of the vessels. 
Both the arterial and venous phases can be visualized. 
They studied 6 severely asphyxiated term infants with 





of severe cerebral injury as described 
DIVA was carried out in the first week of 
life and the significant finding was in the venous 
phase of the examination in which saggital sinus 
thrombosis was found in 5 infants. Of these, 3 also had 
straight sinus thrombosis and of these, one also had a 
transverse sinus thrombosis. In the arterial phase 2 
had internal or common carotid artery thrombosis. It is 
known that in asphyxia the synthesis of prostacyclin 
<PG I2> is reduced and that of Thromboxane T2 increased 
<Farber 1981>. The latter may lead to a state of 
hypercoagulability. The occurence of venous occlusion 
may mean that venous infarction may add to the 
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prexisting hypoxic and ischaemic damage. Voorhies et al 
<1984) postulate that the frequent finding of 
haemorrhagic cerebral infarcts at post mortem may be 
related to venous infarction as illustrated by DIVA. 
The group of infants studied were unusually severely 
affected as 5/6 died and the sole survivor was a severe 
spastic quadriplegic with mental retardation. 
This technique has begun to reveal the contribution of 
venous infarction to asphyxia! brain injury. This is an 
area that thus far has been little discussed. 
3.4.4. Other Techniques 
A number of 
characterize 
other techniques have 
the cerebral state of 
been used to 
the asphyxiated 
neonate. These include the electroencephalogram <Rosen 
1967, 1973, and Archbald et al 1984) and visual evoked 
potential <Woods 1983>. The use of these techniques may 
also be helpful. 







Hypoxic insults are associated with dramatic 
falls in cerebral blood flow leading to 
ischaemia which is exacerbated by subsequent 
cerebral oedema. 
The impact of ischaemia on the brain varies 
with the type of insult. Total asphyxia 
results in damage predominantly to the brain 
stem whereas prolonged partial asphyxia 
results in damage mainly to the cerebral 
cortex and basal ganglia. 
The white matter is more vulnerable to 
ischaemia than is the gray matter. 
Metabolic differences also determine the 
injury pattern after hypoxic-ischaemic 
insults. The hind brain is more vulnerable 
metabolically than is the fore brain and the 
gray matter is more vulnerable in this sense 
than the white matter. 
The final pattern of injury is a blend of 
these opposing tendencies with the length and 
type of insult determining the precise pattern 
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The pattern of cerebral injury seen in human 
asphyxiated infants is fairly well reproduced 
in animals by the model of prolonged partial 
asphyxia. 
The neuropathological patterns of brain 
injury after hypoxic-ischaemic insults can be 
correlated with the clinical type of 
resulting neurological deficit, as well as 
with CT and ultra-sound findings. 
When a community shows a high incidence of 
mentally retarded spastic quadriplegia it is 
reasonable to assume that in the absence of a 
common post natal cause the aetiology is 
perinatal hypoxic ischaemic insults. This 
would appear to be the case in Ciskei and 
probably in many similar areas. Further 
studies on the distribution of type and 
aetiology of cerebral palsy in developing 
areas are needed to confirm this. 
CHAPTER 4 
CLINICAL CRITERIA OF ASPHYXIA 
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4.1. CHANGING CONCEPTS or ASPHYXIA. 
A problem facing any proposed study relating to 
asphyxia is the lack of clarity as to which parameters 
should be used to define it. This stems in part from 
changing concepts of asphyxia. Previously it was felt 
that the term applied to any infant who failed to 
establish adequate spontaneous respiration at birth. It 
was recognised that there was a long and divergent list 
of possible causes for this. More recently the concept 
has narrowed down to include only the consequences of 
hypoxic and/or ischaemic insults in pregnancy and/or 
labour. This concept would not for instance, include 
an infant failing to establish respiration as a result 
of maternal sedation. The need to find valid markers 
of hypoxia/ischaemia for the purpose of defining 
populations of asphyxiated inf ants has lead to the use 
of an increasing number of such markers and more 
recently to the use of "packages" of criteria which 
include an ever growing list of new investigations. 
This chapter aims to review the existing literature on 
the criteria used for defining neonatal asphyxia in the 
clinical situation. Such a review starts with 
consideration of the basic pathophysiology of fetal 
hypoxia-ischaemia and then goes on to consider 
individual and group measures of asphyxia. 
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4.2. PATHOPHYSIOLOGY OF FETAL HYPOXIA-ISCHAEMIA. 
Most of the measures of fetal and neonatal well-being 
such as fetal heart rate, fetal pH and Apgar score for 
example are functions of the altered pathopyhsiological 
state of the fetus. Before considering their validity 
it is useful to look at the pathophysiological process 
as a whole. Animal models and human studies will be 
reviewed. 
4.2.1. ANIMAL MODELS OF ASPHYXIA 
A good deal of experimental work has been done on 
animal models of asphyxia and while it is accepted that 
even the best is not an exact replica of human fetal 
asphyxia, a great deal has been learned from their use. 
4.2.1.1. Total asphyxia : 
A significant contribution to the knowlege of the 
pathophysiology of asphyxia was made by Myers et al 
(1972> who reported the cardiovascular, respiratory, 
metabolic and neuropathological consequences of total 
asphyxia in term monkey fetuses. In this model, as 
mentioned in Chapter 3, fetuses were prevented from 
breathing air at birth by placing a thin saline filled 
rubber sac over the fetal head. The placental 
circulation was stopped by immediate cord clamping. The 
newborn monkeys were subjected to various periods of 
total asphyxia before resuscitation was initiated. 
During this period the heart rate, blood pressure, 
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blood gases and respiratory efforts were monitored. 
It was found that the blood pressure rose very briefly 
after cord clamping and then fell only to rise again at 
2 minutes as a result of catecholamine release. This 
rise peaked at 3 minutes, and was followed by a gradual 
fall to a, low of 2-3 mm Hg by about 13 minutes. At 
blood pressures of less than 5-10 mm Hg a state of 
severe cerebral and myocardial underperfusion exists. 
The heart rate mirrored the changes in blood pressure 
in that after a brief period of no change it fell 
sharply and subseqently rose with the catecholamine 
surge. It fell thereafter to a fixed value of 60 per 
minute in which state there was very little effective 
cardiac output but basal ECG activity continued for a 
long period. 
The arterial p02 fell precipitously to 4-7mm Hg by 1.5 
minutes and remained as such until resuscitation. Such 
rapid change was not seen in the acid base parameters. 
The pH fell steadily at 0.04 units per minute to reach 
6.7 at 13 minutes. The base excess rose to -15 to -20 
in a steady linear fashion over the same period. 
The normal respiratory efforts which were present for 
1-2 minutes were followed by a period of primary apnoea 
lasting to the 6th minute when strong "terminal" 
gasping began. This continued until the 14th minute. It 
is noteworthy that terminal gasping continued even at a 
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time when the circulation had virtually ceased, the 
metabolites entirely anaerobic and the acid-base status 
grossly abnormal. 
Neuropathological changes could be found in the brain 
in fetuses after 10 minutes of total asphyxia. Those 
fetuses who experienced more than 25 minutes of total 
asphyxia regularly died of intractable cardiac failure 
due to hypoxic myocardial inJury. 
4.2.1.2. Prolonged partial asphyxia 
Myers <1972> has used a another model of asphyxia 
which, as discussed in Chapter 3, he feels is more akin 
to the situation of the asphyxiated human infant. The 
fetus is exteriorised, cannulated and returned to the 
uterus. It is then subjected to the consequences of 
banding the maternal abdominal aorta to produce various 
mean aortic pressures distal to the banding. Myers 
(1972> and Brann and Myers (1975) found that mean 
aortic pressures of between 70 and 50 mm Hg could be 
tolerated for prolonged periods with only minor 
evidence of fetal disturbance, while pressures below 40 
mm Hg lead to progressively severe signs of fetal 
distess. These included falling fetal heart rate, blood 
pressure, p02 and pH and a rising pC02 and base excess. 
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4.2.1.3. Fetal heart patterns and acidosis in hypoxia-
ischaemia : 
In human subjects Caldeyro-Barcia et al (1952) 
described the relationship between uterine contractions 
and the associated variations in fetal heart rate. They 
categorized the fetal heart pattern as: Type 1 dips 
which are synchronous with the peak of uterine 
contraction and which are thought to be due to head 
compression altering cerebral blood flow. Slow waves 
are seen on electroencephalographic recording during 
this type of dip. These dips occur during 25-40X of 
uterine contractions after rupture of the membranes and 
cervical dilatation. 
Type 2 dips consist of fetal bradycardia during uterine 
contraction but reaching a nadir 30-60 seconds after 
the contraction is completed. The delay represents the 
time needed for the depletion of intervillous space 





primate model of intrauterine hypoxia-
Myers found that the fetal bradycardia is 
by falls in the fetal blood pressure. As 
the severity of the dips increases with progressive 
maternal asphyxia the acid base status deteriorates, 
the blood pressure falls further and eventually the 
heart rate and fetal blood pressure even between dips 
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are lowered. During severe dips, perfusion of the fetal 
brain and myocardium is seriously impaired. Myers found 
that type 2 dips begin to appear at a fetal pH of 7.10-
7.15 but that fetal brain damage does not occur at 
this pH level even after several hours exposure. On the 
other hand at pH levels below 7.00 fetal brain damage 
occurs regularly. The lower the pH and the longer the 
duration of the insult, the more likely brain damage is 
to occur. 
Myers observes 3 possible outcomes 
experimentally asphyxiated infant 
for the 
Mild asphyxia - pH > 7.10 and fetal blood oxygen 
content >1.5 volumes per cent. There is no evidence of 
subsequent neurologial abnormality or of histological 
evidence of brain damage. 
Intermediate asphyxia - pH 7.00-7.09. These infants 
have asphyxia that permits survival but with evidence 
of permanent brain injury. 
Severe asphyxia - pH< 7.00 and fetal blood oxygen 
content < 0.4-0.8 Y. lasting for several hours. These 
infants all die even if they are initially resuscitated 
and live for a few hours or days. They are unable to 
maintain a normal blood pressure and die as a result of 
hypoperfusion. At post mortem the brains show swelling 
and hemispherical necrosis. 
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-4.2.1.4. Conclusion: 
Myers' animal work is entirely compatible with findings 
in human asphyxia and produces quantitative data 
unobtainable from human work. 
4.2.2. HUMAN EQUIVALENTS OF ANIMAL MODELS : 
Both Althabe et al <1967) and Kublik et al <1969) 
found that Type 2 dips are associated with fetal 
hypoxia as measured by fetal scalp samples of capillary 
blood and tissue oxygen electrodes. 
4.2.2.1. Fetal Heart Patterns: 
A number of authors have demonstrated a close 
association between the occurence of Type 2 dips and 
depression of the neonate <Hon 1959>, Brady and James 
(1962), Kublik et al (1969) and Bissonnette <1975>. 
Painter et al (1978) found that in term infants the 
occurence of severe variable and late deceleration 
fetal heart patterns in labour showed significant 
association with abnormal neurodevelopmental outcome at 
1 year. 
There is a substantial basis for regarding severely 
abnormal fetal heart patterns as 
suggestive of fetal hypoxia. 
being highly 
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4.2.2.2. Fetal acidosis and neonatal depression : 
Beard et al (1967> found a good relationship between 
fetal scalp pH sampling taken within 30 minutes of 
delivery and the subsequent Apgar score of the infant. 
A scalp pH of <7.16 was usually associated with a 
depressed infant and a pH of >7.25 with a vigorous 
infant. pH values between these two were unreliable 
predictors of outcome. Hon and Khazin (1969) had 
similar findings. Both groups found that the 
relationship was only valid if the scalp sample was 
taken no longer than 30 minutes before delivery. 
4.2.3. CONCLUSION ON PATHOPHYSIOLOGY OF HYPOXIA-ISCHAEMIA : 
The interrelationship between fetal scalp pH, fetal 
heart rate patterns and fetal outcome are well 
established. The pH reflects the state of fetoplacental 
gas exchange. Fetal hypoxia will be reflected as 
metabolic acidosis which is a consequence of increasing 
anaerobic metabolism. The ischaemic stress of each 
uterine contraction leads to hypoxia of the myocardium 
and the brain. In an already compromised infant the 
additional stress is not well tolerated. The result is 
significant fetal bradycardia and a reduced level of 
neurological drive at birth. 
The clinical use of type 2 fetal bradycardia and fetal 
scalp acidosis to detect fetuses at risk of asphyxia is 
valid. 
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4.3. EVALUATION OF PARAMETERS CURRENTLY USED IN THE 
DEFINITION OF ASPHYXIA. 
4.3.1. General problems: 
An individual parameter of asphyxia has been considered 
useful if it correlates well with long term 
neurological outcome. Unfortunately the interpretation 
of studies evaluating these criteria have been 
bedevilled by a number of variables. These include 
Gestational age : 
Some studies have limited themselves to term infants 
while others have included data for all gestational 
ages. 
The neurodevelopmental criteria used to asses late outcome 
Established cerebral palsy, mental retardation, speech 
deficits, learning disabilities and a variety of other 
criteria have been used alone or in combination. Some 
studies have used very sophisticated intelligence and 
perceptual testing while others have not been clear as 
to what methods were used. Global statements such as 
"neurologically abnormal" have been used. 
Mortality 
Some studies specifically refer to death in the 
neonatal period while others refer to 1 st year 
mortality. Others do not define the period to whi~h 
their mortality refers. 
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Use of multiple criteria 
Many studies use a main parameter such as an Apgar 
score but also require one or more additional criteria 
such as encephalopathy or failure to achieve sustained 
respiration within a certain period. These additional 
criteria greatly alter the type of infant included in 
any study. 
Lack of Uniformity : 
Very many different criteria or combinations of 
criteria have been used in different studies. 
Amiel-Tison and Ellison <1986> in their review of 
studies of asphyxia recognize problem of definition and 
suggest that any new study of asphyxia must describe 
variables from (1) labour and delivery - signs of fetal 
distress; <2> the immediate newborn period - Apgar and 
need for resuscitation and (3) the neonatal period 
neurological features, including special investigations 
such as ultrasound, CT scan, nuclear magnetic 
resonance, EEG and brain stem auditory evoked response. 
To date studies have defined their cases in terms of 
only one or two of these criteria with resulting 
uncertainty as to what degree of insult the author is 
describing. 
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4.3.2. THE APGAR SCORE AS THE MAIN CRITERION OF ASPHYXIA : 
Prior to 1953 the methods used to asses infants who had 
experienced pre- or intra-partum hypoxia were not 
uniform and the contribution of Apgar C1953) was to 
provide a practical routine method of recording the 
condition of such infants at birth. Subsequent follow-
up studies have confirmed the usefulness of the Apgar 
score but have also pointed out its limitations. 
Those studies which used the Apgar score as the only 
criterion of asphyxia are set out in Table 4.3.1. The 
studies have been sorted first by gestation and then by 
incr~asingly severe Apgar criteria. "Term" has been 
taken to include those specifying at least 37 weeks 
gestational age or of birth weight greater than 2.5Kg. 
Where available the figures for controls with "good" 
Apgar scores, ie 7-10, have been included in brackets. 
It is noted that mortality and handicap ratios as 
compared to controls are high CX10-X50>. 
There is a crude agreement within these categories as 
to mortality and to the incidence of significant 
neurodevelopmental abnormalities in the survivors, but 
there are exceptions. The study by Dweck et al (1974) 
shows an overall mortality of 61~ which is much higher 
than other studies in its group. This study included 
ventilation at resuscitation and the use of alkali as 
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TABLE 4.3.1. STUDIES USING APGAR SCORE AS ONLY CRITERION OF ASPHYXIA. 
================================================================================================ 
AUTHORS l N l SA lCRITERIA FOR l"ORTALITYl OUTCOME X lFOLLOW UP 
lSELECTION X : SEVERE lOTHER lNORMALlMONTHS 
================================================================================================ 
Molteno 1976 l126 :ALL lAPGAR 1 =< 3 13 5.5 l83 l12 
Drage et al 1964 l 1123lALL lAPSAR 1 =< 3 11 - l1 
I 10.3) 
t4elson and Ellenberg 1981 l2764lALL lAPGAR 1 =< 3 17.6 1.B 184 
(1.8) !0.2) 
Nelson and Ellenberg 1979 l788 lALL !APGAR 5 =< 3 44 I 5.1 l51 l84 
Drage et al 1966 l148 lALL !APGAR 5 =< 3 ff 7.4 :12 
N~lson And Ellenberg 1979 l362 lALL !APGAR 10 =< 3 I 68 12.6 l19 l84 I 
---------------------------:----1----:--------------:---------J---------.------:------:----
Drage et al 1964 l878 :aw lAPGAR 1 =< 3 
l)2.5l 








: - : - :1 
l84 
---------------------------:----:----:--------------:---------.---------~---- :------:----
Drage et al 1966 l115 IBW lAPGAR 5 =< 3 
:>2.5: 







Thomson et al 1977 l 86 lTRM lAPGAR 5 =< 3 50 2.3 148 l9b 
10,0) I (0,0) 
Ergander et al 1983 l 76 ITRM !APGAR 5 =< 3 21 1. 7 14.0 158 124-48 
Drage et al 1964 l175 IBW !APGAR 5 =< 3 15 I - l - l 1 
!>2.5: (0.3) 
:--------------------------:----:----:--------------,---------,---------:------:------:----
Nelson and Ellenberg 1981 l127 IBW !APGAR 10 = < 31 34 
DMeck et al 1974 
1>2.51 (1,8) 
I 51 IALL !APGAR 1 =< 3 
l+IPPV & Alkali I 
61 
16. 7 l -
(0,4) 
6 : 6 
: - 184 
119 122-40 
============================================================================================ 
** = Neonatal survivors only. ln.n)= Figures for controls. 
TRM = Ten 
SEVERE= Significant neurodevelopmental abnormality. 
OTHER = Lesser degree of neurodevelopmental abnormality. 
SA = Gestational age. 
BW = Birth weight. 
APGAR t = Apgar score at 1 minute 
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additional selection criteria which will select more 
severely affected infants. The numbers in the study are 
small and the period to which mortality refers is not 
specified. The study of Thomson et al ( 1977> also 
showed a very much higher mortality than comparable 
studies and the reasons for this are not clear. 
Data from the US collaborative study <Drage et al 1964, 
Nelson and Ellenberg 1979 & 1981) had very large 
numbers, careful recording by outsiders of Apgar scores 
and high quality, long term follow-up. It is likely 
that this data will be used as standard reference 
material. 
Conclusions on Apgar score : 
Allowing for the factors mentioned above which make 
accurate numerical comparisons difficult, a few 
reasonable conclusions are possible from the data in 
these studies. 
4.3.2.1. A low Apgar score (0-3) is associated with a very 
-· 
considerably increased risk of mortality and long term 
neurodevelopmental abnormality in groups of mixed 
gestation as well as in term infants. 
4.3.2.2. The incorrect use of a low Apgar score as being 
synonymous with asphyxia has been the subject of a 
recent statement by the American Academy of Pediatrics 
<1986). They note that immaturity, maternal medication, 
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congenital malformation, cardiorespiratory disease and 
other non-asphyxia! factors may affect the score. A low 
score is not necessarily due to fetal hypoxaemia which 
is the essence of asphyxia. They conclude that to 
substantiate a diagnosis of asphyxia, a low Apgar 
score must be accompanied by other markers of fetal 
hypoxaemia such as metabolic acidosis. 
4.3.3. TIME TO SPONTANEOUS RESPIRATION AS A CRITERION 
OF ASPHYXIA. 
Table 4.3.2. below gives the details of a number of 
studies in which the time to spontaneous respiration 
was used as the only criterion of asphyxia. The figures 
reflect a severely affected group of infants with 
mortality from 18 to 33 Y. and abnormal long term 
neurodevelopmental outcome of 15-25Y.. It is of note 
that the outcomes in the studies are similar despite 
widely differing times to spontaneous respiration. 
It should be noted here that the need for endotracheal 
intubation with ventilation at birth is also not 
necessarily indicative of 
Steer <1986> found that 
intubation at birth had 
hypoxaemia. Lissauer and 
57Y. of inf ants requiring 
had neither an abnormal 
cardiotochograph nor placental arterial acidosis. The 
reasons for intubation in this group were related to 
factors such as meconium stained liquor, operative 
delivery or anaesthetic agents given to the mother. 
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TABLE 4.3.2. STUDIES USING TIME TO SPONTANEOUS RESPIRATION AS THE CRITERION FOR ASPHYXIA. 
======================================================================================================== 
AUTHORS l N : SA lCRITERIA FOR SELECTION:"ORTALITYl NEURODEVELOP"ENTAL lFOLLLOW UP 
OUTCOME X 
X :SEVERE lOTHER lNORMAL: KONTHS 
===========================:====:=====:======================:=========:=======:======·======:========== 
Scott 1976 :20 :All :NO RESP OR HEART BEAT l 30 25 45 :36-84 
:AT 1MIN OR TSR >20 MINl 
Desouza et al 1981 :26 :All lTSR > 10 MIN H 16 : 23 61 '24-60 
Mulligan et al 1980 l48 lTerm :IPPV FOR >1 MIN BEFORE: 18 15 67 60 
lSPONT. RESP. 
Svenningsen et al 1982 :30 :Teri :TSR > 30 KIN. 33 20 46 18 
Kappe and Kleiverda 1985 :20 lTer1 :TSR > 15 MIN. 60 20 20 60 
======================================================================================================= 
11 =Neonatal survivors only. 
Key : 
IPPV = Inter1ittent positive pressure ventilation. 
TSR = Ti1e to spontaneous respiration. 
SA = Gestational age. 
Note: Neurodevelopmental outcome·X - refers to the percentage of the whole group with that category 
of abnoraal neurodeveloaental outcome. 
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4.3.4. ENCEPHALOPATHY AS A CRITERION OF ASPHYXIA : 
The development of encephalopathy in an infant who has 
been at risk for asphyxia during pregnancy and labour is 
a fairly easily defined event and worth evaluating as a 
criterion of asphyxia. There have been a number of 
studies that have looked at the mortality and 
neurodevelopmental outcome of infants who have had an 
asphyxia related encephalopathic episode in the early 
neonatal period. Associated features have been used to 
assign the encepalopathy as asphyxial. These features 
have included abnormal fetal heart patterns, meconium 
stained liquor, low Apgar scores, the need for 
ventilatory assistance or acidosis at birth. The details 
of these studies are set out in Table 4.3.3. 
Two of these studies refer to infants of all 
gestational categories and the rest ref er to term 
infants. While the immediate mortality and long term 
neurodevelopmental abnormality rates are relatively 
high, the wide range (6.7-37Y. and 6-47Y.> points to the 
lack of uniformity in the selection criteria. 
Nevertheless one can draw some broad conclusions. It 
seems that an encephalopathic state associated with 
other asphyxia! markers reflects a 
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TABLE 4.3.3. STUDIES USING HYPOXIC-ISCHAEKIC ENCEPHALOPATHY PLUS OTHER FACTORS AS CRITERIA FOR ASPHYXIA. 
================================================================================================== 
AUTHOR l N : SA !CRITERIA FOR SELECTION:KORTALITYl NEURODEVELOPKENTAL !FOL UP 
: IN ADDITION TO HIE : X OUTCOKE X 
ISEVERE:OTHER INORMALIMNTHS 
===========================:====l====:======================t=========:======;======l======t====== 
Brown et al 1974 
Volpe 1976 
Ziegler et al 1976 
194 IAll :AP 1 < 3 OR AP 5 <5 22 
:FET DIS,IPPV ACIDOSIS: 
:SEVERE RDS, CERTAIN 
IANTE PARTUM DISORDERS I 
: 93 :All :AP 1 < 3 OR AP 5 < 5 
:IPPV, MSL, FETAL HRT 
IABN, 
I 90 :Ter1l"SL,FH ABN, AS 1 < 4 
:AS 5 < 61 ACIDOSIS, 













Sarnat and Sarnat 1976 : 21 :36+ IAP 1 =<5 OR AP 5 =<5 10 33 : --- 57 16-12 
!FETAL DISTRESS 
Finer et al 1901 : 95 :Ter1:AP 1 < 5 OR AP 5 < 5 6.7 14.b : 20 49 196 
:IPPV, HSL, FET HT ABN. 
Fitzhardinge et al 1901 : 65 :Ten:AP 5 < 61 MSL, FET HT 
IABN, IPPV > 2 MIN., 
Finer et al 1903 l 82 :Ter1:AP 1 OR 5 < 51 IPPV 
l"SL, FETAL HT ABN. 
Siegel et al 1904 : 32 lTerelAP 1 OR 5 =<4, IPPV, 
:+ FETAL DISTRESS 






47 45 124 
16 67 :21 
22 31 16-24 
19 73 :36-60 
Adsett et al 1985 : 43 lTermlAP 5 < 61 IPPV, 19 l 46.5 : 9.3 : 26 l12-23 
:FETAL DISTRESS, pH<7.2: 
lWITHIN 2 HRS OF BIRTH : 
Levene et al 1986 :122 :Tera: 11 7 11 : 71 :30 
DeSouza and Richards 1978 l 53 lTer1lFETAL DISTRESS Hf 14 l 78 l24-60 
================================================================================================= 
*** = NEONATAL PERIOD SURVIVORS ONLY. 
Key : 
HIE = Hypoxic-ischaetic encephalopathy 
IPPV = Intermittent positive pressure ventilation 
MSL = Heconiu1 stained liquor 
FET HT. ABN = Fetal heart abnormality 
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4.3.4.1. Severity of encephalopathy: 
A number of authors have attempted to refine the use of 
encephalopathy as a marker by looking at how the 
severity of the encephalopathy affects outcome. 
A number of schemes to grade the severity of 
encephalopathy have been devised by Sarnat and Sarnat 
(1976>, Fenichiel (1983>, Brown et al <1974) and Amie! 
-Tison and Ellison <1986). Details of these are given 
in Appendix I. 
Set out in Table 4.3.4. are studies which have looked 
at the outcome of HIE in relation to its severity. They 
stress that outcome correlated with severity of the 
encephaloapthy. As illustration of how various studies 
have done this an analysis of 3 studies which use the 
Sarnat scheme is presented in Table 4.3.5. 
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TABLE 4.3.4. STUDIES RELATING THE SEVERITY OF HYPOXIC-ISCHAEMIC ENCEPHALOPATHY TO OUTCO"E. 
=============================================================================================== 
AUTHORS N : GA OUTCO"E X : Grading :correlation :Follow up 
IDeadlNeurodevelopmentall sche1e !Grade of :"onths 
ISevere:"ildlNormal: :severity 
===========================:=====:=====:====:======:====:======!=========:============:========== 
Finer et al 1981 
Finer et al 1983 
Sarnat and Sarnat 1976 
Levene et al 1986 
Robertson and Finer 1985 
Brown et al 1974 
Desouza and Richards 1979 
Cyr et al 1984 
I 89 :Terlil l 8 --27-- : 65 I Sarnat !Sig c LTF 
49 :Term : 0 16 : 26 : 57 : Sarnat ISig c LTF 
21 I 36+ I 9.5: --33-- : 57 I Sarnat ISig c LTF 
I 
122 :Term : 11 : ---7--- : 82 IFenichiellSig c LTF 
200 !Term : 13 : --15-- : 73 IFenichiellSig c LTF 
93 I All : 22 : 12 14 I 36 I Brown lSig c LTF 
53 lTer1 :111 : 6 14 I 78 l Own lSig C LTF 











LTF = Long Tera Follow-up from a neurodevelop11ental point of vie11. 
GA = Gestational ages included in the study. 
Sig c LTF = Significantly correlates 11ith long ter1 follow-up. 
Note : Neurodevelopmental outcome X - refers to the percentage of the whole group with that 
category of abnor1al neurodevelotental outcome. 
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TABLE 4.3.5. POOLED DATA FROM 3 STUDIES USING SARNAT SCHEME 
============================================================ 
Sarnat : Categories of Outcome 
Degree of handicap Grading: Died! :Totals 
Severe !Mod !Mild !Normal 
============================================================ 
1 1 0 0 6 26 33 21 
2 2 16 16 20 50 104 67 
3 6 10 2 0 0 18 12 
============================================================ 
Totals 9 17 18 26 76 155 100 
============================================================ 
Chi-square = 58.24 DF = 8 p = < 0.001 
From Finer et al <1981 & 1983>, and Sarnat and Sarnat C1976). 
The fairly close correlation between outcome and 
severity of encephalopathy suggests that grading of 
hypoxic ischaemic encephalopathy should become a 
routine clinical practice which will assist in 
prognostication. 
Recently a 17 point scoring scheme of the neurological 
state of the asphyxiated newborn has been proposed by 
Lipper et al (1986). In a group of 34 term asphyxiated 
infants it was found that the score correlated well with 
neurodevelopmental outcome at 1 year of age. This would 
seem to be a more practical scheme for routine purposes 
than the Prechtl method which is very time consuming. 
4.3.5. FETAL ACIDOSIS AS A CRITERION OF ASPHYXIA. 
The idea that fetal metabolic acidosis consequent upon 
anaerobic metabolism might be a good marker of 
intrauterine hypoxia was favourably regarded as it is 
easy to measure and the results objective. 
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Initially attempts were made to correlate umbilical 
arterial acidosis with Apgar score. Bolton <1985) found 
a poor correlation between the Apgar score at 1 minute 
and umbilical placental arterial pH. Sykes et al (1982) 
in a study of umbilical arterial acid-base status and 
Apgar scores in a large group of normal deliveries 
found that while there was a statisically significant 
inverse correlation of Apgar score with increasing 
acidosis, the relationship was not close. In fact many 
acidotic infants were born very vigorous and many 
depressed inf ants were not acidotic. They found the 
incidence of 1 minute Apgar score < 3 to be 3.8Y. of 
their sample and that of base excess of > 12 mmol/l was 
12. 9Y.. 
Low et al (1983) found that a group of term infants with 
umbilical arterial metabolic acidosis at birth had 
significantly lower Apgar scores at birth than a non 
acidotic control group, but did not have any higher 
neonatal mortality or different long 
neurodevelopmental outcome. <See Table 4.3.6.) 




: N : GA CRITERIA FOR SELECTION:MOR: OUTCOME Y. :F/U 
: Y. :SEV !OTH :NOR:MTHS 
:====:==== ======================:===:====:====:===:==== 
37 :TRM Cases had umbilical 
arterial b.base 
< 34 meq/l 
: 3 
: ( 2) 
: 16 : 77: 72 
: (18): (76) 
======================================================== * 3137 CASES DEVELOPED ENCEPHALOPATHY. 
( ) = Figures for 59 controls with buffer base >34 meq/l. 
From Low et al (1983). 
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Lauener et al (1983) found that while only 10.7Y. of 
infants with an umbilical artery pH of< 7.15 had a 1 
minute Apgar score of < 5 the proportion of non-acidotic 
infants with a similar Apgar score was lower (1.2Y.>. 
They found that of 98 infants who had this degree of 
acidosis at birth, 2 had significant neurodevelopmental 
problems at 2 years of age. Unfortunately no controls 
were used so that the relative risk associated with the 
acidosis could not be determined. 
Acidosis probably represents recent fetal hypoxia and 
when used alone as a marker, the level of acidosis used 
by Low et al for example is not a sensitive indicator of 
asphyxia. 
4.3.6. COMBINATIONS OF PARAMETERS IN CHARACTERISING ASPHYXIA. 
Given the limitations of individual items, several 
authors have put together combinations of criteria in an 
attempt to avoid the disadvantages of single parameters. 
The important idea that a combination of Apgar score and 
pH might be a better marker of infants at neurological 
risk came from De Souza et al <1983). They found that of 
24 infants who were depressed at birth <modified Apgar 
0-2>, only those 3 infants who also had a low umbilical 
venous pH were neurologically abnormal in the . neonatal 
period. The 40 inf ants who had acidosis but were not 
depressed at birth were all neurologically normal. 
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Although these numbers are small they suggest that a 
combination of criteria may be more predictive than 
either alone. 





of classifying perinatal asphyxia which 
a variety of parameters to provide a 
staging from mild to severe. Details of 
given in Appendix II. It may well be that 
these or similar combination schemes will eventually be 
used to characterize the insult experienced by an 
individual infant. If the above 2 schemes become widely 
accepted and used it will be important to obtain 
reliable prognostic data for each stage/grade. 
Van der Elst and Malan (1986> found that when they used 
Rothberg's scheme about 40% of patients in the milder 
grades 1 and 2 had encephalopathy. This highlights the 
need to agree on a standard definition and grading of 
encephalopathy. 
4.3.7. OTHER MARKERS OF ASPHYXIA: 
In an attempt to delineate asphyxia in a more 
physically measurable way, ultrasound, EEG, and CT scan 
have been evaluated as markers of asphy~ia. 
4.3.7.1. Electroencephalography as a marker of asphyxia: 
Finer et al <1981> and Sarnat and Sarnat <1976> have 
both described EEG findings in groups of term infants 
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who had suffered asphyxia related encephalopathy. They 
found that 69Y. <N=51> and 85Y. <N=46) respectively had 
abnormal EEGs in the first few days of life. The changes 
were low voltage or supression patterns. They both found 
a correlation between early EEG abnormalities and long 
term neurodevelopmental abnormalities. Finer (1983) in a 
later study of a similar group of infants could find no 
such correlation. The position of EEG in this situation 
remains unclear. 
4.3.7.2. Ultrasound as a marker of asphyxia : 
Siegel et al. (1984) in a controlled study found 62Y. of 
from hypoxic-ischaemic 32 term infants suffering 
encephalopathy <HIE> to have abnormal ultrasound 
appearances. These findings were associated with a 
significantly higher immediate mortality as well as 
with a higher incidence of long term neurodevelopmental 
abnormalities. The method was specific in that only 
2/10 had an abnormal outcome after a normal scan and 
sensitive in that only 1/19 with abnormal outcomes had 
had a normal scan. Babcock et al <1983> found it to 
have a sensitvity of 86Y. and a specificity of 100/. in a 
similar study. 
Ultrasound has also been used to study cerebral blood 
flow in infants with HIE. Archer et al (1986> found that 
in 43 term asphyxiated infants who survived for more 
than 2 days, an abnormal cerebral artery Doppler 
waveform predicted an abnormal neurodevelopmental 
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outcome at a median age of 18 months with a sensitivity 
of 100Y. and a specificity of 81Y.. Den Ouden et al <1987) 
found very similar results with this method but found a 
somewhat lower specificity. 
4.3.7.3. Computed tomography as a marker 0£ aaphyxia 1 
It is becoming clear that CT scans can be effectively 
used in neurodevelopmental prognostication in an 
asphyxiated inf ant. 
Finer et al (1983) found 461. of 43 CT scans, done in 
the first 7 days of life, to be abnormal in a group of 
term· infants with HIE. The typical appearances have 
already been discussed in Chapter 3. However they 
could find no association between the mere presence of 
CT scan abnormalities and long term neurodevelopmental 
outcome. 
On the other hand the severity of CT changes seems to 
correlate well with neurodevelopmental outcome. 
Fitzhardinge et al (1981) studied 65 term infants with 
HIE and showed a a strong correlation with adverse 
neurodevelopmental outcome at 2 years. Adsett et al 
<1985) also studied term infants with HIE and found an 
association between the severity and extent of 
hypodensities in the brain parenchyma on CT scan and 
poor neurodevelopmental outcome at 18 months. In neither 
of the above studies was the exact timing of the scan 
stated and it is likely that scans done at 1-4 weeks 
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when the appearances are more definite would have given 
a stronger association. 
Lipper et al <1986) have developed a "low density index" 
for quantifying the low density areas on CT scans 
produced by hypoxia-ischaemia. They performed CT scans 
on 21 term asphyxiated infants within the first. 48 hours 
of life and found that the low density index was 
strongly associated with mortality and adverse 
neurodevelopmental out.come. 
It is clear that CT scanning is a very valuable 
prognostic tool in infants with HIE but t.he timing is 
import.ant. 
4.3.7.4. Computed tomography Vs 
prognostication : 
Ultra-sound in 
Babcock et al <1983> compared US and CT scanning as to 
their ability to predict abnormal neurodevelopmental 
outcome at. 4 months of age following asphyxia <Apgar at 
5 minutes =<6> in 27 term infants. Eight had abnormal US 
-appearances, all of whom had abnormal neurodevelopment.al 
outcomes. US was designated as "early" if done at 7 days 
of age or less and as "late" if done after 7 days of 
age. The result for accuracy, sensitivity and 
specificity are tabulated below. 
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Y. Y. Y. 
Accuracy 71 89 100 
Sensitivity 46 86 100 
Specificity 100 100 
======================================================= 
From Babock et al (1983). 
Note CT scan was performed after the 7th day. 
4.3.7.5. Chemical markers of asphyxia: 
Not surprisingly severe hypoxia induces changes in many 
organs other than the brain and induces chemical 
alterations that are becoming recognised and being 
assesed as markers of asphyxia. None have yet become 
widely used in clinical practice. These include : 
Arginine vasopressin (Speer et al 1984, Wiriyathian et 
al 1986, De Vane and Porter 1980), Hypoxanthine 
<Swanstrom and Bratteby 1982, Thiringer 1983), thyroid 
hormone (Borges et al 1985), liver enzymes <Zanardo et 
al 1985, Fitzsimons et al 1984) catecholamines <Cheek 
et.al 1963), creatine phosphokinase <Rossi et al 1986, 
Amato et al 1986> and CSF lactate dehydrogenase 
(Fernandez 1986). These interesting aspects 
unfortunately cannot be persued in detail here. 
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4.4. CONCLUSIONS : 
It is clear that no one criterion is absolute. A range 
of criteria of increasing severity may be used and as 
more data accumulate the prognostic equivalent for each 
set of criteria emerges. 
4.4.1. The Apgar score is well documented in terms of 
outcome but it has low specificity in that a significant 
proportion of those with the lowest scores have a normal 
outcome. 
4.4.2. The time to spontaneous respiration is a useful 
measure but thus far the studies on its outcome are few 
and have used a variety of times as criteria. 
to select severely affected infants. 
It tends 
4.4.3. Encephalopathy seems to be a marker that is easy to 
establish and to grade clinically and which correlates 
well with outcome. It is however a marker at the more 
severe end of the spectrum. 
4.4.4. Placental acidosis when taken alone would seen to 
represent one of the mildest criteria of asphyxia and 
should not be used alone but rather in combination with 
others. De Souza et al (1983) remark that the Apgar 
score and fetal pH in~ividually are "blunt instruments" 
in representing fetal compromise and that to use them in 
combination would result in a more effective measure. 
Placental acidosis is however an objective marker that 
./ 
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an inf ant has recently been subjected to an hypoxic 
insult of whatever severity. 
4.4.5. Ultrasound and CT scanning allow visualisation of the 
cerebral injury itself and have been shown to be 
sensitive and specific when judged against 
neurodevelopmental outcome. Their disadvantage is that 
the changes are not reliably visualised for some days 
and so would not be suitable for deciding soon after 
birth which infants had experienced a sufficiently great 
hypoxic-ischaemic insult to necessitate therapeutic 
measures being instituted. 
CHAPTER 5 
EPIDEMIOLOGY OF ASPHYXIA NEONATORUM 
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The literature on the epidemiology of asphyxia 
neonatorum will be reviewed beginning with the 
incidence, proceeding to its significance as a cause of 
perinatal death and then dealing with its antecedents 
in pregnancy and labour. Finally the relationship 
between asphyxia and cerebral palsy will be reviewed. 
5.1.1. INCIDENCE: 
The incidence of asphyxia as quoted by a number of 
studies is summarised in Table 5.1.1. The rates given 
vary from 12.9 to 0.48 Y.. This wide range relects the 
differing selection criteria of the studies. For example 
Sykes et al (1982) found a high incidence of 12.9Y. when 
umbilical arterial meta~olic acidosis was used as the 
sole criterion. This selected a large group of very 
mildly affected infants. In contrast, in the same study 
the incidence as defined by an Apgar score at 1 minute 
of <3, was only 3.8Y.. Studies using more stringent 
criteria indicate an incidence of about 1Y.. The figure 
for groups of term infants is between 0.17 and 0.9Y.. One 
of the few studies from the developing world situation 
is that by Molteno (1976) which showed an incidence of 
1.4Y. which is very similar to studies from the developed 
world. Unfortunately the incidence for term infants was 
not quoted separately. 
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TABLE 5.1.1. STUDIES OF THE INCIDENCE OF NEONATAL ASPHYXIA : 
==================================================================================== 
AUTHORS lGA lN :No.Del :Definition ofl Incidence X :country 
lAsphyxia l All lTermlPrem l 
===========================:====:====:======:=============:=====·====:=====:======= 
Sykes et al 1982 
Nelson and Ellenberg 1981 
Brown et al 1974 
Sykes et al 1982 
Nelson and Ellenberg 1981 
Molteno 1976 
MacDonald et al 1980 
Cyr et al 1984 
Mulligan et al 1980 
Ergander et al 1983 
Finer et al 1981 
Levene et al 1985 
lAll : 116 : 895 :Base Excess i12.9 - l UK 
l )12 Hol/l • ' 
lAll l2764l49000 !Apgar 1 =< 3 l5.b - l USA 
!All l760 l14020 IWide criterial5.4 - l - l UK 
lSee note. 
lAll l 34 : 895 lApgar 1 < 3 l3.8 - l UK 
:All .; - l49498 lApgar 5 =< 3 11.5 ,0,89l 7.6 l USA 
l<2.5kl Coll 
lAll l - 13167 lApgar 5 =< 3 ll.4 l - l - l SA 
!All 1447 l38405 lIPPV > 1 ll.16 10.4 162.3 l USA 
ltin to spont.: :>38wl<2711 l 
I respiration. 
lAll 1103 l9901 lIPPV >1 min 11.04 l0.9 l 59.Sl CANADA 
lbefore spont : 
lrespn. +-HIE l 
lAll 133 l13221 lTiae to spontll.O : -
lRespn. )1 1inl 
l<t Kgl 
- l USA 
IAll 116 119969 !Apgar 5 =< 3 l0.48 l0.17l 1.6 l SWEDEN 
l<38N l 
lTrm l 95 120155 !Significant l - l0.36l - l CANADA 
lEncephalopthy: 
:Tn :126 l20975 lPost asphyxia: - :0.6 : - l UK 
lencephalopthyl 
==================================================================================== 
GA = Sestational age No. Del = Number of deliveries 
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The USA collaborative study reported by Nelson and 
Ellenberg (1981) involved a very large group of 
neonates in which Apgar scores were well documented and 
as such may well provide the best reference data on 
this topic. They found the incidence overall to be 
1.8Y., in deliveries at term 0.89Y. and for infants < 2.5 
Kg, 7.6Y.. 
5.1.2. Relative causes of neonatal death 
An indirect way of looking at the incidence of asphyxia 
is to look at its importance as a cause of neonatal 
death. Its importance as a problem in the developing 
world is clearly shown by reference to the Table 5.1.2. 
in which causes of neonatal death from a number of 
South African neonatal units have been categorised in a 
standard way. All the units serve communities of 
largely low socioeconomic status except that of Cooper 
et al (1984) which serves a much more affluent 
population in Johannesburg. The striking feature is 
that asphyxia is by far the largest single cause of 
neonatal death among term infants in all units except 
that of Cooper et al. 
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TABLE 5.1.2. CASES OF NEONATAL DEATH IN SOUTHERN AFRICAN NEONATAL UNITS. 
AUTHORS 
====================================================================================================: 
: B.w.: No. : X Cause of Death Unit 
:Pre1 llnf :Cong lAsphyx :other: 
===========================:=====:=====:=====:=====:=====:======:====================================: 
Cooper et al !1984) lAI I : 57 l 34 18 : 38 10 
Henning and Beyers !1984l !All 166 : 60 16 7 10 
Hay et al !1984> lAll 135 l 30 : 38 7 : 13 
Ri ssi k !1983) lAll : 363 : 30 l 17 9 : 35 
Power and Bok 11983) lAll : 171 l 46 t - 8 : 34 
- l Johannesburg Hospital 
7 : Tygerberg Hospital Cape To11n I 
12 : Garankua Hospital Pretoria 
9 : Baragwaneth Hospital JHB 
12 l Cecilia nakiwane Hospital 
: Ciskei 
-----------------------------------------------------------------------------------------------------. 
Cooper et al 11984) D2.5 : 20 : - 15 l 65 : 15 5 : Johannesburg Hospital 
I 
I 
f Henning and Beyers 11984) l>2.5 : 18 : - 17 17 : 44 I 22 : Tygerberg Hospital Cape Town I ' 
Ri ssik l1983l 1>2.5 : 89 : - 8 17 : 59 16 l Baragwaneth Hospital JHB 
Power and Bok I 1983) l>2.0 : 74 : - 15 : 65 20 : Cecilia Makiwane Hospital 
: Ciskei 
====================================================================================================== 
Prem = Preterm 
Inf = Infection 
Cong = Congenital 
Asphyx = Asphyxia 
CHAPTF:R ri 
C llAPT C:lt ti 
F:PTD· 
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5.2. ANTECEDENT FACTORS IN PREGNANCY AND LABOUR : 
There are a number of studies which investigate the 
factors in pregnancy and labour which precede asphyxia 
but with few exceptions they lack non asphyxiated 
control groups. Table 5.2.1. details 6 controlled 
studies. Unfortunately even these suffer from the 
problems of varying definitions of asphyxia, differing 
criteria of gestation and small numbers. Firm 
conclusions are thus difficult to arrive at. The 
studies by MacDonald et al <1980) and Cyr et al (1984> 
avoid these difficulties more than the others and 
examine a wide range of factors. 
In all the studies in which it was included gestational 
age was highly associated with asphyxia, especially in 
preterm infants. In the studies where the numbers of 
cases were large and many factors examined, fetal 
distress, abruptio/ante-partum haemorrhage, 
malpresentations, non-elective caesarian section, and 
hypertension were found to be regularly associated with 
asphyxia. In the very large study by Macdonald et al 
(1980) several other factors were also found to be 
significantly associated. 
From the nature of these positive associations it is 
tempting to infer that asphyxia tends to occur with 
conditions associated with uterine vascular pathology 
such as hypertension and abruptio or with prolonged 
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TABLE S.2.1. CONTROLLED STUDIES RELATIN6 ANTENATAL FACTORS TO INCIDENCE OF ASPHYXIA AND OR HYPOXIC-ISCHAEMIC 
EtlCEPHALOPATHY. 
============================================================================================================= 
AUTHORS l SA l N l CRITERIA FOR 
: ASPHYXIA 
PARAMETERS SHONIN6 Sl6NIFICANT 
ASSOCIATION. 
=========================:====:====:===================:====================================================== 
Dweck et al 11974) : ALL: 15 : AS 1 =< 3 
: + IPPV & IV 
l Buffer. 
:Gestational age, Birth Weight, Incidence of pregnancy 
land delivery abnor1alities.1 
:!Nos. too s1all for individual factors to be analysed. 
:factors to be analysedl. 
MacDonald et al 11980) lALL :447 : IPPV > 1 sin 
before spont. 
respiration. 
:Race, marital status, diabetes,toxae1ia 1breech 1 
:growth retardation. Low social status. 
!Caesarian Section for: Fetal distress, prolapsed 
:cord, abruptio1 placenta previa, prolonged 
!rupture of 1e1branes 1 isoi11unization,·s1all for 
:gestational age, gestational age. 
Tho1son et al 11977) 
Cyr et al 119841 
6rauz et al l1983J 
TRl'll 31 AS 1 1in < 0 or :caesarian section, Intrapartu1 hae1orrhage, 
, AS 5 min < 5 l fetal distress. 
ALU 93 : IPPV >3 min before:Fetal distress, APH, prolapsed cord, hypertension, 
l spontaneous !prolonged trial of labour, shoulder dystocia, 
: respiration +- :1alpresentation, breech, •id-forceps, large for 
: Encephalopathy. :gestational age, non- elective caesarian section, 
:birth weight and gestational age. 
:TRl'I '187 l Fetal distress and:Gestational age. 
: neonatal acidosis.:<Only factor exa1ined). 
Rothberg et al !1986) :TRM 13 : Chorionic acidosis:No significant associations. 
Bolton !1985J :mi. 29 l Apgar 1 1in < 7 :Maternal age & parity. 
l!Antenatal clinic visits not significant). 
============================================================================================================== 
* These factors included pre-ecla1psia, antepartum haeaorrhage, fetal distress, outlet dystocia, prolonged 
rupture of 1e1branes and 1alpresentation. 
SA = 6estational age 
AS = Apgar score :: 
TRI'! - Ter1 
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placental compression as in prolonged labour with a 
malpresentation. 
Two other studies did not use controls and related 
factors in pregnancy and labour to the severity of 
encephalopathy in one and to long term 
neurodevelopmental outcome in the other. Details are 
given in Table 5.2.2. below. Neither study found 
significant associations. In as much as the contrast in 
variables between patients with different grades of HIE 
for example will not be as great as that between 
patients with HIE and controls, greater numbers may be 
needed in this type of study to show significant 
differences between variables than in controlled studies. 
TABLE 5.2.2. STUDIES RELATING ANTENATAL EVENTS TO INCIDENCE 
OF ASPHYXIA AND/OR HYPOXIC-ISCHAEMIC ENCEPHALOPATHY. 
============================================================ 
No. YR : GA ! N :PREGNANCY & : PARAMETERS SHOWING 




81 TRM 95 !STAGES OF HIE 
:& SEVERITY OF 
!LONG TERM CNS 
!OUTCOME 
85 TRM !226 !STAGES OF HIE 
:& SEVERITY OF 









1. Finer et al < 1981>. 
2. Robertson and Finer <1985>. 
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Finally in this discussion of the epidemiology of 
asphyxia it is necessary to consider the relationship 
between asphyxia and cerebral palsy which has 
traditionally been taken as the ultimate outcome of 
severe asphyxia. 
5.3. ROLE OF ASPHYXIA IN CEREBRAL PALSY 
The classical view of the aetiology of cerebral palsy 
originating in the perinatal period is that the 
infant's brain suffered either a mechanical injury or a 
damaging hypoxic-ischaemic insult leading to cerebral 
infarction, haemorrhage or both or that there was a 
congenital abnormality of the brain. The view of Little 
(1862>, recently reviewed by Paneth <1986>, was that 
these injuries occured during labour and were manifest 
as CNS depression at birth. This depression was 
observed clinically as intra-partum asphyxia or failure 
to establish respiration. It was for this reason that 
for many years asphyxia was seen as central in the 
aetiology of cerebral palsy. · 
Certain paradoxes have been pointed out recently by 
authors such as Niswander <1985). Firstly there are many 
children with cerebral palsy who were not asphyxiated at 
birth. Nelson and Ellenberg (1986) reporting from the 
Collaborative study note that only 21% of 189 children 
aged 7 years with cerebral palsy had had any marker of 
intrapartum asphyxia. In their review Paneth and Stark 
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(1983) state that SOY. of cases of cerebral palsy have no 
documented depression at birth. 
Studies of the pre- and peri- natal antecedents of 
cerebral palsy are set out in Table 5.3.1. In all of 
these studies children with cerebral palsy were 
compared with controls. A large variety of significant 
associations were found in the studies but there were a 
few that recurred. In 7 studies the following factors 
were frequently quoted Fetal distress (5), 
gestational age/birth weight <4>, hypertension/pre-
eclampsia (4), antepartum haemorrage (3), small for 
gestational age (2), social status <2>, multiple 
pregnancy <2> breech (2). 
It appears that it is factors related to fetal well 
being in utero rather than aspects of labour or the 
condition of the baby at birth that seem to relate to 
cerebral palsy. 
The second paradox is that the majority of infants 
asphyxiated at birth do not exhibit cerebral palsy later 
on. In Tables 4.3.1.- 4.3.4. it was seen that between 50 
and 95 Y. of infants with asphyxia! markers at birth have 
normal outcomes in infancy and childhood. The proportion 
depends on the severity of the criteria for defining 
asphyxia. 
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TABLE 5.3.1. THE OBSTETRIC ANTECEDENTS OF LONG TERM ABNORMAL NEUROLOGICAL OUTCOME PARTICULARLY CEREBRAL PALSY. 
============================================================================================================== AUTHORS l GA : · N : CASES 
lCASESl 
PARAMETERS SHOWING SIGNIFICANT 
ASSOCIATION. 
==============================:====:=====:=======================:============================================ 
Milligan et al !1980) 
Taylor et al !1985) 
Dale and Stanley (1980) 
Hagberg et al (1976) 
Ni s11ander 0985) 
Nelson and Bro1an !1977) 
lALL l 65 : Abnor1al neurological l"Prolonged" and "Acute• stress,birth weight 
: outcolile. :gestational age, sex, social status. 
l ALLl300 : Abnormal neurological :Pregnancy : severe hypertension, pri1iparity 
l outco11e. :previous neonatal death, APH, premature 
!uterine activity, premature delivery, SSA, 
:fetal tachycardia. 
ALL!315 I Abnormal neurological :Previous abortion, threatened abortion, 
: outcome. IAPH, prolonged rupture of 1e1branes, PET, 
!multiple pregnancy, breech, fetal 
:distress •, failed obstetric proceedure 1 1 
:birth weight 1, gestational age 1, SSA. 
Ji = significant on multivariate analysis. 
ALLl560 : Cerebral palsy. !Birth weight, PV bleeding in pregnancy, 
:toxaemia, multiple births. 
ALll 34 : Cerebral palsy at 18 :No difference in sub-standard obstetric 
: months of age. :care. 
ALL: 50 : Cerebral palsy and 
I 1ental retardation at 
: 7 years of age. 
:Fetal bradycardia in 2nd stage. 
:use of mid cavity forceps. 
:!Wide range of social and obstetric 
:factors exa1inedl. BW and OFC. 
Nelson and Ellenberg !1986) I ALLl 189 Cerebral palsy at 7 :11aternal mental retardation, severe 
: years of age. lproteinuria maternal seizures, maternal 
lhyperthyroidis111 breech presentation. 
========================================================================================================== 
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A final paradox is that not every inf ant who develops 
hypoxic-ischaemic encephalopathy is depressed at birth. 





shown signs of fetal distress, is vigorous 
but goes on to have seizures at 8-12 hours 
For example in the study reported in Chapter 
<47Y.> infants who later developed HIE had 





These paradoxes have lead authors such as Niswander 
<1985) and Paneth (1986) to question the role of 
asphyxia in the aetiology of cerebral palsy. 
On the other hand a great deal of evidence links intra-
partum asphyxia with cerbral palsy. Studies concerned 
with the neurodevelopmental sequelae of intra-partum 
asphyxia are set out in Tables 4.3.1-4.3.4. They show 
that with increasing severity of asphyxia there is a 
rising proportion of neurodevelopmentally abnormal 
outcomes in childhood. 
These studies include follow-up studies of infants with 
hypoxic-ischaemic encephalopathy which indicate that 
some 20-40X of such inf ants have neurological 
abnormalities in later childhood. Furthermore in cases 
of cerebral palsy following hypoxic-ischaemic 
encephalopathy there is a shift in the type of cerebral 
palsy in favour of spastic quadriparesis which is a 
pattern of brain damage seen in the experimental animal 
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work quoted above. The weight of experimental animal 
evidence indicates that hypoxic-ischemic insults produce 
neuropathological lesions that correspond to the picture 
seen in human spastic cerebral palsy. 
A unifying theory that would explain most of the 
disparate findings about asphyxia and cerebral palsy is 
suggested 
(a) Many inf ants who later have cerebral palsy suffer 
hypoxic-ischaemic insults in utero. The fact that the 
timing and the severity of these insults varies accounts 
for the variablility of associated findings such as the 
occurence of depression at birth and/or encephalopathy. 
(b) Severity of insult : An insult severe enough to 
produce cerebral palsy will always also produce 
temporary central nervous system depression and later 
encephalopathy. A somewhat lesser insult might produce 
temporary central nervous system depression and 
encephalopathy but not later cerebral palsy. A still 
lesser insult will produce temporary central nervous 
system depression followed by rapid recovery and not 
lead to encephalopathy or to later cerebral palsy. 
(c) Timing : When the insult occurs long before birth 
the fetus will have recovered from the acute insult by 
the time of birth and thus be neither depressed at birth 
nor encephalopathic in the neonatal period. An insult 
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some hours before birth will allow time for the infant 
to recover from the immediate effects. There will be no 
depression at birth but encephalopathy will develop some 
hours later. If an insult occurs very close to birth 
itself the infant will still be depressed from the acute 
insult and will manifest a low Apgar score and other 
signs of acute asphyxia. Such an inf ant may or may not 
go on to develop encephalopathy depending on the 
severity. 
This theory would explain the paradoxes that not all 
cases of cerebral palsy have had depression at birth nor 
HIE in the neonatal period, and that not all infants 
suffering from asphyxia or HIE will go on to have 
cerebral palsy. 
Difficulty in initiating respiration at birth may well 
not be a cause of cerebral palsy in itself. It may be 
better to think of it as one of a number of markers of a 
cerebral insult in utero. Similarly HIE and cerebral 
palsy may be seen as markers of increasing severity. 
From this theory one could predict that antenatal 
disorders relating to placental well being such as 
antepartum haemorrhage, pre-eclampsia, poor fetal growth 
etc are associated with cerebral palsy as they would 
predispose a fetus to ~ntra-uterine hypoxic-ischaemic 
insults. 
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The intrauterine insult may not always be hypoxic-
ischaemic. Nelson and Ellenberg <1986) have shown that a 
considerable number of their cerebral palsy cases in a 
community survey had developmental anomalies of the CNS. 
The authors do not state the types of cerebral palsy 
associated with the CNS anomalies but from animal 
experimental work it would be surprising if they 
produced the same pattern of disorder as does hypoxia-
ischaemia. 
5.4. SUMMARY 
This review has attempted to examine the literature with 
a number of questions in mind : 
5.4.1. What is the incidence of asphyxia neonatorum? 
The incidence as found in a variety of recent studies is 
given. It is a great defect in the literature that 
studies from the developing world are missing. This . is 
not surprising in view of the fact that details of a 
very large number of deliveries are needed. This type of 
data base is infrequently kept in the developing world 
situation. More data in this area is needed. 
Is the raised incidence of asphyxia in socially deprived 
communities merely a matter of poor access to obstetric 
care or is there an underlying (possibly placental) 
condition whose nature we do not understand and which 
disappears with economic advancement ? 
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5.4.2. What clinical or biochemical markers in pregnancy and 
labour are regularly associated with an increased risk 
of asphyxia ? 
A number of studies have attempted to look at the 
contribution of a large range of factors in pregnancy 
and labour to the occurence of asphyxia. There are 
surprisingly few consistent associations in well 
contolled trials. Such associations include fetal 
distress, abrubtio and other antepartum haemorrage, 
malpresentations, non elective caesarian sections, and 
hypertension. None of the quoted controlled studies 
found that socioeconomoic status was associated with the 
occurence of 
comparative 
asphyxia. Nevertheless studies 
neonatal mortality from developed 
of 
and 
underdeveloped communities clearly show that whereas 
asphyxia in term infants is a major problem in the 
underdeveloped world it is much less so in more 
economically advanced communities. Socioeconomic status 
is thus associated with asphyxia when viewed on a 
global scale. 
5.4.3. Does the nature of these markers give us any idea as 
to the basic pathophysiological mechanisms underlying 
asphyxia ? 
The underlying pathophysiology of asphyxia largely 
remains obscure. Placental separation for what ever 
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cause is a clear mechanism of fetal hypoxia. Obstructed 
labour with prolonged rep·eated placental .squeezing by 
uterine contractions leading to poor fetal perfusion is 
also understandable. How hypertension and toxaemia lead 
to fetal hypoxia is less clear but the process most 
probably involves decr~ased utero-placental blood 
flow. It is also clear that severe fetal hypoxia and/or 
hypotension may occur for no obvious reason. The 
occurence of ufet~l distressu in this situation being 
no more than an indication by the fetus that it is in 
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6.1.INTRODUCTION 
In order to institute preventive measures for a 
condition it is necessary to study its epidemiological 
associations. Unless one has a reasonable idea as to the 
cause of asphyxia as it occurs locally and as to the 
categories of pregnant women particularly at risk, one 
is not in a position to institute effective preventive 
programmes. A number of possible associations had been 
suggested by local obstetricians and paediatricians. 
These included factors of health service use such as 
antenatal care and place of delivery, as well as 
obstetric factors such as breech delivery and vacuum 
extraction. The review of literature in Chapter 5 makes 
it clear that there are few consistent epidemiological 
associations with asphyxia. It was thus felt to be very 
important to study local factors in order to provide 
data relevant to a developing world situation. 
The following epidemiological study was undertaken in 
an attempt to assemble such local data. It was hoped 
that the information gathered would have significance 
beyond the immediately local situation and be helpful 
at least in the Southern African context. 
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6.2.PATIENTS AND METHODS 
6.2.1.Patients: 
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The following 3 groups of mothers were investigated 
6.2.1.1.Non-Asphyxiated Controls. 
All those women who delivered at Cecilia Makiwane 
Hospital between February and October 1984 and whose 
infants were 37 weeks or more of gestational age and 
whose 5 minute Apgar scores were 7 or more were 
designated as controls. These women numbered 2758. 
Data was gathered routinely on all mothers delivering 
in the hospital and entered onto a standard form by the 
obstetric medical and nursing staff. It was then coded 
by one Obstetric Senior Medical Officer who entered it 
into a computer data base for analysis. "The data base 
had been set up for the obsetric department by the 
author for the purpose of gathering this data. 
6.2.1.2. Mothers of Infants in the therapy Trial. 
A further 116 mothers were selected on the basis that 
their term infants had had a chorionic arterial base 
excess of >-11 and had had either a 5 minute Apgar 
score of less than 7 or had shown evidence of fetal 
distress. 
Further details of these infants are given in 
section 8.2.1. of the report on the therapy trial. 
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6.2.1.3. Mot.hers of Infants with clinically evident Hypoxic 
Ischaemic Encephalopathy <HIE>. : 
Forty seven mothers whose infants were of of more than 
37 weeks gestation and who exhibited clinical signs of 
HIE in the immediate neonatal period, were selected. 
Their infants had shown clinical evidence of hypoxic-
ischaemic encephalopathy, t.he diagnosis of which was 
based on the following criteria 
1. Onset. of encephalopat.hic signs such as 
abnormal levels of consciousness, seizures, 
or abnormally increased or decreased tone 
within 48 hours of delivery. 
2. The absence of any other explanation for the 
encephalopathy such as meningitis, 
hypoglycaemia, electrolyte or other metabolic 
disturbance. 
3. The manifest.at.ion of one of the clinical 
patterns typically displayed by infants with 
HIE. 
In both of the last 2 groups of mothers, details of 
their antenatal course, labour and delivery were 
obtained by the author from the antenatal and obstetric 
records. In each case the specialist obstetrician in 
charge of the case was asked to review the case with 
the records and to give his opinion as to the cause of 
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the infant's asphyxia. 
6.2.1.4. Terminology for the groups. 
The mothers of infants in the therpy trial will be 
known as the TRIAL group and those with the 
encephalopathic inf ants as the HIE group. A combination 
of the above 2 groups will be referred to as the 
combined asphyxia group. This term is in keeping with 
the concept of asphyxia used throughout this thesis in 
which a combination of biochemical and clinical 
criteria reflect a failure of adequate fetal 
oxygenation. This has been set out in section 1.2 of 
the introduction. It should be noted that in terms of 
this concept a low Apgar score is not an absolute 
prerequisite for inclusion in an asphyxiated group. It 
must be made clear that the three groups were entirely 
discreet and in no way overlapped each other. 
6.2.2. Data handling and statistics. 
Data for the "trial" and "HIE" patients were gathered 
by the author on proformas and entered into a computer 
data base for analysis. Data relating to the controls 
was gathered from the obstetric data base as reported 
above. Statistical analyses were carried out by the 
author and consisted of Chi-square testing with Yates 
correction for small numbers where necessary <Swinscow 
1977). The level of probability accepted as significant 
was p=<0.01. 
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6.3.RESULTS : 
6.3.1. Maternal Age: 
Reference to Table 6.3.1.1. will show that there was no 
significant difference between the maternal ages in 
each of the 3 groups. The mean age of the HIE group was 
somewhat lower than the other 2 but this difference did 
not reach statistical significance. 
TABLE 6.3.1.1. MATERNAL AGE 
YEARS CONTROLS TRIAL HIE TOTALS 
============================================ 
-15 31 2 2 35 
16-20 802 32 19 853 
21-25 860 43 13 916 
26-30 547 24 5 576 
31-35 321 11 4 336 
36-40 143 3 3 149 
41-45 35 1 36 
46+ 5 5 
NO DATA 14 1 15 
============================================ 
TOTAL 2758 116 47 2921 
TABLE 6.3.1.2. MATERNAL AGE - PERCENTAGES 
YEARS CONTROLS TRIAL HIE TOTALS 
============================================ 
-15 1. 1 1. 7 3.8 1. 2 
16-20 29.1 27.6 35.8 29. 1 
21-25 31. 2 37.1 24.5 31. 3 
26-30 19.8 20.7 9.4 19.7 
31-35 11.6 9.5 7.5 11. 5 
36-40 5.2 2.6 5.7 5. 1 
41-45 1. 3 0.9 1.2 
46+ 0.2 0.2 
NO DATA 0.5 1. 9 0.5 
============================================ 
TOTAL 100.0 100.0 100.0 100.0 
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6.3.2. Gravidity 
Reference to Table 6.3.2.1. will indicate that there 
was a higher proportion of primigravidae among the 2 
asphyxiated groups as compared to the controls but the 
difference was only significant between the HIE and 
control groups. Chi square =16.73 DF = 3 p = < 0.001. 
TABLE 6. 3. 2. 1. GRAVID A 
============================================ 
GRAV CONTROLS TRIAL HIE TOTALS 
============================================ 
1 909 54 27 990 
2 784 26 3 813 
3 443 17 6 466 
4 243 11 5 259 
5 193 3 1 197 
6 96 2 1 99 
7 43 1 1 45 
8 21 21 
9 + 19 1 1 21 
NO DATA 7 1 2 10 
============================================ 
TOTAL 2,758 116 47 2,921 
TABLE 6.3.2.2. GRAVIDA - PERCENTAGES. 
=============================================== 
GRAV CONTROLS TRIALS HIE TOTALS 
==============·================================= 
1 33.0 46.6 57.4 33.9 
2 28.4 22.4 6.4 27.8 
3 16. 1 14.7 12.8 16.0 
4 8.8 9.5 10.6 8.9 
5 7.0 2.6 2. 1 6.7 
6 3.5 1. 7 2. 1 3.4 
7 1. 6 .9 2. 1 1. 5 
8 .8 .7 
9 + . 7 .9 2. 1 .7 
NO DATA . 3 .9 4.3 .3 
=============================================== 
TOTALS 100.0 100.0 100.0 100.0 
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6.3.3. Parity : 
Table 6.3.3.1. shows that the pattern for parity was 
similar to that for gravidity. The proportion of 
nulliparity in the trial group was greater than for 
controls and even higher in the HIE group. The 
difference between the control and 2 asphyxiated groups 
taken together was significant. Chi square = 21.07 DF = 
3 p = <0.001. There was no difference between the 2 
asphyxiated groups. 
TABLE 6.3.3.1. PARITY. 
============================================= 



















































TOTALS 2, 758 116 47 .2, 921 
TABLE 6.3.3.2. PARITY - PERCENTAGES 
==================================~=========== 
CONTROLS TRIALS HIE TOTALS 
============================================== 
0 34.3 





































TOTALS 100.0 100.0 100.0 100.0 
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6.3.4. Antenatal Care : 
A number of aspects of antenatal care were examined. 
6.3.4.1. Stage of pregnancy at booking -
Table 6.3.4.1.1. shows that the asphyxiated groups 
together had a significantly higher proportion of 
unbooked mothers than the controls <Chi square = 17.96 
DF = 1 p=<0.001). There was no significant difference 
in this respect between the 2 asphyxiated groups. 
Considering only those that had booked, the asphyxiated 
groups tended to have booked earlier as compared to the 
controls. <Chi square = 12.36 DF =1 p=<0.001). There 
was no significant difference in this respect between 
the 2 asphyxiated groups. 
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TABLE 6 . 3 . 4 . 1. 1. WEEKS AT BOOKING 
============================================= 
CONTROLS TRIAL HIE TOTALS 
============================================= 
UNBOOKED 307 28 8 343 
1-12 24 1 25 
13-16 53 3 2 58 
17-20 151 10 1 162 
21-24 307 9 6 322 
25-28 635 35 8 678 
29-32 586 16 7 609 
33-36 376 13 9 398 
37-40 224 1 225 
41+ 1 1 
NO DATA 95 1 4 100 
============================================= 
TOTALS 2,758 116 47 2,921 
TABLE 6.3.4.1.1. WEEKS AT BOOKING - PERCENTAGES 
=================================================== 
CONTROLS TRIALS HIE TOTALS 
=================================================== 
UNBOOKED .11 . 1 24.1 17.0 11. 7 
1-12 .9 2. 1 .9 
13-16 1. 9 2.6 4.3 2.0 
17-20 5.5 8.6 2. 1 5.5 
21-24 11. 1 7.8 12.8 11. 0 
25-28 23.0 30.2 17.0 23.2 
29-32 21. 2 13.8 14.9 20.8 
33-36 13.6 11. 2 19. 1 13.6 
37-40 8. 1 2. 1 7.7 
41+ .9 
NO DATA 3.4 .9 8.5 3.4 
=================================================== 
TOTALS 100.0 100.0 100.0 100.0 
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6.3.4.2. Number of Antenatal visits 
Reference to Table 6.3.4.2.1. will show that the modal 
category of Antenatal visits was 5-8 with about 40Y. of 
all patients attending that many times. There were no 
significant differences between the groups in the 
pattern of number of visits. 
TABLE 6.3.4.2.1. NUMBER ANTENATAL VISITS: 
==================~========================== 



















































TOTALS 2,758 116 47 2,921 
TABLE 6.3.4.2.2. NUMBER OF ANTENATAL VISITS -
PERCENTAGES : 
================================================ 
CONTROLS TRIALS HIE TOTALS 
=====:========================================== 
NIL 11. 1 24.1 17.0 11. 7 
1&2 10.0 4.3 2. 1 9.7 
3&4 18.7 15.5 12.8 18.5 
5&6 22.6 14.7 23.4 22.3 
7&8 15.6 20.7 14.9 15.8 
9&10 10.7 12.1 12.8 10.7 
11&12 4.8 3.4 6.4 4.8 
13&14 2. 1 4.3 2.2 
15+ 1. 3 .9 2. 1 1. 3 
NO DATA 2.9 8.5 2.9 
================================================ 
TOTALS 100.0 100.0 100. 100.0 
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6.3.5. Antenatal Disorders 
Table 6.3.5.2. shows that the proportion in each group 
with any type of antenatal disorder, rose from 30X in 
controls to 46X in the trial and 63X in the HIE group. 
For analysis the disorders were grouped into the 
"UTERO-PLACENTAL PATHOLOGYff group -(pregnancy induced 
hypertension, eclampsia, abruptio, reduced fetal 
movements, intrauterine growth retardation and post 
term), "OTHER DISORDERS", "NO DISORDERS" and "MISSING". 
The asphyxiated groups had a much higher proportion of 
disorders especially of the utero-placental pathology 
group. The difference between the controls and the 
combined asphyxia groups was highly significant <Chi 
square =170.04 DF=3 p=<0.001) while there was no 
significant difference between the trial and HIE 
groups. The proportion of mothers whose antenatal 
disorders were unknown or for which data was missing 
was similar in all 3 groups. 
It is of interest that in no case was cephalopelvic 
disproportion 
disorder. 
<CPD> identified as an antenatal 
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TABLE 6.3.5.1. ANTENATAL DISORDERS: 
================================================ 
CONTROLS TRIAL HIE TOTALS 
================================================ 
NONE 1, 929 57 17 2,003 
PIH 258 16 8 282 
ECLAMPSIA 7 1 8 
ABRUPT IO 5 5 
DIABETES 4 1 1 6 
MULTIPLE PREG 6 6 2 14 
PLACENTA PR EVIA 3 3 
OTHER APH 17 1 18 
CARDIAC 5 5 
RED FET MVT 1 1 
IUGR 3 1 4 
POST TERM 2 2 
OTHER 4 3 7 14 
UNKNOWN 63 27 5 95 






RED FET MVT 
IUGR 
2,758 116 47 2,921 
= Pregnancy induced hypertension 
= Other antepartum haemorrage 
= -Reduced fetal movements 
= Intrauterine growth retardation 
TABLE 6.3.5.2. ANTENATAL DISORDERS - PECENTAGES. 
==================================================== 
CONTROLS TRIALS HIE TOTALS 
==================================================== 
NONE 69.9 49.1 36.2 68.6 
PIH 9.4 13.8 17.0 9.7 
ECLAMPSIA .3 .9 .3 
ABRUPT IO . 2 .2 
DIABETES • 1 .9 2.1 .2 
MULTIPLE PREG .2 5 .. 2 4.3 .5 
PLAC PRAEVIA . 1 . 1 
OTHER APH . 6 .9 .6 
CARDIAC .2 .2 
RED FET MVT .9 
IUGR 2.6 2. 1 . 1 
POST TERM 4.3 • 1 
OTHER . 1 2.6 14.9 .s 
UNKNOWN 2.3 23.3 10.6 3.3 
NO DATA 16.6 8.5 15.8 
==================================================== 
TOTALS 100.0 100.0 100.0 100.0 
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6.3.6. Evidence of Fetal Distress : 
Evidence of fetal heart abnormalities plus meconium 
stained liquor was one of the major criteria for 
selecting the trial group so this group will be left 
out of the comparisons in this section. 
Table 6.3.6.2. shows that 25.5Y. of the HIE group had 
had type 2 dips on fetal heart monitoring and 34.0X had 
meconium stained liquor only. The HIE group had 
significantly more fetal distress of any type than did 
controls. <Chi square =78.7 DF=l p=<0.001>. Reduced 
fetal movements as a sign of fetal distress was found 
in 5 controls and 4 trial patients. 
TABLE 6.3.6.1. EVIDENCE OF FETAL DISTRESS 
============================================= 
CONTROLS TRIAL HIE TOTALS 
============================================= 
FH T2D 
FH + MSL 
MSL 




























TOTALS 2,758 116 47 2,921 
See following page for key. 
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TABLE 6.3.6.2. EVIDENCE OF FETAL DISTRESS 
- PERCENTAGES 
============================================== 
CONTROLS TRIALS HIE TOTALS 
=========~==================================== 
FH T2D 3.0 12.9 8.5 3.5 
FH + MSL 21. 6 17.0 1.1 
MSL 9.8 49.1 34.0 11. 7 
RED FET MVT • 2 3.4 .3 
OTHER • 1 • 1 
NONE 80.1 12.9 38.3 76.8 
UNKNOWN 6.9 2. 1 6.5 
============================================== 
TOTALS 100.0 100.0 100.0 100.0 
KEY 
FH T2D = Fetal Heart type 2 dips or ~orse. 
FH + MSL 
RED FET MVT 
= As above plus meconium stained liquor. 
= Reduced fetal movements. 
6.3.7. Method of Delivery. 
As can be seen from Table 6.3.7.2. the frequency of 
caesarian section was 13.1, 62.1, and 48.9Y. in the 
control, trial and HIE groups respectively. For 
analysis the methods of delivery were grouped as normal 
vertex delivery <NVD>, caesarian section and other. 
Thus grouped, the difference between the asphyxiated 
groups and controls was highly significant. <Chi square 
=280.5 DF=2 p=<0.001). There were no breech deliveries 
among the 2 asphyxiated groups and only 1 forceps 
delivery. Vacuum extraction was used significantly more 
often in the trial and HIE groups than in the controls 
<Chi square= 33.4 DF=2 p=<0.001). 
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TABLE 6.3.7.1. METHOD OF DELIVERY 
============================================= 
CONTROLS TRIAL HIE TOTAL 
============================================= 
NORMAL VERTEX 2,318 35 16 2,369 
CAESARIAN 360 72 23 455 
BREECH 18 18 
FORCEPS 2 1 3 
VACUUM 50 9 5 64 
UNKNOWN 10 2 12 
============================================= 
TOTALS 2,758 116 47 2,921 
TABLE 6.3.7.2. METHOD OF DELIVERY - PERCENTAGES. 
================================================= 





























TOTALS 100.0 100.0 100.0 100.0 
6.3.8. Duration of the first stage of labour : 
As can be seen in Table 6.3.8. this stage was 
significantly longer in the combined asphyxiated 
groups than in controls (Chi square =26.57 DF=3 
p=<0.001>, while there was no difference between the 
two asphyxiated groups. 
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TABLE 6 • 3 .• 8. 1. DURATION OF STAGE 1 
===================================================== 
HOURS CONTROLS TRIAL HIE TOTALS 
===================================================== 
C/S BEFORE LABOUR 251 9 4 264 
1-6 788 20 5 813 
7-9 578 25 9 612 
10-12 424 16 10 450 
13-15 251 14 6 271 
16-18 156 12 4 172 
19-21 71 5 4 80 
22-24 31 7 2 40 
25-36 22 5 1 28 
37+ 4 3 7 
NO DATA 182 2 184 
===================================================== 
TOTALS 2,758 116 47 2,921 
TABLE 6.3.8.2. DURATION OF STAGE 1 - PERCENTAGES. 
======================================================= 
HOURS CONTROLS TRIALS HIE TOTALS 
======================================~================ 
C/S BEFORE LABOUR 9. 1 7.8 8.5 9.0 
1-6 28.6 17.2 10.6 27.8 
7-9 21.0 21. 6 19. 1 21. 0 
10-12 15.4 13.8 21. 3 15.4 
13-15 9. 1 12. 1 12.8 9.3 
16-18 5.7 10.3 8.5 5.9 
19-21 2.6 4.3 8.5 2.7 
22-24 1. 1 6.0 4.3 1. 4 
25-36 .8 4.3 2. 1 1.0 
37+ . 1 2.6 . 2 
NO DATA 6.6 4.3 6.3 
--- ==================================================== 
TOTALS 100.0 100.0 100.0 100.0 
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6.3.9. Resuscitation 
Table 6.3.9.2. shows that the two asphyxiated groups 
together had much higher percentages of mask and 
endotracheal tube <ET> ventilation than the controls 
(Chi square =901.2 DF=l p=<0.001}. The HIE group had 
the highest percentage <46.8Y.} of endotracheal tube 
ventilation and was significantly different in this to 
the trial group <Chi square= 5.55 DF=l p=<0.02). 
TABLE 6.3.9.1. METHOD OF RESUSCITATION 
==========~===================================== 



























TOTALS 2,758 116 47 2,921 
TABLE 6.3.9.2. METHOD OF RESUSCITATION - PERCENTAGES. 
===================================================== 



























TOTALS 100.0 100.0 100.0 100.0 
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6.3.10. Birth Weight. 
The birth weights of the 3 groups are set out in Table 
6.3.10. There was no significant difference between the 
3 groups in mean birth weights. Equally there was no 
difference in the proportions of birth weights above 
and below 2500 grams between the controls and the 
combined asphyxia! groups <Chi squared= 0.18 DF = 2>. 
TABLE 6.3.10. BIRTH WEIGHTS IN STUDY GROUPS 
<Grams). 
================================~================ 
BIRTH WEIGHTS CONTROLS HIE TRIAL 
================================================= 
1500-1750 12 
1751-2000 8 1 
2001-2250 35 1 
2251-2500 110 1 5 
2501-2750 237 6 8 
2751-3000 473 4 21 
3001-3500 1122 16 46 
3501-4000 609 16 28 
4000 + 109 2 7 
MISSING 43 1 
================================================= 
TOTALS 2758 47 116 
MEAN (Gms.) 3220 3309 3270 
SD 470.6 489.2 473.1 
CONTROLS vs HIE t = 1.276 DF = 2759 NS 
CONTROLS vs TRIAL t = 1.122 DF = 2829 NS 
HIE vs TRIAL t = 0.472 OF = 160 NS 
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6.3.11. Apgar scores of HIE group 
Finally it is of interest to look at the Apgar scores 
of the 47 infants who subsequently developed clinical 
hypoxic ischaemic encephalopathy <HIE>. The control 
group and the trial group are biased in that they were 
both selected partly on the basis of the Apgar score so 
they will not be further considered here. The scores of 
the HIE group are set out in Table 6.3.10. 
TABLE 6 . 3. 11. APGAR SCORES OF HIE GROUP 
========================================! 
APGAR SCORE 1 Minute 5 Minutes : 
===============:============ ===========: 
0-3 : 23 (49Y.) 5 (11Y.) 
===============!============ =========== 
4-6 14 ( 30Y.) 14 (30Y.) 
===============:============ =========== 
7 + 8 (17Y.> 25 (53Y.) 
=============== ============:=========== 
MISSING 2 ( 4 Y.) 3 ( 6Y.) 
=============== ============:=========== 
TOTAL 47 (100Y.) : 47 (100Y.) 
===============:============:=========== 
It is of note that 47Y. of these encephalopathic infants 
had 1 minute Apgar sco~es 4 or more and 83Y. had 5 
minute scores of 4 or more. 
-~~----------~---------------------' 
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6.3.12. Cause of Asphyxia designated by obsetrician 
The causes of asphyxia designated after review by the 
specialist obstetrician in charge of the case are shown 
in Table 6.3.12. There is no significant difference 
between the patterns of the trial and HIE groups. Taken 
together the largest group is cephalopelvic 
disproportion <CPD>. The next largest is that in which 
after thorough review no cause could be assigned. 
Pregnancy induced hypertension <PIH>, abruptio and 
intrauterine growth retardation <IUGR> respectively 
were the next most important causes. Maternal sedation, 
difficulties with the cord and overt maternal infection 
were seen to be less common. 
Due to the way routine data was collected it was 
unfortunately not possible to discuss control cases 
with the obstetricians in the same way as for the HIE 
and TRIAL groups. 
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TABLE 6. 3. 12. 1. OBSTETRICIAN'S CAUSE OF ASPHYXIA 
======================================================== 
TRIAL HIE TOTALS ======================================================== UNKNOWN 
CEPHALOPELVIC DISPROPORTION 
PREGNANCY INDUCED HYPERTENSION 
ECLAMPSIA 
CPD + PIH 
PROLAPSED CORD 






INTRUTERINE GROWTH RETARDATION 
POST TERM 












































7 ========================================================= TOTALS 116 47 




TRIALS HIE TOTALS ========================================================= UNKNOWN 
CEPHALOPELVIC DISPROPORTION 
PREGNANCY INDUCED HYPERTENSION 
ECLAMPSIA 
CPD & PIH 
PROLAPSED CORD 






INTRA UTERINE GROWTH RETARDATION 
POST TERM 












































4.3 ========================================================= TOTALS 100.0 100.0 100.0 
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6.4. DISCUSSION 
6.4.1. Selection bias of controls: 





selected patients delivered at 
means of selection was that 
the 
those 
attending booking clinics at one of the peripheral 
clinics were assesed and referred for hospital delivery 
only if one or more risk factors was present. A 
schedule of these is provided in Appendix III. 
6.4.2. Limited Number of variables : 
The number of variables that could be examined was 
limited to the items of data routinely gathered by the 
obstetric department on the patients used here for 
controls. 
6.4.2.1. Socioeconomic status 
Socioeconomic status is one item that it would have 
been desirable to examine. As discussed in Chapter 5 
<Table 5.1.2.) asphyxia is a much more important cause 
of neonatal death in underdeveloped as compared to 
developed regions. This suggests that socioeconomic 
status is an important variable. 
In the studies of the epidemiological associations of 
asphyxia summarised in Table 5.2.1. only that of 
MacDonald et al <1980) looked at socioeconomic status. 
They found that asphyxia was associated with a lower 
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socioeconomic status. The other studies did not 
investigate this factor either because the numbers 
were too small or because the studies were carried out 
in a rather uniform social environment which did not 
allow analysis of this factor (Bolton 1985). 
6.4.3. Parity 
There was an excess of primiparous patients amongst the 
groups with asphyxiated infants. It is surprising that 
in a number of studies of the epidemiology of asphyxia 
the effect of gravidty and/or parity is not mentioned. 
The study of Bolton (1985) from Baragwanath Hospital in 
Soweto is of particular interest in that it is from a 
community and a service with many similarities to our 
own. He also found an association between low parity 
and asphyxia. A similar association was found by Cyr et 
al (1984) from Montreal. On the other hand Dweck <1974) 
et al from Birmingham Alabama found that parity was not 
associated with asphyxia. Unfortunately their numbers 
were very small <15>. 
The association between asphyxia and primiparity found 
in the present study is strong and in view of Boltons 
similar finding it seems that in a developing world 
situation this association is real. 
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6.4.4. Antenatal clinic attendance 
The extent to which mothers did not book at all for 
antenatal care was relatively low at 11.5Y.. Hamilton 
et al (1987) are more stringent in regarding "booking" 
as attendance at antenatal clinic on at least 3 
occasions. Even by this strict criterion only 21.4Y. of 
all deliveries in hospital were not "booked". There 
were significantly more unbooked mothers in the 
combined asphyxia groups as compared to controls. 
The stage of pregnancy at booking is overall rather 
late with 42Y. booking after 28 weeks. 
The number of antenatal clinic visits in the three 
groups was not significantly different. The number of 
visits was relatively high with 64Y. of attenders 
appearing 5 or more times. 
The pattern of antenatal clinic use seems to be that 
most pregnant women delivering in the health service do 
book but do so relatively late and then attend 
frequently thereafter. 
Bolton (1985) from Baragwaneth Hospital in Soweto found 
a mean number of visits of 4.27 and no difference 
between asphyxiated and control groups in this respect. 
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6.4.5. Antenatal disorders 
Reference to the studies detailed in Table 5.2.1. 
indicates that there is a group of antenatal disorders 
that have been regularly associated with asphyxia. This 
group includes hypertension, "toxaemia", pre-eclamptic 
toxaemia, intrauterine growth retardation, antepartum 
haemorrhage, prolapsed cord, prolonged rupture of 
membranes, features of cephalopelvic disproportion and 
malpresentations. 
These associations are in agreement with the findings of 
the present study. There was a much greater incidence of 
antenatal disorders in the 2 asphyxiated groups as 
compared to controls and this was particularly so for 
the "utero-placental" group of disorders. On the other 
hand it is of note that CPD was not diagnosed as an 
antenatal disorder in a single case. Nevertheless even 
though CPD tended to be diagnosed in retrospect it was 
a major antenatal association with asphyxia in this 
study. It is striking that with the exception of the 
"mechanical" problems the rest of these disorders all 
would seem to have utero-placental pathology of one 
sort or another in common. 
6.4.6; Fetal Distress : 
Here discussion of the Trial group will be left out as 
it was heavily biased for signs of fetal distress by 
the selection criteria. 
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The HIE group had shown abnormalities in the rate and 
or pattern of the fetal heart 8.7 times more often than 
the controls and meconium staining of the liquor 5.2 
times more often. In the HIE group 60X had shown one or 
more signs of fetal distress as compared to 13X in the 
control group. These figures indicate that the 
classical signs of fetal distress were neither very 
sensitve nor very specific for asphyxia in this study. 
Reference to Table 5.2.1. reveals that every study in 
which the relationship between fetal distress and 
neonatal asphyxia was evaluated, the association was 
significant. 
6.4.7. Mode of Delivery: 
The caesarian section rate ranged from 13X in controls 
to 62X in the Trial group. The differences beween the 
controls and the two asphyxiated groups were highly 
significant. 
Rothberg et al <1986) did not find caesarian section to 
be more common amongst asphyxiated inf ants than controls 
but the numbers in their study were small (13 cases). On 
the other hand the studies of Thomson (1977>, MacDonald 
\ 
(1980) and Cyr et al <1984) all found that caesarian 
section was associated with asphyxia. MacDonald and Cyr 
further found that the association was only present when 
it had been performed for some acutely occuring 
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complication of pregnancy or labour and not when 
performed electively. It is likely that the reason for 
performing a caesarian section may be more important 
than the procedure itself. 
Vacuum extraction was used infrequently but 
significantly more so in the trial and HIE groups <BX & 
11X> than in controls <2X>. It is difficult to comment 
on the significance of forceps delivery as only 1 HIE 
and 2 controls were born in this manner. Breech 
delivery cannot be implicated in asphyxia in this study 
as no asphyxiated infant was born in this way. 
The mode of delivery is more likely to be a secondary 
phenomenon to the underlying cause of asphyxia than to 
be a primary cause itself. Thus CPD will cause asphyxia 
by prolonging labour and will for the same reason tend 
to lead to delivery by caesarian section. The use of 
the vacuum is similarly a secondary phenomenon although 
this instrument does have the ability to cause cerebral 
trauma in its own right. 
6.4.8. Duration of first stage : 
A long first stage of labour seems to be a significant 
association of asphyxia. This is not surprising 
considering the placental compression that occurs with 
each uterine contraction. 
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6.4.9. Resuscitation of the Infant : 
This study confirms that inf ants who become 
encephalopathic in the neonatal period are not 
necessarily depressed at birth. It was not unexpected 
that 66Y. of subsequently encephalopathic infants needed 
active ventilation at birth as compared to only l.6Y. of 
controls. On the other hand it is surprising that as 
many as 30Y. of the infants who later deveoloped 
encephalopathy did not need active resuscitation. 
6.4.10. Birth Weight : 
It is interesting to note that in the term infants 
studied, growth retardation was not significantly 
associated with asphyxia as it is here defined. There 
were no more growth retarded infants among the two 
asphyxiated groups than among the normal controls. 
6.4.11. Apgar scores : 
It is furthermore remarkable that half of later 
encephalopathic infants had Apgar scores at 1 minute of 
4 or more. This is so despite the presumption that 
these infants had suffered significant hypoxic insults 
in utero. The lack of sensitivity of Apgar score in 
predicting encephalopathy or subsequent handicap has 
been discussed in section 5.4. in connection with the 
role of asphyxia in the aetiology of cerebral palsy. 
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6.4.12. Obstetric cause : 
The leading cause of asphyxia assigned in retrospect by 
the attending obstetric specialist was cephalopelvic 
disproportion (39Y.>. This is particularly significant 
in the light of the fact that it was not diaganosed at 
all as an antenatal problem. 
If one creates a category broadly taking in utero-
placental pathology it would include pregnancy 
induced hypertension, eclampsia, abruptio, intrauterine 
growth retardation, post term and diabetes. This 
category accounts for about 22Y. of the cases of 
asphyxia. 
In another 27Y. of all cases of asphyxia the 
obstetrician could assign no cause. In the absence of 
cephalopelvic disproportion or one of the utero-
placental pathologies referred to above, it is tempting 
to speculate that there is a reservoir of placento-
fetal pathology that is neither evident clinically nor 
visible on inspection of the placenta or membranes. 
This would include subclinical amnionitis or 
unrecognised disease of utero-placental vessels. 
The study and elucidation of this large group of 
ttocculttt causes would seem to be of great importance as 
until the various at present unknown specific causes 
are unravelled therapeutic and preventive measures 
cannot be developed to combat the problem. 
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The problem of asphyxia seems to decline as the 
socioeconomic status of a community rises. While the 
reason for this may be partly nutritional in reducing 
intrauterine growth retardation, and partly to do with 
improvement in obstetric care, it may well he that the 
"occult" group of disorders disappears with rising 
affluence, without our ever defining the cause. The 
reduction in the problem in affluent societies has the 
effect of reducing the necessity for obstetricians in 
those areas who have the resources to do the necessary 
research to elucidate the problem further. The 
underdeveloped parts of the world suffering from the 
problem are the least able to afford research into the 
problem. 
The knowledge and technology to avoid the adverse 
consequences of cephalopelvic disproportion are already 
available. Also the utero-placental group of causes is 
to a large extent already amenable to meticulous 
obstetric care during the antenatal period and labour. 
Unfortunately these conditions remain prevalent in the 
developing world. It must be possible to reduce the 
problem of asphyxia in the third world by making 
effective use of existing knowledge. The challenge to 
those working in developing world obstetrics is to 
organise services and to train staff in such a way as 
to bring that knowledge to bear on the problem. 
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Failure to do so will result in a continuation of the 
existing high incidence of major neurodevelopmental 
handicap in communities that do not have the resources 
to alleviate the social and economic burden that this 
places upon them. 
6.5. CONCLUSIONS : 
6.5.1. The positive epidemiological associations of this 
group of 163 asphyxiated infants were 
* Low gravidity and parity. 
* Not booking for antenatal care. 
* The occurence of antenatal disorders. 
* The occurence of classical fetal distress. 
* A prolonged first stage of labour. 
* Delivery by caesarian section. 
* Delivery by vacuum extraction. 
6.5.2. The factors found not to be associated with asphyxia 
were : 
* Maternal age. 
* The number of antenatal visits. 
6.5.3. The causes of asphyxia assigned by the obstetrician 
in charge of the cases were in order of importance : 
* Cephalopelvic disproportion. 39% 
* No cause detected. 27% 
* Utero-placental pathologies. 22% 
* Other 8% 
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6.5.4. 
6.5.5. 
The leading components of the utero-placental 
pathologies were 
* Pregnancy induced hypertension 10.4X 
* Abruptio placentae 4.9X 
*Intrauterine growth retardation 3.7X 
* Post term 1.SX 
The incidence of causes such as cord disorders and 
maternal sedation is very small. 
6.5.6. Less than a half of subsequently encephalopathic 
inf ants had Apgar scores of 3 or less at one minute. 
6.5.7. The obstetric challenges with repect to asphyxia in 
the developing world are 
* To organize health sevices and train staff of all 
types to bring existing knowlege to bear on the 
problem of this severely handicapping disorder. 
* To ensure that the primiparous patient receives 
particular attention both antenatally and during 
labour and especially to ensure adequate screening 
of pelvic adequacy. 
* To regard the "placental pathology" group of 
disorders as placing the pregnant woman in a very 
high risk group needing extra supervision during 
pregnancy and labour. 
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* To unravel the large group of apparently occult 
causes of asphyxia and by elucidating the causes 
hopefully contribute to its prevention. 
CHAPTER 7 
TREATMENT OF ASPHYXIA NEONATORUM 
.. 
I 
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7.1. INTRODUCTION. 
This chapter deals with the literature relating to the 
treatment of perinatal asphyxia paying special 
attention to the use of barbiturates and 
corticosteroids. It begins with' a very brief review of 
well established general principle~ of treatment and 
goes on to deal with the evidence for a protective role 
for barbiturates following hypoxic-ischaemic cerebral 
insults. Next the literature on the theoretical and 
practical value of corticosteroids in this situation is 
examined. Finally the literature relating to the 
clinical use of barbiturates and corticosteroids in the 
clinical situation of the asphyxiated term 
neonate is considered. 
7.2. GENERAL MANAGEMENT OF THE ASPHYXIATED INFANT. 
human 
The general management of the asphyxiated infant has 
been reviewed by a number of authors including Volpe 
(1976), Voorhies and Vannucci (1984), and Hill (1985> 
and is well established. The main points will be 
briefly mentioned here only to place what follows in 
context. After 
transferred to 
adequate resuscitation the patient is 
a high care area for subsequent 
management. Throughout, adequate ventilation is 
essential to avoid both further hypoxia and the 
cerebral vasodilatation associated with hypercapnia. It 
I 
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may be necessary to use assisted ventilation to achieve 
this. Metabolic acidosis and electrolyte disturbances 
need to be checked for and treated actively. An 
adequate circulation is required to limit further 
ischaemic damage to the brain and other organs. 
Hypotension associated with hypovolaemia may occur and 
blood volume restoration become necessary. Hypoxic-
ischaemic myocardial damage may occur resulting in 
further cerebral under-perfusion. This needs to be 
detected and treated vigorously. Ischaemic gut damage 
may lead to a transient paralytic ileus needing a 
period of bowel rest, nasogastric drainage and on 
qccasion, intravenous alimentation. In severe cases 
renal damage of sufficient severity to cause anuria 
occurs which needs active management of acute renal 
failure. 
Review of some of the more contentious issues in 




An active debate has continued as to whether supra-
normal blood glucose levels are helpful in limiting 
cerebral damage after hypoxic-ischaemic insults. 
Britton (1945) and Yannucci <1978) have pointed out the 
dangers of hypoglycaemia superimposed on hypoxic 
ischaemic brain damage and most authors have advocated 
r 
( 
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active maintainance of at least a normal blood glucose. 
Holowach-Thurston et al <1973, 1974) found that glucose 
administered to rats before a hypoxia! insult had a 
protective effect in that the survival rate was 
increased 15 fold and brain energy resources were 
relatively spared. They also found that the glucose 
content of brain tissue in asphyxiated rats was low 
depite normal or even elevated blood levels. These 
findings raised the possibility that the provision of 
super-normal blood glucose in asphyxiated infants might 
be beneficial. The elevated blood glucose level might 
help by allowing more glucose to enter the hypoxic 
brain to be used as substrate in anaerobic glycolysis. 
On the other hand Myers and Yamaguchi <1977>, using a 
juvenile monkey model showed that artificially induced 
hyperglycaemia during asphyxia contributed to 
subsequent cerebral oedema and aggravated the 
neurological condition by increasing lactic acidosis. 
Voorhies et al (1982) cast further doubt on the value 
of hyperglycaemia when they found that pretreatment of 
asphyxiated rats with glucose may accentuate the extent 
of brain damage. 
The current consensus as expressed by Hill (1985) seems 
to be that euglycaemia is the most suitable environment 
for the asphyxiated human infant. 
f 
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7.2.2. Management of cerebral oedema 
It has been held for some time that application of 
effective measures to reduce cerebral oedema would 
improve the outcome in asphyxiated inf ants. These 
measures have included head position, fluid 
restriction, and the administration of steroids and/or 
hyperosmolar fluids such as mannitol. 
Lou Marsh et al (1977) comment that in non-newborn 
neurosurgical intensive care, the head-up position 
reduces intracranial pressure by improving venous 
return from the head. They also note that in patients 
in whom the intracranial pressure is being monitored, 
wide swings of pressure are seen when the patient's 
head is turned. Little attention seems to have been 
paid thus far to head position in the aphyxiated 
neonate with raised intracranial pressure. 
Avoiding the administration of excessive quantities of 
hypotonic fluids to patients with cerebral oedema is 
normal practice. The reasons given by Fenichel (1983) 
are that hypotonic fluids leak easily across the 
damaged vascular epithelium and accumulate as tissue 
fluid in the brain. Furthermore inappropriate secretion 
of antidiuretic hormone after asphyxia! brain injury 
leads to water intoxication with aggravation of 
cerebral oedema. For both of these reasons authors such 
as Fenichel <1983), Lou Marsh (1977> and Volpe (1976> 
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recommend restriction of the total fluids to 50-70% of 
normal. 
The other agents frequently used in an attempt to 
reduce cerebral oedema in asphyxiated inf ants are 
steroids, particularly dexamethasone and hypertonic 
solutions such as mannitol. The use of dexamethasone is 
the subject of a separate section of this review and 
will not be discussed here. 
The effectiveness of mannitol in severely asphyxiated 
term infants has been reported by Levene and Evans 
(1985). They monitored the intracranial pressure by 
means of a subarachnoid catheter and infused .20Y. 
mannitol Clgm /Kg) over 20 minutes on 9 occasions in 4 
patients. They found that there was a fall of 
intracranial pressure within 20 minutes of starting the 
infusion and by 40 minutes there was a 35Y. drop in 
intracranial pressure that was sustained for a further 
4 hours. 
systemic 
In some cases they were able to monitor 
blood pressure and so estimate cerebral 
perfusion pressure. In all such cases there was a 
significant rise in.cerebral perfusion pressure which 
was sustained for at least a further 4 hours. No 
adverse alterations in serum electrolyes or urinary 
specific gravity were found in any case. They conclude 
that mannitol is a useful adjunct to the management of 
raised intracranial pressure in severely asphyxiated 
inf ants. 
( 
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Marchal et al (1974} also reported on the use of 
mannitol but did not use controls and the outcome was 
thus uncertain. Fenichel (1983} and Voorhies and 
Vannucci (1984) recommend the use of Mannitol in cases 
of severely raised intracranial pressure in asphyxiated 
infants in doses of 0.25-1.00 gm/kg. 
Hahn (1980} notes that the 
given 4-6 hourly. 
effectiveness of 
hyperosmolar solutions in reducing intracranial 
pressure depends on the integrity of the blood brain 
barrier, and that in a severely asphyxiated infant this 
integrity is to a greater or lesser degree disturbed so 
that the substance tends to migrate into the tis•ue 
fluid and equilibriate with the oedematous area. At 
this point it loses its effectiveness. Volpe (1976) 
avoids the use of hypertonic solutions because of a 
fear of inducing intracranial haemorrhage presumably 
from rapid brain shrinkage inducing shearing forces on 
blood vessels. 
In summary, the available evidence suggests ~hat the 
use of mannitol in the severely asphyxiated infant with 
CT or ultra-sound evidence of cerebral oedema is likely 
to limit cerebral infarction. Further prospective 
trials in this area are necessary. 
' ; 
J 
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7.2.3. Seizure control 
Seizures occur frequently in the asphyxiated infant and 
immediate investigations are necessary to exclude 
metabolic or infective causes for the seizures. These 
include cerebrospinal fluid examination, blood glucose, 
serum sodium, calcium, magnesium and urea. Such 
metabolic disturbances need active management. 
The avoidance or early treatment of seizures is of 
great importance in the management of the asphyxiated 
infant. Meldrum and Nilsson <1976) have demonstrated a 
many fold increase in cerebral oxygen consumption 
during seizures. Furthermore King et al (1967) and 
Howse et al (1974> have shown that in experimental 
animals the energy reserves of the brain are depleted 
in status epilepticus. The inference is that the known 
increase in cerebral blood flow during seizures cannot 
keep pace with the increased metabolic demand and hence 
the possibility of further ischaemic damage to the 
brain is real~ Another factor compounding the problem 
is cerebral vasodilation produced by the hypercapnia 
following hypoventilation during the seizure. This 
will contribute to an already raised intracranial 
pressure. 
As will be reviewed below, barbiturates may possibly 
have a beneficial effect on the long term outcome of 
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at present to use phenobarbitone as the first line 
prophylactic anticonvulsant agent in these inf ants. The 
variable metabolism of phenobarbitone even in the same 
patient from day to day makes regular blood level 
measurements desirable. Fenichel (1983) prefers to use 
phenytoin as it is less sedating. 
7.2.4. Naloxone : 
Naloxone has been widely used in the resuscitation of 
the asphyxiated infant especially when opiate 
depression is thought to be the cause. Recent reports 
by Goodlin (1981) and Young <1984) provide evidence 
that naloxone may be deleterious in asphyxiated 
infants. Young et al used the Levine model of asphyxia 
in young rats who were given various doses of naloxone 
at various times after the asphyxia! insult. As 
compared to controls the naloxone treated rats had 
greater rates of cerebral infarction and reduced 
survival. The reason for this is not clear but may 
operate through the known cardiotoxic effect of 
naloxone in reducing cardiac output and thus cerebral 
perfusion. 
7.3. POSSIBLE MECHANISMS OF BARBITURATE PROTECTION • 
This section will review literature relating to the 
theoretical mechanisms which may underly the protective 
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7.3.1 Reduction in cerebral metabolism. 
Since the work in 1946 of Himwich et al. (1947> it has 
been known that barbiturates reduce cerebral oxygen 
consumption by up to SSY.. This is clearly advantageous 
in a hypoxic situation. 
Gardiner <1980) found that in the calf anaesthetised 
with sodium pentobarbitone, the cerebral metabolism 
was reduced by 28Y. as compared to controls. In lambs 
the reduction was 22Y.. Astrup et al (1981> found that 
pentobarbitone administered to dogs under halothane 
anaesthesia reduced cerebral utilisation of both oxygen 
and glucose by about 30Y.. In a similar dog model using 
thiopentone, Michenfelder (1974), found that despite a 
marked fall in oxygen uptake in the presence of the 
barbiturate, cerebral metabolism was not rendered 
anaerobic, as reflected by normal levels of adenosine 
triphosphate, phosphocreatine and lactate. He also 
found that cerebral metabolism was progressively 
reduced by increasing doses up to the point of 
electrical silence on electroencephalogram <EEG>. 
Larger doses did not reduce cerebral metabolism 
further. He concludes that thiopental does provide 
cerebral protection up to the point of electrical 
silence on EEG, but not beyond that point. 
Ten day old mice pre-treated with large intraperitoneal 
doses of phenobarbitone (150mg/Kg) before decapitation, 
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showed a slower rise in cerebral adenosine 
monophosphate and inorganic phosphate than did controls 
(Lowry et al 1964). The authors interpret this as being 
due to the effect of phenobarbitone in reducing 
cerebral metabolism. Wechsler et al (1951) in the study 
of human adults undergoing thiopentone anaesthesia also 
found a significant reduction in cerebral metabolic 
rate as measured by rate of cerebral oxygen 
consumption. These results were confirmed by Pierce et 
al <1962> in a similar study. 
7.3.2. Effect on cerebral blood flow 
Gardiner in the study referred to above found a 35~ 
decrease in cerebral blood flow in the calf under 
sodium pentobarbitone anaesthesia. Similar findings 
were reported by Astrup et al (1981) in their dog 
model. 
Contradictory findings come from Wechsler et al (1951) 
who studied 12 human adults anaesthetised with 
thiopentone. They used the. nitrous oxide method to 
estimate the cerebral blood flow which they found to be 
.slightly increased . They attribute this to the 
vasodilating effect of the raised pC02 which they 
documented. On the other hand Pierce et al (1962) in a 
similar human study found a reduction in cerebral blood 
flow under thiopentone anaesthsia which was greatly 
exagerated by hyperventilation. The level of pC02 is 
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clearly very important factor to control for in any 
study of cerebral blood flow. This is because the 
sedative' action of the barbiturate will produce 
hypoventilation, leading in turn to C02 retention and 
hence to cerebral vasodilation. This effect may then 
overwhelm the vasoconstrictive effect of the 
barbiturate. 
The cerebral vasoconstrictive effect of barbiturates 
is potentially protective when part of the brain is 
rendered hypoxic by an arterial infarct. The damaged 
vessels in the ischaemic area do not respond to the • 
vasoconstrictive effect of the barbiturate which does 
however affect the rest of the brain. Blood would be 
diverted from the normal to the ischaemic area, 
alleviating the ischaemia to a degree. This phenomenon 
is known as the "reverse steal" effect <Steen <1980>. 
This mechanism is however unlikely to protect in the 
case of whole brain hypoxia such as occurs in perinatal 
asphyxia. 
7.3.3. Effect on reduction of intracranial pressure : 
That barbiturates reduce raised intracranial pressure 
has been documented by Rockoff et al. (1979) in a group 
of young children and adolescents with Reye's Syndrome 
in an intensive care situation. They found that the 
dose of mannitol required to maintain a normal 
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institution of pentobarbital therapy. 
7.3.4. Effect on brain glucose : 
Mayman et al 1964 report that during pentobarbital 
anaesthesia the concentration of glucose in mouse brain 
more than doubles. In the light of the discussion above 
on the role of glucose in the asphyxiated brain such a 
rise in brain glucose is probably protective to the 
immature individual with cerebral hypoxia. 
7.3.5. Effect on catecholamine release inhibition : 
Cheek et al. <1963) found that in the human fetus and 
newborn infant anoxia causes an increase in circulating 
catecholamines. Maynert (1964> has found that the 
release of catecholamines from the adrenal gland and 
brainstem can be prevented by barbiturates. This may 
well be important as Emerson (1942) found that 
pretreating anoxic animals with adrenaline shortens 
survival time. 
7.3.6. Effect on free radical quenching : 
A controversial is~ue is that concerning the role of 
the barbiturates in »quenching» free radicals <Flamm et 
al 1977>. A review of free radicals in cellular 
metabolism is provided by Demopoulos (1973). Steen and 
Michenfelder (1980) state »a free radical is a molecule 
with an unpaired electron in its outer orbital and 
hence is in a high energy state and is extremely 
reactive". Superoxide is a free radical present in 
I , 
I 
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normal cells. Minute amounts are generated in normal 
metabolism. The enzyme superoxide dismutase is present 
in all aerobic cells to quench this free radical and 
hence prevent its disruptive effects. The cellular 
membranes including those of the mitochondria are also 
capable of quenching small ammounts of free radicals 
formed as intermediate metabolites. In hypoxia there is 
a deficiency in the electron acceptor at the end of the 
electron transport chain. Free radicals build up beyond 
the membrane's capacity to buffer them and reactions 
are initiated which disrupt the mitochondrial 
membranes. 
Flamm et al. (1978) found that the barbiturate 
methohexital could block free radical production in the 
brains of cats after occlusion of a middle cerebral 
artery. They also showed that it could scavenge certain 
free radicals in vitro. They concluded that 
methohexital's protective effect was due in part at 
least to its free radical quenching ability. 
Smith el al. (1974) studied the in vitro free radical 
quenching properties of 4 different barbiturates and 
found that while thiopental was very active, 
methohexital was slightly active and pento- and pheno-
barbitone not active at all. Differences in vivo free 
radical quenching have also been found. Flam et al. 
(1977, 1978) found active free radical production 
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after middle cerebral artery ligation despite 
pentobarbital anaesthesia. 
Experimental studies of barbiturate protection in 
animals experiencing hypoxia suggest that all the above 
barbiturates afford protection despite these 
differences in their in vitro and in vivo free radical 
quenching properties. The role that the free radical 
quenching properties of some barbiturates play in the 
protection against hypoxia remains uncertain. 
I 
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7.4. PROTECTIVE EFFECT OF BARBITURATES IN ANIMAL MODELS OF 
HYPOXIC-ISCHAEMIC CEREBRAL INJURY. 
There have been a number of animal studies 
investigating the protective effect of barbiturates in 
cerebral hypoxia. Many of these have been concerned 
with the effects of barbiturates on cerebral 
ischaemia/hypoxia in adult animals. 
7.4.1. Adult animal studies 
7.4.1.1. Treatment before insult 
The earliest work in this field came from Emerson et al 
(1942> who found that pretreatment with ethanol and to 
a lesser extent with pentobarbitone, prolonged the 
survival time of adult mice subjected to hypoxia by 
barometric decompression. Arnfred and Secher <1962} 
found that pretreatment with intravenous thiopentone 
improved mortality and survival time of adult mice 
subjected to hypoxia by inhalation of oxygen mixtures 
of 5Y. or less. 
Later studies by Wells et al (1963}, Withjelm et al 
<1965> and Goldstein et al <1966) all found that 
barbiturates given before an hypoxic/ischaemic insult 
minimized the subsequent neurological deficit. 
7.4.1.2. Treatment during insult 
Yatsu et al <1972) using a rabbit model showed that 
f 
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methohexital given during the insult was beneficial to 
the neurological outcome. 
7.4.1.3. Treatment after the insult: 
These studies are of particular interest as treatment 
after the 
barbiturates 
insult is the only possible use 
in human asphyxia. The studies will 
of 
be 
divided into those concerned with ischaemia of a part 
of the brain as opposed to those involved with whole 
brain insults. 
7.4.1.4. Focal brain ischaemia 
Smith et al (1974) using dogs and Hoff et al (1975)' 
Mosley et al <1975> and Michenfelder 1978 all using 
adult primate models of acute cerebral ischaemia in 
which a single cerebral artery was ligated have shown 
that barbiturates given after the insult are beneficial. 
7.4.1.5. Whole brain ischaemia 
A interesting monkey model was that of Bleyaert et al 
(1978) in which whole brain ischaemia was produced by 
rapid neck vessel compression. The protective effect of 
thiopental given at various doses and various intervals 
after the ischaemic insult was studied. They took 
particular pains to standardise the life support 
conditions for experimental and control animals. They 
found a very significant protective effect which was 
greater the earlier the therapy was given after the 
I 
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insult. These benefits were demonstrated both in the 
clinical neurological state at 7 days of age as well as 
histologically. 
Todd et al (1982> examined the protective effect of 
high dose thiopental given to adult cats shortly after 
global cerebral ischaemia. They found a significant 
reduction in the immediate mortality from neurological 
causes but no protection against long term neurological 
deficit in survivors. 
7.4.2. Neonatal animal studies 
There is a body of work concerned specifically with the 
protective effect of barbiturates on asphyxiated animal 
neonates. These are set out in Table 7.4.1. 
All these studies on the effects of barbiturates in 
neonatal animals experiencing asphyxia show a clear 
protective effect except that of Fisher et al <1975) 
who found that phenobarbitone administered to neonatal 
monkeys before asphyxiation by occlusion of their 
endotracheal tubes had no protective effect. Their 
percentage of survivors and time to last gasp was no 
different in a group of 8 treated as compared to 6 
untreated controls. 
Campbell et al <1968> used 48 hour old monkey neonates 
who were pretreated with intraperitoneal 
pentobarbitone prior to subjecting them to anoxia by 
' ( 
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TABLE 7. 4.1. STUDIES ON THE PROTECTIVE EFFECT OF BARBITURATES IN NEONATAL ASPHYXIA 
============================================================================================================= 
AUTHOR AND YEAR :Year: N : Species:Katurity: Hypoxic : Drug Used : Dose 
: insult : 
Effect of 
: protective drug. 
=====================:====:===!========:========:=========~===============:==========:======================= 
Camp be 11 et al (1969l:1967: 62: Rabbit 'Newborn lOOX N2 :Pentobarbitone 20mg/Kg :Duration of primary 
x2: inhaled :apnoea inceased. 
:Tite to last gasp 
:significantly prolonged. 
:Total no.gasps = 
Cockburn et al !19691: 1969: 2t:Rhesus ,Newborn :Bag over :Pentobarbitone :Maternal :Duration of primary 
:monkeys .: lhead lanaesthes.lapnoea increased. 
I before JTice to last gasp 
: first !significantly prolonged. 
:breath. :Total No. gasps 
: increased. 
Good Ii n I 1965! l1965l1391Rabliit :Newborn llfaternal :Pentobarbitone I Maternal :Increased number 
:death lanaesthes. lof fetuses could 
:before lbe resuscitated. 
:delivery.: 
Fisher et al (1975) : 1975: 14 :Monkeys I Newborn :Occluded lPhenobarbitone lBmg/Kg lNo protection in 
:ETT. :time to last gasp 
lor survival. 
================================================================================================================ 
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inhalation of lOOX nitrogen. They found that the 
pretreated group had a very significant prolongation of 
primary apnoea as well as of the time to the last gasp 
as compared to controls. 
Cockburn et al (1969) produced asphyxia in neonatal 
monkeys by placing a fluid filled bag over their heads 
before the first gasp at caesarian section. In the 
experimental group the mothers were anaesthetized with 
pentobarbitone and in controls local anaesthesia was 
used. The duration of primary apnoea and the time to 
the last gasp were both significantly prolonged in the 
experimental group. 
Both Cockburn and Campbell also looked for differences 
in the response to resuscitation at various times after 
the last gasp. Campbell's group using rabbits found 
that a significantly higher percentage of treated 
animals could be resuscitated to survival and that the 
treated group had a shorter time to spontaneous gasping 
after the initiation of resuscitation. Cockburn had 
very similar findings in Rhesus monkeys with a shorter 
time to the first spontaneous gasp as well as to the 
onset of rhythmic breathing. Goodlin (1965) also found 
that rabbit fetuses which were asphyxiated in utero by 
maternal death, 
the maternal 
but pretreated with pentobarbitone via 
anaesthetic, had a higher rate of 
resuscitatibility than untreated controls. 
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Goodlin and Lloyd C 1970 > in a similar 
investigated 
number of 
the relative protective efficacy 




phenobarbitone produced a higher rate of survival than 
pentobarbitone which is the drug used in most animal 
trials. 
The studies of both Campbell et al (1968> and Cockburn 
et al (1969) included data on the acid-base status of 
the animals during terminal asphyxia. Campbell's group 
found that in the rabbits the pH one minute after the 
last gasp was the same in treated and untreated groups 
when the time of anoxia was controlled for. The pC02 on 
the other hand was 30mm higher in the treated group. 
On the other hand Cockburn et al (1969) with Rhesus 
monkeys found that the pH fell and the pC02 rose less 
rapidly in the barbiturate pretreated animals. They 
concede that the unanaesthetised animals struggled much 
more than those under barbiturate anaesthesia and that 
this alone could account for the differences observed. 
Myers (1972) found in his model of total asphyxia in 
newborn rhesus monkeys that pretreatment with 
pentobarbitone resulted in less neuropathological brain 
damage if the agent was given as an anaesthetic prior 
to asphyxia. If it was given as an injection 
immediately prior to the insult the protection was 
minimal. The difference was thought to be due to the 
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longer time available in the case of the anaesthetized 
animals for the barbiturate to penetrate brain tissue. 
When given to animals who were already acidotic at 
birth and presumably having already experienced 
intrauterine asphyxia it provided little protection 
regardless of when the barbiturate had been given. 
Cockburn et al (1969) also examined the 
neuropathological appearances of the brains at post 
mortem and found that treated survivors had less severe 
neuropathological lesions than untreated animals. 
However the location of the injury was mainly in the 
brainstem and this is not at all similar to the pattern 
seen in the human asphyxiated neonate. The nature of 
the insults cannot thus be strictly comparable. 
Brann <1970) however has described a pattern of injury 
similar to that in human infants in newborn monkeys. 
The mothers were subjected to periods of hypotension 
before delivery. The degree of asphyxia of the fetus 
was varied by altering the severity of the maternal 
hypotension. He showed a decrease in the severity of 
neurological damage for a given degree of asphyxia when 
the mother had received pentobarbitone as an 
anaesthetic agent. While this work needs to be extended 
and the methodology refined a protective effect of 
barbiturate seems likely in an animal model which seems 
to be quite similar to that in humans. 
CHAPTER 7 TREATMENT OF ASPHYXIA NEONATORUM Page 157 
The other major difficulty in interpreting the 
significance of this experimental neonatal work is that 
in all cases the barbiturate was administered before 
the insult. This is olearly not normally possible in 
the human clinical situation where therapeutic agents 
are given after the event. 
It would thus appear that in experimental models 
barbiturates have useful protective effects on neonatal 
hypoxia when administered before the insult. 
7.5. THE DOSAGE OF PHENOBARBITONE IN NEONATES. 
The use of phenobarbitone by intravenous and oral 
routes of administration in the therapy trial reported 
in Chapter 8 necessitates a review of dosage regimens 
and related serum levels in term newborns. 
7.5.1. Dosage and serum levels 
Studies on the relationship between phenobarbitone 
dosage and serum levels were carried out by Jalling 
<1975) and Lockman et al (1979). Jalling studied 18 
term infants with seizures. In some cases she used the 
oral and in others the intramuscular route of 
administration. Lockman et al studied 39 neonates of 
all birth weights and gestational ages. In both studies 
frequent serial phenobarbitone levels were taken after 
the initial loading dose or repeated oral doses. 
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In both studies there was a linear relationship between 
dosage and subsequent peak phenobarbitone level. 
Jalling found that the peak serum level was 1.3 x dose 
(in mg/kg) as micrograms (ug) per millilitre, for the 
intramuscular and rather lower for the oral route. For 
example a single intramuscular dose of 15mg/Kg produced 
a peak phenobarbitone level of 19.Sug/ml. Lockman et al 
found that to achieve a serum level of 20ug/ml it was 
necessary to give 18.2+-6.5 mg/Kg intramuscularly of 
phenobarbitone. Donn et al (1985) in a later 
publication used a much larger dose (intravenous 
loading dose of 30mg/Kg) in a group of 10 asphyxiated 
term newborns at risk of seizures. Phenobarbitone 
levels were 30.0 +- 3.2 ug/ml. at an interval of 2 
hours after the dose. 
Lockman et al <1979) found that the peak phenobarbitone 
level was not different in patients who had received 
the substance via the IM route, as compared to those 
who had received it via the IV route. Nevertheless the 
time after the dose at which the peak level is achieved 
clearly depends on the route of administration. Jalling 
found that 90% of the peak l•vel was achieved within 4 
hours of an IM dose and within 8-12 hours of an oral 
dose. Donn et al found that the peak after an IV dose 
occurs within minutes. 
The half life of phenobarbitone after administration 
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was studied by these authors. In a standard dosage 
regimen of 30mg/kg Donn et al (1985) found a 1/2 life 
of 148 +-55 hours. Jalling on the other hand with a 
wide variety of doses and routes of administration 
found a 1/2 life of between 59 and 182 hours. She also 
found that the rate of disappearance of phenobarbitone 
from the blood varied from day to day in individual 
patients and that this variability was not attributable 
to birth weight, gestational age, age of infant or 
medications taken by the mother or inf ant. The 
differences seeemed to reflect day to day changes in 
the infant's condition. 
Lockman found that after a loading dose (intramuscular 
or intravenous>, the serum level did not fall 
significantly for the first 24 hours and did so very 
variably thereafter. Maintainance doses would thus not 
need to be started until after that time. 
Phenobarbitone seems to cross into the cerebrospinal 
fluid in such a way that a steady CSF:plasma ratio is 
established after a delay of some hours. Jalling 
measured serial .simultaneous CSF and serum 
phenobarbitone levels in 9 patients and found that a 
steady ratio of between 0.48 and 0.83 was established 
by about 17 hours. 
7.5.2. Anticonvulsant levels of phenobarbitone in the 
newborn : 
The studies quoted above found that the serum level of 
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phenobarbitone at which seizures are controlled is 
between 12 and 30 ug/ml. Jalling notes however that 
neonatal seizures have a strong tendency to resolve 
spontaneously which makes it difficult to be certain 
that a given level of anticonvulsant is responsible for 
the cessation of seizures in an individual patient. 
Gal et al (1982} found that some infants required 
higher serum levels to achieve control of seizures. 
They found that 60 out of 71 neonates with seizures 
responded to phenobarbitone and the levels at which 
they did so were as follows : 
60% responded at a serum level of <20 ug/ml. 
28X " " " " " " 20-30 ug/ml. 
12% " " " " " " >30 ug/ml. 
The concern over the dangers of respiratory and 
cardiovascular depression caused by serum levels of 
phenobarbitone of 30-40 ug/ml seem to be unfounded as 
Donn et al could find no effect of the loading dose on 
heart rate, mean blood pressure or respiratory rate in 
their group of infants. 
These authors all concur that seizures occuring as part 
of hypoxic ischaemic encephalopathy in the newborn are 
particularly difficult to control. Of Donn's 10 
asphyxiated patients 3 had seizures and only 1 of these 
responded to phenobarbitone even at the higher dose 
that he employed. 
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Anticonvulsant levels of phenobarbitone are not 
necessarily those at which protection against asphyxial 
insult will be produced. The dose for this may well be 
higher. 
7.6. THE ROLE OF CORTICOSTEROIDS IN THE TREATMENT OF 
HYPOXIC-ISCHAEMIC BRAIN INJURY. 
The role of corticosteroids in the treatment of 
hypoxic-ischaemic cerebral injury is mainly involved 
with their ability to prevent or limit cerebral oedema. 
Their place in the treatment of the affected neonate 
remains very controversial. This section will review 
the available literature. 
7.6.1. Cerebral oedema 
Katzman et al <1977>, Anderson et al. <1979) and Fishman 
(1982> have reviewed the subject of cerebral oedema and 
they make a distinction between vasogenic and cytotoxic 
cerebral types. This concept seems to be important in 
understanding the role of steroids in this situation. 
"Vasogenic" cerebral oedema results from the leakage of 
large molecules through the structurally alter~d blood-
brain barrier into the extracellular space of the 
brain. This is followed osmotically by water which 
moves in the tissue planes of the white matter. An 
increase in arterial blood pressure will promote this 
type of oedema. Vasogenic cerebral oedema will show 
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contrast enhancement on CT scanning. Furthermore due to 
free communication of the extracellular space with the 
CSF compartment, large molecules, especially protein, 
will appear in the CSF. 
"Cytotoxic" cerebral oedema on the other hand is the 
result of the breakdown of active transport systems 
which regulate the distribution of electrolytes and 
water across cell membranes. Wat.er accumulates 
intracellularly and at. first does not expand the 
extracellular space. The oedema is confined to the gray 
matter and is not affected by arterial pressure. 
A comparison between the two types of cerebral oedema 
is set out in Table 7.6.1. 







Affected by blood pressure 
Contrast enhances CT scan 
Blood-brain barrier affected 




Not affected by BP 
No enhancement 
Celluar transport systems 
affected 
CSF protein unaffected 
Corticosteroids said not 
to help 
============================================================ 
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Cerebral oedema following ischaemia has been studied 
and found to consist of both types of process ocurring 
more or less in sequence. The initial ischaemic/hypoxic 
insult causes a cytotoxic effect with its accompaning 
type of cerebral oedema. As cells die and release their 
lysosomal contents, osmotically active substances 
appear in the extracellular fluid and attract water. 
Occuring somewhat later, there is damage to the blood-
brain barrier which adds the element of vasogenic 
oedema. The oedema itself causes compression of 
cerebral capillaries which further reduces cerebral 
blood flow further compounding the situation. 
A body of literature indicates that corticosterioids 
are helpful in treating cerebral oedema of the 
vasogenic but not the cytotoxic form. For example 
Yamaguchi et al (1976) found that dexamethasone did not 
reduce brain water in rats subjected to bilateral 
carotid artery ligation (cytotoxic oedema) but did so 
in those subjected to local brain trauma (vasogenic 
oedema). The oedema surrounding tumors and brain 
abscesses responds both experimentally and clinically 
to. steroids. 
The mechanisms underlying this action are thought to 
involve firstly a vascular membrane stabilizing effect 
in which membrane dissociation and lysosomal enzyme 
release is reduced and injury by free radicals is 
CHAPTER 7 TREATMENT OF ASPHYXIA NEONATORUM Page 164 
prevented. Thus vascular permeability is controlled. 
Secondly the clearance of extracellular oedema fluid 
via its communication with the CSF is enhanced. The 
effect of steroids is to increase the reabsorbtion of CSF 
as well as to reduce production. 
7.6.2. The use of cortico•teroid• in animal trial• 
Animal studies involving the use of corticosteroids in 
neonatal asphyxia have been contradictory. 
De Souza and Dobbing <1973) from Manchester chose to 
study the 5 day old rat as it closely resembles the 
term human neonate in its stage of brain maturation in 
that neuronal numbers have virtually stopped increasing 
and glial cells and neuronal interconnections have 
begun to appear. They found that the rats rendered 
hypoxic near to the point of death in a low · oxygen 
tension jar had significantly increased brain water, 
increased brain sodium and reduced brain potassium as 
compared to non-asphyxiated controls. Pretreatment with 
dexamethasone at a dose of 20 mg/Kg intraperitoneally, 
significantly reduced these changes whilst lower doses 
did not. A similar effect was seen when dexamethasone 
was given at a dose of 20mg/Kg immediately after the 
asphyxia! insult. They also noted that a rise in blood 
glucose seen in non-dexamethasone treated asphyxiated 
animals was prevented by pretreatment with 
dexamethasone at the same dose. Apart from a 
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significant increase in total brain carbohydrate, 
dexamethasone treatment of normal rats did not alter 
any of the measured parameters when examined 2 hours 
later. 
In a further publication Adlard and De Sousa <1976) 
using the same animal model found that asphyxiated 
animals had 43Y. less total brain adenosine triphosphate 
than non-asphyxiated controls. Pretreatment with 
dexamethasone 20mg/Kg had a significant 
effect on adenosine triphosphate reduction. 
retarding 
As a result of this work Adlard and De Sousa's group 
feel that the action of dexamethasone may involve a 
preservation of the energy dependent electrolyte pump 
mechanism by preserving adenosine triphosphate. The 
increase in brain carbohydrate may act to provide 
energy reserves against anaerobic metabolism. 
Altman et al. (1984) studied the effect of dexamethasone 
on asphyxiated. 7 day old rats. They used the Levine 
procedure in which a unilateral common carotid artery 
ligation was performed some 3 hours before the animals 
were asphyxiated in a SY. oxygen environment for 3,5 
hours. They found that pretreatment with dexamethasone, 
either 4 or 40 mg/Kg, had no effect on the differences 
in brain water between the cerebral hemispheres, on the 
fall in brain ATP, on the fall in cerebral blood 
glucose or on the rise in cerebral blood lactate. 
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Dexamethasone treatment also made no difference to the 
neuropathological appearances. 
difference was that treated 





This experimental model with its combination of 
prolonged ischaemia and hypoxia would seem to be nearer 
the human asphyxiated neonate and the results thus more 
valid than those of the Manchester group whose model 
involved only severe hypoxia. 
7.6.3. Use of corticosteroids in human neonatal patients 
So far there have been very few studies investigating 
the effect of steroid treatment in the asphyxiated 
human neonate. A few studies such as that by 
Svenningsen (1975> (see above} have used dexamethasone 
as part of a treatment package with inconclusive 
results. 
A recent publication from Levene and Evans <1985) 
reports on the effect of dexamethasone in severely 
asphyxiated inf ants with documented raised 
intracrainial pressure ( >lOmm Hg>. They gave these 
inf ants a single intravenous dose of dexamethasone (4 
mg} and monitored intracranial pressure via a 
subarachnoid catheter. They simultaneously monitored 
systemic blood pressure and hence derived the cerebral 
perfusion pressure. They found that in the 7 inf ants 
studied dexamethasone produced a fall in intracranial. 
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pressure which was sustained for at least 6 hours. 
However a simultaneous fall in systemic blood pressure 
resulted in no net change in cerebral perfusion 
pressure. They conclude that there is little place for 
dexamethasone therapy in severely asphyxiated infants. 
7.6.4. Possible undesirable effects of dexamethasone : 
Early 
<1973} 
work on suckling rats by Adlard and DeSouza 
showed that a single dose of dexamethasone 
either 1 or 20mg/Kg had profoundly negative effects on 
the growth of the whole body as well as that of brain 
and thymus at 3 weeks of age. 
hydrocortisone produced similar 
effects. It will be recalled that in 
Treatment with 
but less marked 
rats it was a dose 
of 20mg/Kg that produced some degree of cerebral 
protection following asphyxia. 
A worrying feature of the use of large doses of 
dexamethasone in human newborns comes from a McGill 
group of Fitzhardinge et al <1974}. They followed a 
group of preterm infants who had had hyaline membrane 
disease and received 2 doses of hydrocortisone 
<12.Smg/Kg} during the first 24 hours of life as well as 
a carefully matched control group which had not received 
the hydrocortisone. At 1 year of age there were no 
differences in growth, number of infections nor any 
aspect of immune competence. The treated group had a 
slight increase in neurological abnormalities (3/13 vs 
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vs 0/14), relative delay in gross motor development and 
an increase in the incidence of minor EEG 
abnormalities. In a subsequent related publication by 
Gunn et al. <1981>, 11 out of 14 cases and 7 out of 13 
controls of the original Fitzhardinge group were seen 
at 5 years of age. There were no differences in somatic 
growth or intelligence quotient. Although there were no 
differences in other aspects of immune competence, 
cases had significantly lower T-lymphocyte counts, an 
increased percentage of lymphocytes with C3 receptors. 
There was also a suggestion that cases had had a 
greater number of serious infections. Eight out of 11 
cases had had an episode of pneumonia or otitis media 
over the period 1-5 years while 2 out of 7 controls had 
had the same. 
7.6.5. Conclusion on corticosteroids 
The place of steroids in hypoxic/ischaemic brain injury 
remains unclear. Despite theoretical considerations 
suggesting that it might be helpful for at least the 
vasogenic phase of this type of injury the animal and 
human work is very equivocal and there a dearth of 
adequate trials in the human asphyxiated neonate. On 
the specifically negative side, several studies have 
recorded an increased mortality among treated cases. 
Its effect on the growth and immune competence of the 
newborn rat is profound and negative effects on the 
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immune competence of human children aged 5 years have 
been documented. It is especialy worrying that the 
doses found to be therapeutic against asphyxia in 
experimental animals are large enough to cause major 
growth and immune problems later. 
It would seem to be important to investigate the 
possible beneficial effect or otherwise of 
dexamethasone in the mild to moderately asphyxiated 
infant because unless a clear benefit is demonstrated 
its routine use in such patients should be discontinued 
in view of the serious potential side effects of this 
medication in the neonate. 
7.7. TRIALS ON THE PROTECTIVE EFFECT OF BARBITURATES IN THE 
ASPHYXIATED HUMAN INFANT. 
Two studies by Finer et al <1981 and 1983) have 
examined the use of phenobarbitone and betamethasone in 
asphyxiated term infants. In neither instance was a 
case/control design used. Rather, infants who had been 
treated with a variety of agents, as decided upon in 
each case by the attending physician, were evaluated as 
to the outcome. 
The first of these two studies <Finer et al 1981) 
looked at 95 term infants with hypoxic-ischaemic 
encephalopathy. Sixty two percent were given 
phenobarbitone after seizures had commenced and 29% 
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received betamethasone prophylactically soon after 
birth. Some received both, and others only one, form of 
therapy. The numbers in each category are not stated. A 
variety of other agents were given in each case as the 
clinical need arose. Patients were not assigned to any 
one form of treatment on a random basis and the form of 
treatment was not uniform. The findings were that no 
significant relationship could be found between any 
form of drug therapy and long term neurodevelopmental 
outcome. 
In their later study Finer et al. (1983) 
29 term infants with HIE who had 




physician. This group was not different in 
neurodevelopmental outcome to similar patients who had 
not received betamethasone. The criticisms of the first 
trial apply to this study also. 
A Swedish prospective case/control trial of the 
possible protective effect of certain forms of therapy 
comes from Svenningsen et al. (1982). Term infants were 
randomly assigned either to a treatment or to a control 
group. The criteria for inclusion were such that 
inf ants had had inadequate respiration and severe 
hypotonia which had persisted after 30 minutes of 
intensive resuscitation. Management for each group was 
identical with respect to I.V. fluids, anticonvulsants 
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and other aspects of therapy. The treatment group 
received in addition phenobarbitone, betamethasone and 
lasix very soon after birth. Doses of phenobarbitone 
were large <20mg/Kg in first 24 hours and then 10 mg/Kg 
per 24 hours thereafter) and achieved peak levels 
(range 150-375 ug/l) 3 days after delivery. There was a 
significant difference in neonatal mortality in favour 
of the treated group (0/14 vs 5/16). There were 
significantly fewer children at 1 year with 
neurodevelopmental abnormalities in the treated group. 
The effect of treatment on the occurence of seizures is 
shown below and the treated group had a lower incidence 
of seizures at all times. 
TABLE 7.7.1. OCCURENCE OF SEIZURES IN EXPERIMENTAL 
















From Svenningsen et al (1982). 
The reduction in the incidence of seizures in later 
life is particularly interesting as this suggests that 
therapy may indeed have a useful protective effect 
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against cerebral injury. One confounding variable in 
this trial was the time of onset of artificial 
ventilation. 
ventilation 
The treatment ·group had 
administered for much more 
mechanical 
liberal 
indications than the control group. The two groups had 
no significant difference in the frequency with which 
mechanical ventilation was used but in the treatment 
group it was administered significantly earlier. This 
factor'? which in itself may well have been responsible 
for differences observed, makes interpretation of the 
effects of drug therapy difficult to evaluate. 
A more recent approach has been to induce thiopentone 
coma in severely affected infants with the intention of 
maximising the effect of barbiturates on reducing 
cerebral metabolism. 
In such a study, Eyre and Wilkinson (1986) induced 
thiopentone coma in 6 very severely asphyxiated infants 
for a median duration of 127 hours. They monitored the 
EEG and adjusted the rate of thiopentone infusion to 
keep the EEG isoelectric. They had major difficulties 
with circulatory hypotension related to barbiturate 
dosage. The study did not use controls but half of the 
infants died in the immediate neonatal period and the 
survivors all had major handicap. The authors conclude 
that while it is possible to maintain prolonged 
thiopentone coma it is technically very demanding and 
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the benefits not evident. It is possible that the 
severity of the patients selected for the therapy put 
the patients beyond help and that such therapy might be 
beneficial in somewhat less severely affected infants. 
Another recent case-control study looked at the 
protective effect of a high dose thiopental infusion. 
Goldberg et al (1986) in a case-control trial studied 
severely asphyxiated term infants with encephalopathy 
requiring artificial ventilation. Cases received 
additional therapy in the form of a thiopental infusion 
for the first 24 hours while controls did not. They 
monitored blood pressure and intracranial pressure for 
the first 72 hours in both groups and followed their 
neurodevelopmental progress for 3 years. Blood pressure 
was maintained at normal levels with the use of pressor 
agents if necessary. Although cases needed more pressor 
support than controls there were no significant 
differences in intracranial pressure, cerebral 
perfusion pressure or neurodevelopmental outcome. The 
authors conclude that the difficulties in maintaining 
blood pressure with this form of therapy are not 
balanced by neurodevelopmental gains and that this form 
of treatment is not beneficial. As with the ~tudy of 
Eyre and Wilkinson this study involved only very 
severely affected inf ants in whom cerebral damage may 
well have been beyond any possible protective effect. 
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7.7.1. Conclusions on human trials 
There is a suggestion that in a very severely 
asphyxiated group 
betamethasone and 
the combination of 
lasix offers some 
phenobarbitone, 
benefit to 
patients in terms of survival and quality of outcome. 
Nevertheless to date there is no reported case-control 
trial of the effect on neurodevelopmental outcome of 
the combination of phenobarbitone and dexamethasone 
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8.1. INTRODUCTION. 
Previous discussion has emphasised the importance of 
asphyxia as a leading cause of neonatal death and 
severe handicap in term infants in Ciskei. The study of 
epidemiology has cast some light on the factors 
associated with asphyxia in this area which may help to 
direct preventive 
priorities for 
efforts as well as indicating some 
further research. Whilst future 
prevention is important, the current problem facing 
paediatricians looking after newborns in the Ciskei is 
the number of infants asphyxiated at birth and/or 
developing encephalopathy in the first few hours of 
life. The immediate problem is to decide on the most 
appropriate treatment regimen for such infants with a 
view to limiting future handicap. 
The literature review on the treatment of the post 
asphyxial infant has indicated that whilst certain 
aspects are relatively non-controversial, the issue as 
to whether a regimen of phenobarbitone and 
dexamethasone given soon after birth is beneficial, is 
largely undecided. The resolution of this issue becomes 
all the more important when it is recalled that Adlard 
and De Sousa <1973) have demonstrated harmful effects 
on the later growth of suckling mice treated with 
dexamethasone and that Fitzhardinge et al (1974) have 
found late immune defects in humans treated with 
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hydrocortisone as preterm infants. The routine use of 
dexamethasone in asphyxiated infants can only be 
justified if its protective advantages outweigh these 
possible hazards. 
In the literature review much evidence was brought 
forth to suggest that both barbiturates and 
corticosteroids may be beneficial in hypoxic-ischaemic 
experimental animals including primates, but convincing 
evidence of their effectiveness when used in the human 
aspyhxiated infant was lacking. 
Despite this lack of evidence, many centres in this 
sub-continent 
dexamethasone 
have been using phenobarbitone 
as a protective regimen in 
and 
the 
asphyxiated term infant. This regimen was often used in 
our unit before this trial and it was decided to assess 
its efficacy. An unfortunate but practical reason as to 
why such a trial could be carried out in our setting 
was the high incidence of asphyxia. We would be able to 
recruit enough cases to carry out the trial in a 
reasonable time span. 
8.2. PATIENTS AND METHODS 
8.2.1. SELECTION OF CASES AND CONTROLS. 
Potential candidates for the trial were the infants of 
mothers delivering at term in the labour ward of 
Cecilia Makiwane Hospital. This delivery facility has 
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24 hour resident obstetric and paediatric medical 
staff cover. The newborn nursery is adjacent to the 
labour ward and routine attendance of paediatric 
resident staff at all high risk vaginal and caesarian 
deliveries is practiced. 
Patients were admitted to the trial immediately after 
birth on the basis of the following criteria : 
(a) Being of more than 37 weeks of gestation 
AND 
(b) Having had a 5 minute Apgar score of less than 7 
AND/OR 
(c) Having shown signs of fetal distress 
AND 
(d) Showing a placental chorionic arterial 
deficit excess of > 11. 
base 
After satisfying the selection criteria they were was 
divided into CASES and CONTROLS by a random process of 
envelope selection by the resident paediatric doctor. 
Gestation was assessed by using available obstetric 
data. If any doubt existed as to the gestation of an 
infant it was confirmed using the Ballard modification 
of the Dubowitz method of estimating gestational age in 
newborns. <Ballard 1977). 
Both 1 and 5 minute Apgar scores were assessed in all 
instances by attending paediatric residents. 
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Fetal distress was taken to be the presence of meconium 
stained liquor and/or the presence of fetal heart 
irregularities detected either clinically or by means 
of the cardiotochograph. Established reduction of fetal 
movements, either observed by the mother or detected by 
means of fetal kick chart monitoring, was also taken as 
evidence of fetal distress. 
Placental arterial blood was obtained by the resident 
doctor within 10 minutes of birth by puncture of an 
artery running over the surf ace of the chorion. The 
blood was collected into a heparinised plastic syringe 
and taken immediately for blood gas estimation on a 
Radiometer "Blood Gas Laboratory". In the event of a 
delay of more than a 5 minutes the blood was placed in 
a plastic bag which was surrounded by crushed ice. 
Analysis was performed within 30 minutes. 
8.2.2. TREATMENT REGIMENS. 
' CASES were treated from the time of selection at birth 
with a loading dose of Sodium Gardenal 15mg/Kg 
intravenously and Phenobarbitone Smg/Kg/24 hours was 
given orally in 2 daily doses starting at 12 hours of 
age and continuing for at least 72 hours. It was 
continued for longer if the clinical condition 
indicated this. They were also given dexamethasone 0.5 
mg/Kg intravenously 6 hourly for 72 hours. 
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CONTROLS did not receive phenobarbitone and 
dexamethasone. 
In other respects all patients received the same 
treatment. In anticipation of some degree of 
inappropriate antidiuretic hormone secretion following 
the cerebral insult, the total fluid intake was 
restricted to SOml/Kg/24 hours for the first 48-72 
hours of life. In view of the possibility of ischaemic 
bowel damage, patients were kept nil by mouth for the 
first 48 hours and longer if necessary until adequate 
bowel sounds were audible. .The routine intravenous 
fluid was NEONATALYTE CSABAX> the composition of which 
is set out in Appendix V. Seizures were treated with a 
loading dose of phenytoin 8 mg/Kg intramuscularly 
followed by 4mg/Kg per mouth 12 hourly thereafter. 
8.2.3. BIOCHEMICAL EVALUATION. 
Blood was taken by resident medical staff at between 48 
and 72 hours of age for estimation of serum sodium, 
potassium, urea and creatinine. While every effort was 
made to take blood within these limits practical 
considerations made this sometimes impossible. The 
blood was submitted for routine multichannel analysis 
at the East London and Border Pathology Laboratory. 
8.2.4. PHARMACOLOGICAL EVALUATION. 
Blood was taken at the same time as in 8.2.3. above for 
serum phenobarbitone estimation. The serum was 
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separated by the hospital laboratory by centrifugation 
immediately and stored at -20 degrees 
later transmission t.o the Department 




serum phenobarbitone was carried out by Or.J.S.Cridland 
using the EMIT immunoassay method <Syba Co.). 
8.2.5. CLINICAL EVALUATION. 
The infants were subject. to the routine clinical care 
in the hospital nursery and regular clinical 
annotations were made by the attending medical staff. 
Neither the author nor the nursing staff engaged in the 
follow-up were at any time during the trial aware as 
to whether an infant was allocated as a case or as a 
control. The trial was in this sense truly blind. The 
author examined the inf ants at between 48 and 72 hours 
of age and carried out. both a Prechtl assessment 
(Prechtl 1977> and a conventional neurological 
examination for which a proforma · is provided in 




Method of resuscitation, Apgar scores and the time 
to sustained respiration. 
Prechtl evaluation by the author at 48-72 hours of 
age. 
8.2.5.3. General and neurological examination at 48-72 
hours by the author. 
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8.2.5.4. Daily neurological assessment by nursery medical 
staff. 
8.2.5.5. Specific details of feeding particularly the age 
at which nasogastric feeding was no longer needed. 
8.2.5.6. The occurence and age of onset of seizures. 
8.2.5.7. The occurence and severity of jaundice. 
8.2.5.8. The age at discharge. 
A set of the proformas used for data recorded in the 
nursery is provided in Appendix VIII. 
8.2.6. MATERNAL DATA. 
Data was extracted from the obstetrical records soon 
after birth by the author and entered on a proforma. If 
necessary data was obtained from the obstetrical staff 
by personal communication. The nursery is located 
adjacent to the labour ward thus facilitating exchange 
of information. 
Each case was discussed by the author and paediatric 
collegues with the assembled obstetric staff at a 
weekly perinatal meeting at which an attempt was made 
to assign a cause to the asphyxia ("Obstetric cause"). 
The opinion of the attending consultant obstetrician 
was taken as definitive. On occasion a particular case 
would miss being discussed in which case the consultant 
obstetrician would be asked to peruse the records and 
to assign a cause. 
Social and residential data was obtained from the 
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mother prior to delivery to enable follow up at home to 
be carried out. 
8.2.7. FOLLOW-UP SHEDULES. 
Patients were visited in their homes at the following 
ages : 6 weeks, 3, 6 and 9 months. Data was recorded on 
proformas relating to the following : 
Weight was recorded with the infants unclothed 
using a hanging spring scale which was zeroed 
before each measurement and was calibrated with a 
standard weight regularly. 
Occipito-frontal head circumference was measured 
with a fibre glass tape measure taking at least 3 
readings and using the greatest figure obtained. 
Feeding performance. 
Scores of performance in age appropriate test 
items of the Denver Developmental Screening Test 
<DDS!). <Frankenburg and Dodds 1967>. 
Social Data to facilitate the next follow-up visit. 
Copies of the proformas used for each follow-up visit 
are to be found in Appendix IX. 
Follow-up visits were carried out by a team of 2 
registered nurses who had been orientated in the 
specific items of the DOST by the author. These 
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specific nurses have for some years been involved in 
assisting at the Neurodevelopmental Clinic at the 
hospital and also in running a Day Training Centre for 
mentally retarded children. 
In scoring the DOST the following procedure was used. 
At each follow-up visit a specific number of age 
appropriate test items were prescribed to be applied. 
Details of the items used at each visit are provided in 
Appendix IX. A point was scored for each item of the 
test passed by the baby. This was divided by the number 
of test items applied to the child and the result 
expressed as a percentage. However if a specific item 
could not be used on a particular baby the denominator 
was reduced by the number of items not applied. In 
categorizing results a score of less than 66X was 
regarded as ttprobably abnormaltt. It is appreciated that 
this is not the orthodox method of scoring the Denver 
Developmental Sceening Test but it was considered 
expedient under the unfavourable home circumstances in 
which the assessments were often made. This will be 
considered further in the discussion. 
8.2.8. FINAL EVALUATION. 
For this evaluation the patients attended the hospital 
out-patients department within a few weeks of their 
first birthday. 
the author 
On this occasion they were examined by 
and the following data recorded on 
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proformas 
Weight and Occipito-frontal head circumference. 
Performance in the items of the DDST appropriate 
for about 1 year. 
The result of a conventional neurological and 
general physical examination. The neurological 
examination was carried out in accordance with the 
methods of Paine and Oppe (1966) and for which a 
proforma is included in Appendix IX. The results 
of the examination was recorded as a 4 point scale 
from De Sousa and Richards (1978) modified 
according to the severity of neurological 
abnormality and resulting handicap 
Normal - No abnormal neurological finding. 
Probably normal - Neurological findings of slight 
or doubtful significance. 
Probably abnormal - Definite disorder but 
producing little or no physical handicap. 
Abnormal - Definite and obviously handicapping 
disorder. 
The outcome of the Du Toit rattle hearing test 
using the Du Toit rattle as prescribed by Prof. Du 
Toit of the ENT Dept. of Tygerberg Hospital. In 
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any case of doubt the child was referred to the 
ENT dept. of the hospital for free field audiometry. 
A simple test of vision using the childs 
attentiveness to a 6 cm diameter red pom-pom. In 
any case of doubt the child was referred to the 
Eye Dept of the hospital for more formal 
assessment. 
A copy of the proforma used in the final evaluation is 
included in Appendix IX. 
8.2.9. CONSENT. 
Prior to the start of the trial, the phenobarbitone and 
dexamethasone regimen had been used erratically in the 
neonatal unit. Some asphyxiated infants would receive 
it and others would not. This was largely determined by 
the personal preference of the attending consultants 
and doctors. The trial placed on a random basis, a 
decision that had hitherto been one of erratic 
preference. 
In planning it was realised that many mothers would 
deliver by caesarian section under general anaesthesia 
and would not be in a position to give informed consent 
for several hours after delivery. Nev•rtheless it was 
seen as important to start the therapeutic regimen 
immediately after delivery if any benefit was to be 
obtained. In the event 62Y. of the patients delivered by 
caesarian section (see TABLE 8.3.8.). Thus, where 
CHAPTER 8 THERAPY TRIAL Page 186 
possible, consent was obtained for participation in the 
trial prior to commencement. However for the reasons 
given above it was not possible in many cases to obtain 
consent for participation in the initial selection 
process for the use of the drug regimen. In these 
cases, consent was obtained as soon as the mother was 
in a position to discuss the matter and always on the 
first day after delivery. In no case was consent 
refused. 
8.2.10. DATA ANALYSIS 
Data from all proformas were entered by the author onto 
¥ 
a computer data base for analysis. All such analysis 
and tabulation were carried out by him. 
8.2.11. STATISTICAL METHODS. 
Student's t-test was used when comparing mean values 
and the Chi- squared test or Fisher's exact probability 
test were used when comparing proportions of infants in 
various categories. If the total number in the analysis 
was less than 100 or if any individual data cell had a 
value of less than 10 the Yates correction of the Chi-
square test was used <Swinscow 1977). In a number of 
cases tables of data had to be collapsed to allow Chi-
square analysis. Details are given under results. 
The Chi-square and t-tests were carried out by the 
author but Fisher's exact test was carried out by 
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statisticians of the Medical Research Council. 
Unless otherwise stated, statistical significance was 
taken to be a probability of <0.05. 
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8.3. RESULTS : 
A total of 116 infants entered the trial. Of these 64 
were allocated as cases and 52 as controls. 
DATA TO CONFIRM COMPARABILITY OF TWO GROUPS. 
In this section data will be presented to indicate that 
the case and control groups were comparable except for 
the use of phenobarbitone and dexamethasone. 
8.3.1. OBSTETRIC DETAILS 
8.3.1.1. Maternal age. 
The mean (+-S.D.> maternal ages were: 
CASES 23.4 (+-5.6) years. Range 15-43. 
CONTROLS 24.2 C+-6.1> years. Range 16-38. 
The difference was not significant. Ct = 0. 793 N=l 16). 
8.3.1.2. Gravidity and Parity. 
The distribution of gravidity and parity are shown in 
Tables 8.3.1.1. and 8.3.2.1. 
TABLE 8.3.1.1. GRAVIDITY OF CASES AND CONTROLS 
================================================= 
GRAV IDA CASES CONTROLS TOTALS 
================================================= 
1 29 25 54 
2 16 10 26 
3 1 1 6 17 
4 4 7 1 1 
5 1 2 3 
6 2 2 
7+ 2 2 
MISSING 1 1 
================================================= 
TOTALS 64 52 116 
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TABLE 8.3.1.2. GRAVIDITY OF CASES AND CONTROLS 
PERCENTAGES. 
-------------------------------------------------
GRAV IDA CASES CONTROLS TOTALS 
================================================= 
1 45.3 48.1 46.6 
2 25.0 19.2 22.4 
3 17.2 11. 5 14.7 
4 6.3 13.5 9.5 
5 1. 6 3.8 2.6 
6 3. 1 1. 7 
7+ 3.8 1. 7 
MISSING 1. 6 .9 
-------------------------------------------------
TOTALS 100.0 100.0 100.0 
TABLE 8.3.2.1. PARITY. 
================================================= 
PARITY CASES CONTROLS TOTALS 
-------------------------------------------------
0 32 24 56 
1 14 11 25 
2 8 6 14 
3 5 6 11 
4 2 3 5 
5 2 2 
6 1 1 
7+ 1 1 
MISSING 1 1 
================================================= 
TOTALS 64 52 116 
TABLE 8.3.2.2. PARITY - PERCENTAGES. 
================================================= 
PARITY CASES CONTROLS TOTALS 
================================================= 
0 50.0 46.2 48.3 
1 21. 9 21. 2 21. 6 
2 12.5 11. 5 12. 1 
3 7.8 11. 5 9.5 
4 3. 1 5.8 4.3 
5 3. 1 1. 7 
6 1. 9 .9 
7+ 1. 9 . 9 
MISSING 1. 6 .9 
-------------------------------------------------
TOTALS 100.0 100.0 100.0 
CHAPTER 8 THERAPY TRIAL Page 190 
No significant. differences could be shown bet.ween the 
two groups by Chi squared testing 
Gravidit.y Chi squared = 3.015 DF = 3. 
Parity Chi squared = 0.945 DF = 3. 
8.3.1.3. Antenatal Care Usage. 
Eighteen cases and 10 controls were not. booked and 
hence did not receive antenatal care. Data for 1 case 
was missing which leaves data for 87 patients who 
at.tended antenatal care at least. once in pregnancy. The 
difference bet.ween cases and controls in regard to non-
booking was not significant. Chi-square = 0.88 DF=l. 
Information regarding the weeks at. booking, number of 
antenatal care visits and the weeks of gestation at the 
last. visit are set. out in Table 8.3.3. 
For most continuous data, full ranges are given in 
Appendix VI. 
TABLE 8.3.3. ANTENATAL CARE USE. 
========================================================= 
CASES CONTROLS t. - TEST 
========================================================= 
VISIT MEAN SD MEAN SD t VAL. N SGN 
========================================================= 
BOOKING WKS 27.6 5.3 27.0 4.8 0.526 87 NS 
No.VISITS 6.71 3. 1 6.97 3.0 0.393 87 NS 
WKS LAST VST 38.6 1. 5 38.5 1. 4 0.457 87 NS 
========================================================= 
SGN = Significance. 
NS = Not significant. 
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8.3.1.4. Complications of Pregnancy. 
The distribution of complications of pregnancy as 
detected during antenatal care is set out in Table 
8.3.4.1. 
TABLE 8.3.4.1. COMPLICATIONS OF PREGNANCY. 
===================================================== 
CASES CONTROLS TOTALS ===================================================== UNBOOKED 17 
NONE 33 
PREGNANCY INDUCED HYERTENSION 6 
ECLAMPSIA 
INTRAUTERINE GROWTH RETARDATION 2 
MULTIPLE 3 
ANTEPARTUM HAEMORRAGE ? CAUSE 
ALBUMINURIA 1 
DIABETES 1 


















1 -----------------------------------------------------TOTALS 64 52 116 
TABLE 8.3.4.2. COMPLICATIONS OF PREGNANCY - PERCENTAGES. 
======================================================= PERCENTAGES : CASES CONTROLS TOTALS ======================================================= UNBOOKED 26.6 19.2 23.3 NONE 51.6 46.2 49. 1 PREGNANCY INDUCED HYPERTENSION 9.4 19.2 13.8 ECLAMPSIA 1. 9 .9 INTRAUTERINE GROWTH RETARD. 3. 1 1. 9 2.6 MULTIPLE 4.7 5.8 5.2 ANTEPATRUM HAEMORRAGE ? CAUSE 1. 9 .9 ALBUMINURIA 1. 6 3.8 2.6 DIABETES 1. 6 • 9 REDUCED FETAL MOVEMENTS 1.6 .9 ======================================================= TOTALS 100.0 100.0 100.0 
No significant differences could be shown between the 
two groups on Chi squared testing : 2.521 DF = 2. 
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8.3.1.5. Presentation. 
The distribution of presentation is set out in 
Table 8.3.5.1. 
TABLE 8.3.5.1. PRESENTATION: ALL CASES 





1 ================================================= TOTALS 64 52 116 
TABLE 8.3.5.2. PRESENTATION - PERCENTAGES. 
================================================= 





.9 ================================================= TOTALS 100.0 100.0 100.0 
8.3.1.6. Evidence of Fetal Distress. 
The distribution of the evidence for fetal distress is 
set out in Table 8.3.6.1. 
TABLE 8 . 3 . 6 . 1. EVIDENCE OF FETAL DISTRESS : ALL CASES 
======================================================· 
CASES CONTROLS TOTALS ====================================================== NONE 
MECONIUM STAINED LIQUOR 
MSL+FH 
FETAL HEART ABNORMALITY 















4 ====================================================== TOTALS 64 52 116 
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TABLE 8.3.6.2. EVIDENCE FOR FETAL DISTRESS 
PERCENTAGES. 
================================~====================== 
CASES CONTROLS TOTALS ======================================================= NONE 
MECONIUM STAINED LIQUOR 
MSL+FH 
FETAL HEART ABNORMALITY 















3.4 ======================================================= TOTALS 100.0 100.0 100.0 
No significant differences could be shown between the 
two groups on Chi squared testing : 3.441 DF = 2. 
8.3.1.7. Complications of Labour. 
The distribution of the complications of labour is set 
out in Table 8.3.7.1. 
TABLE 8.3.7.1. COMPLICATIONS OF LABOUR. 
======================================================== COMPLICATION : CASES CONTROLS TOTALS ======================================================== NONE 22 
DELAYED ACTIVE PHASE 7 
MECONIUM STAINED LIQUOR 11 
CEPHALOPELVIC DISPROPORTION 10 
OTHER FETAL DISTRESS 7 
MULTIPLE 
CORD ROUND NECK 
ABRUPT IO 1 
ECLAMPSIA 
PROLAPSED CORD 1 
MALPRESENTATION. 2 
PROLONGED RUPTURE OF MEMBRANES 1 



























1 ======================================================== TOTALS 64 52 116 
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TABLE 8.3.7.2. COMPLICATIONS OF LABOUR - PERCENTAGES. 
======================================================= COMPLICATION : CASES CONTROLS TOTALS ======================================================= NONE 34.4 25.0 30.2 DELAYED ACTIVE PHASE 10.9 21. 2 15.5 MECONIUM STAINED LIQUOR 17.2 13.5 15.5 CEPHALOPELVIC DISPROPORTION 15.6 13.5 14.7 OTHER FETAL DISTRESS 10.9 7.7 9.5 MULTIPLE 3.8 1. 7 CORD ROUND NECK 3.8 1. 7 
ABRUPT IO 1.6 3.8 2.6 ECLAMPSIA 1. 9 .9 PROLAPSED CORD 1. 6 1. 9 1. 7 MALPRESENTATION 3. 1 1. 9 2.6 PROLONGED RUPTURE MEMBRANES 1.6 .9 PREGNANCY INDUCED HYPERTENS. 3. 1 1. 7 PLACENTA PREVIA 1. 9 . 9 ======================================================= TOTALS 100.0 100.0 100.0 
No significant differences could be shown between the 
two groups on Chi squared testing : 3.23 DF = 4. 
8.3.1.8. Method of Delivery. 
The distribution of the.method of delivery is set out in 
Table 8.3.8. 1. 
TABLE 8.3.8.1. METHOD OF DELIVERY. 
================================================= 
CASES CONTROLS TOTALS ================================================= UNASSISTED 20 







9 ================================================= TOTALS 64 52 116 
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TABLE 8.3.8.2. METHOD OF DELIVERY - PERCENTAGES. 
================================================= 















TOTALS 100.0 100.0 100.0 
No significant differences could be shown between the 
two groups on Chi squared testing : 0.078 OF = 1. 
8.3.1.9. Duration of the First Stage of Labour. 
This data excludes 4 cases and 5 controls who had 
elective caesarian sections before labour. The mean 
(+-S.D.> duration of the 1st stage of labour for the 2 
groups was : 
CASES 15.03 (17.7> hours. Range 1-131. 
CONTROLS 12.69 <7.0) hours. Range 3-34. 
The difference was not significant. Ct = O. 852 N = 107). 
8.3.1.10. Placental Weight. 
Data for this item was missing for 7 cases and 4 
controls. The mean (+-S.0.) placental weight for the 2 
groups was 
CASES 556 (85.7) grams. Range 420-800. 
CONTROLS 571 (116.8 > grams. Range 450-1200. 
The difference was not significant. Ct= 0.782 N = 105>. 
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8.3.1.11. Indications for Operative Delivery. 
The distribution of the indications for operative 
delivery in the 86 relevant patients is set out in Table 
8.3.9.1. 
TABLE 8.3.9.1. INDICATIONS FOR OPERATIVE DELIVERY. 
======================================================= 
CASES CONTROLS TOTALS 
======================================================= 
CEPHALOPELVIC DISPROPORTION 12 
FETAL DISTRESS 18 
ECLAMPSIA 1 
PROLAPSED CORD 1 
DELAYED ACTIVE PHASE 9 
FETAL DISTRESS + PIH 2 
POOR MATERNAL EFFORT 


























TOTALS 44 37 81 
TABLE 8.3.9.2. INDICATIONS FOR OPERATIVE DELIVERY -
PERCENT. 
======================================================== 
PERCENTAGES : CASES CONTROLS TOTALS 
======================================================== 
CEPHALOPELVIC DISPROPORTION 27.3 29.8 28.4 
FETAL DISTRESS 40.9 32.4 37.1 
ECLAMPSIA 2.3 2.7 2.5 
PROLAPSED CORD 2.3 2.7 2.5 
DELAYED ACTIVE PHASE 20.4 13.5 17.3 
FETAL DISTRESS + PIH 4.5 8. 1 6.2 
POOR MATERNAL EFFORT 2.7 1. 2 
INTRAUTERINE GROWTH RETARDATION - 2.7 1. 2 
MALPRESENTATION 2.3 1.2 
ABRUPT IO 2.7 1. 2 
PLACENTA PREVIA 2.7 1. 2 
========================================================= 
TOTALS 100.0 100.0 100.0 
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8.3.1.12. Maternal Sedation. 
The distribution of maternal sedation prior to delivery 
is set out in Table 8.3.10.1. 
TABLE 8.3.10.1. MATERNAL SEDATION. 
·================================================ 

























TOTALS 64 52 116 
TABLE 8.3.10.2. MATERNAL SEDATION - PERCENTAGES. 
=================================================== 







< 2HRS BD 
> 2HRS BD 
















TOTALS 100.0 100.0 100.0 
BD = Before delivery. 
No significant differences could be shown between the 
two groups on Chi squared testing: 0.163 OF= 2. 
8.3.1.13. Obstetricians Assigned Cause of Asphyxia. 
The causes of asphyxia, as it is defined in this work, 
which were assigned in each case by the obstetrician 
are set out in Table 8.3.11.1. 
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TABLE 8.3.11.1. OBSTETRICIANS CAUSE OF ASPHYXIA. 
========================================================== 
CAUSE CASES CONTROLS TOTALS 
========================================================== 
UNDETERMINED 14 15 29 
CEPHALOPELVIC DISPROPORTION 31 16 47 
PREGNANCY INDUCED HYPERTENSION 5 5 10 
ECLAMPSIA 1 1 2 
CPD + PIH 1 1 
PROLAPSED CORD 1 1 
CORD ROUND NECK 1 1 2 
MATERNAL SEDATION 2 2 
ABRUPT IO 3 2 5 
MATERNAL INFECTION 1 1 2 
INTRAUTERINE GROWTH RETARDATION 5 5 
POST TERM 1 2 3 
UTERINE INERTIA 1 1 
PLACENTA PR EVIA 1 1 
MISSING 2 3 5 
========================================================== 
TOTALS 64 52 116 
TABLE 8.3.11.2. OBSTETRICIANS CAUSE OF ASPHYXIA. 
PERCENTAGES. 
=========================================================== 
CAUSE CASES CONTROLS TOTALS 
=========================================================== 
UNDETERMINED 21. 9 28.8 25.0 
CEPHALOPELVIC DISPROPORTION 48.4 30.8 40.5 
PREGNANCY INDUCED HYPERTENSION 7.8 9.6 8.6 
ECLAMPSIA 1.5 1. 9 1. 7 
CPD + PIH 1. 9 .9 
PROLAPSED CORD 1. 9 .9 
CORD ROUND NECK 1.5 1. 9 1. 7 
MATERNAL SEDATION 3.8 1. 7 
ABRUPT IO 4.7 3.8 4.3 
MATERNAL INFECTION 1. 5 1. 9 1. 7 
INTRAUTERINE GROWTH RETARD 7.8 4.3 
POST TERM 1.5 3.8 2.6 
UTERINE INERTIA 1. 9 .9 
PLACENTA PREVIA 1. 9 .9 
MISSING 3. 1 5.8 4.3 
=========================================================== 
TOTALS 100.0 100.0 100.0 
No significant differences could be shown between the 
two groups on Chi squared testing : 6.270 DF = 5. 
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8.3.2. INFANTS' DATA. 
8.3.2.1. Resuscitation of the Infant. 
The distribution of the method of resuscitation required 
for each infant is set out in Table 8.3.12.1. 
TABLE 8.3.12.1.RESUSCITATION. 
================================================ 


















TOTALS 64 52 116 
TABLE 8.3.12.2. RESUSCITATION - PERCENTAGES. 
================================================= 



















TOTALS 100.0 100 .. 0 100.0 
Key : ETT = Endotracheal tube. 
No significant differences could be shown between the 
two groups on Chi squared testing : 5.296 DF = 3. 
8.3.2.2. Apgar Score at 5 minutes. 
The mean (+- S.D.> 5 minute Apgar scores of the cases 
and controls were 7.75 <2.33) ··and 6.88 (2. 59) 
respectively. This difference is not significant. 
< t=l.89 DF=114 >. 
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8.3.2.3. Sex of Infants. 
The sex of the infants is set out in Table 8.3.13. 
TABLE 8.3.13. SEX OF INFANTS 







59 ===================================================== TOTALS 64 52 116 ====================================================== 
There was no significant difference in the distribution 
of sexes between cases and controls. <Chi square= 1.75 
DF= 1 >. 
8.3.2.4. Birth Weight and Gestational age. 
The data for these two parameters are set out in Table 
8. 3. 14. 
TABLE 8.3.14. BIRTH WEIGHT AND GESTATIONAL AGE. 
=========================================================== CASES CONTROLS t - TEST =========================================================== MEAN SD MEAN SD t N SIG =========================================================== BIRTH WEIGHT 3279 













SIG = Significance 
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8.3.2.5. Placental Chorionic Arterial Blood gas Determinations. 
The values obtained for pH, pC02 and base excess are set 
out in Table 8.3. 15. 
TABLE 8.3.15. PLACENTAL CHORIONIC ARTERIAL BLOOD GAS 
DETERMINATIONS. 
---------------------------------------------------------
CASES CONTROLS t - TEST 
========================================================= 
























8.3.3. PHENOBARBITONE LEVELS. 
It was intended to obtain phenobarbitone levels on all 
cases at 48-72 hours of age to confirm the therapeutic 
regimen. ·Unfortunately due to a power failure a number 
of deep frozen specimens were lost. 39 specimens were 
finally analysed out of a possible 64 cases. 
The mean phenobarbitone level was 130.1 mmol/l (+-69.4) 
f 
median 121 and range 21 to 378 mmol/l. 
The mean age at sampling was 73.1 hours (+-32.8>, 
median 71 and range 18 to 184 hours. 
In order to see if the age at sampling was a important 
factor in the level of phenobarbitone a test of 
correlation was performed which showed found no 
association. R = -0.110. 
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8.3.4. OUTCOMES DURING THE INFANT'S STAY IN THE NURSERY. 
8.3.4.1. Mortality. 
Four infants, all in the control group, died in the 
early neonatal period. The difference between the 2 
groups is significant. <Fisher's exact probability = 
0.038). The details are set out below. 
TABLE 8.3.16. DETAILS OF DEATHS IN EARLY NEONATAL PERIOD: 
=============================================~============ 
CASE: AGE AT'DETAILS OF :FITS :TRAUMA OTHER FEATURES 
No. : DEATH ENCEPH. 
-------
003 28 hrs 
009 72 hrs 
071 16 hrs 




















Caput Meconium aspir. 




Key: PR = Primitive reflexes. 
8.3.4.2. Scores in the Prechtl Test at 48-72 hours. 
The results of the Prechtl assessment were in two parts. 
Due to the nature of the test and its requirement that 
babies are in the correct state of arousal for each of 
the test items, it was impossible to carry out all the 
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items on any one baby. A "completeness score" indicates 
the number of items sucessfully carried out divided by 
the full number of items in the test expressed as a 
percentage. The "Prechtl score " is the number of points 
scored divided by the maximum possible number of points 
obtainable for the items tested. 
Due to the author being on occasion unavailable to 
carry out the test, data is missing for 15 cases and 9 
controls. The difference in missing data is not 
sign if leant. Chi-squared <Yates) = 0.33 DF=l. The 
following data refers to the remaining 92 patients. 
The data relating to the age in hours at performing the 
assessment, the completeness score and the actual 
scores are set out in Table 8.3.17. below. 
TABLE 8.3.17. PRECHTL TEST SCORES. 
========================================================= 
CASES CONTROLS t - TEST 
---------------------------------------------------------
MEAN SD MEAN SD t VAL. N SIG 
========================================================= 
AGE @ TEST 62.7 15.8 68.6 16.3 1. 771 92 NS 
~ COMPLETE 62. 1 13.5 63.6 10.9 0.611 92 NS 
SCORES 50.8 12.9 65.2 15.9 4.780 92 <0.001 
========================================================= 
The cases scores significantly lower on the Prechtl 
assessment than did the untreated controls. 
8.3.4.3. Neurological Examination at +- 48 hours. 
This was carried out in 97 patients. The others being 
missing for reasons given in 8.3.4.2. above. 
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The mean (+-S.D.) age at carrying out the examination 
for the 2 groups was as follows 
CASES 65.2 <21.2). 
CONTROLS 68.6 <15.9). 
This difference is not significant. t = 0.903 N = 97. 
The distribution of the result of the ~xamination · for 
each infant is set out in Table 8.3.18.1. 
TABLE 8.3.18.1. NEUROLOGICAL STATE AT 48-72 HOURS. 
=============================================== 
CASES CONTROLS TOTALS 
=============================================== 
NORMAL 4 
PROBABLY NORMAL 5 














TOTALS 64 52 116 
TABLE 8.3.f8.2.NEUROLOGICAL STATE AT 48-72 HOURS 
PERCENTAGES. 
================================================= 























TOTALS 100.0 100.0 100.0 
It can be seen from Table 8.3.18.2. that more cases 
fell into the abnormal categories than did controls. 
This difference was highly significant on Chi squared 
testing : 33.935 DF = 2. p = < 0.001. 
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8.3.4.4. Biochemical Values. 
The age in hours at sampling as well as the values for 
the biochemical parameters are set out below in Table 
8.3.19. Data for 17 cases and 17 controls were not 
available. However the difference in the proportions of 
patients without data was not significantly different 
between cases and controls. <Chi square = 0.520 
OF= 1>. 




MEAN SD MEAN SD t-VAL N SIG 
=========================================================== 
Hours 
AGE ® SAMPLING 68.3 30.7 70.4 27.7 0.313 80 NS 
Mol/litre 
SODIUM 136.7 5.9 141. 0 4. 1 3.624 81 <0.001 
POTASSIUM 4.9 1. 2 4.6 1. 0 0.965 81 NS 
UREA 6.8 3.3 4. 1 3.5 3.643 82 <0.001 
CREATININE 81. 7 22.9 83.9 22.9 0.374 70 NS 
============================================================ 
8.3.4.5. Other Illness during Perinatal Period. 
The occurence of other illness during the perinatal 
period is set. out in Table 8.3.20.1. 
TABLE 8.3.20.1. CONCURRENT ILLNESS IN THE NEONATAL PERIOD. 
==================================================== 
ILLNESS CASES CONTROLS TOTALS 
==================================================== 
NONE 54 
MECONIUM ASPIRATION 10 
TRANSIENT TACHYPNOEA 
SUBAPONEUROTIC HAEMORRAGE -











TOTALS 64 52 116 
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TABLE 8.3.20.2. CONCURRENT ILLNESS IN THE NEONATAL 
PERIOD. PERCENTAGES. 
==================================================== 




















TOTALS 100.0 100.0 100.0 
There were no significant differences in the occurence 
of other illness in the 2 groups . Chi square = 0.591 
DF = 1. 
8.3.4.6. Seizures. 
The occurrence and timing of seizures in the nursery are 
set out in TABLE 8.3.21.1. 
TABLE 8.3.21.1. SEIZURES IN THE NURSERY 
============================================== 
CASES CONTROLS TOTALS 
============================================== 
NONE 
@ 25-48 HRS 
@ 13-24 HRS 















TOTALS 64 52 116 
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TABLE 8.3.21.2. SEIZURES IN THE NURSERY - PERCENTAGES 
================================================= 
CASES CONTROLS TOTALS 
================================================= 
NONE 98.4 84.6 92.2 
@ 25-48 HRS 3.8 1. 7 
@ 13-24 HRS 1. 6 1. 9 1. 7 
@ 6-12 HRS 1. 9 .9 
MISSING 7.7 3.4 
================================================= 
TOTALS 100.0 100.0 100.0 
No significant difference could be demonstrated between 
cases and controls in regard to seizures. 
Fisher's exact probability= 0.211 
8.3.4.7. Jaundice. 
The peak levels of total serum bilirubin in the nursery 
are set out in Table 8.3.22.1. 
TABLE 8.3.22.1. NEONATAL JAUNDICE. 
========================================== 


















TOTALS 64 52 116 
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TABLE 8.3.22.2. NEONATAL JAUNDICE - PERCENTAGES. 
================================================= 
MMOL/L CASES CONTROLS TOTALS 
================================================= 
NIL-<150 100.0 78.8 90.5 
150-199 7.7 3.4 
200-249 1. 9 .9 
250-299 3.8 1. 7 
MISSING 7.7 3.4 
================================================= 
TOTALS 100.0 100.0 100.0 
Seven controls developed a total serum bilirubin > 150 
mmol/l while none of the cases did so. This difference 
was significant using Fisher's exact probability test 
p=0.002. 
8.3.4.8. Age at Independent Feeding. 
The ages at which babies were able to feed without 
nasogastric tube assistance are set out in Table 
8.3.23.1. 
TABLE 8.3.23.1 .. AGE AT INDEPENDENT FEEDING. 
========================================== 
DAYS CASES CONTROLS TOTALS 
========================================== 
2 39 32 71 
3 4 7 11 
4 5 1 6 
5 6 1 7 
6 2 1 3 
7-9 2 1 3 
10 1 1 
10+ 2 1 3 
MISSING 4 7 1 1 
========================================== 
TOTALS 64 52 116 
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DAYS CASES CONTROLS TOTALS 
================================================= 
2 60.9 61. 5 61. 2 
3 6.3 13.5 9.5 
4 7.8 1. 9 5.2 
5 9.4 1. 9 6.0 
6 3. 1 1. 9 2.6 
7-9 3. 1 1. 9 2.6 
10 1. 9 .9 
10+ 3. 1 1. 9 2.6 
MISSING 6.3 13.5 9.5 
================================================= 
TOTALS 100.0 100.0 100.0 
There was no significant difference between cases and 
controls in this respect. Chi square= 2.190 DF = 3. 
8.3.4.9. Age at Discharge from Nursery. 
For the 112 infants who survived the mean (+-S.D> age 
in days on discharge from the nursery was as follows : 
CASES 7.92 <3.92) days. Range 3-21. 
CONTROLS 6.47 <4.21> days. Range 3-29. 
This difference was not significant. t = 1.865 N = 112. 
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8.3.5. FOLLOW-UP 
Details of the deaths and losses from the trial are set 
out in Tables 8.3;24.1. and 8.3.24.2. 
TABLE 8. 3. 2 4. 1. FATE OF PATIENTS ENTERING TRIAL. 
================================================== 
CASES CONTROLS TOTAL 
================================================== 
DIED IN NURSEY 0 4 4 
DIED DURING YEAR 1* 1** 2 
LOST TO FOLLOW UP 12 10 22 
When last seen 
Nursery 10 9 
6 week visit 2 1 
--------------------------------------------------
TOTAL DIED/LOST 13 15 28 
-----------------------~--------------------------
FOLLOWED TO 1 YEAR 51 37 88 
================================================== 
TOTALS 64 52 116 
================================================== 
* Died at 25 weeks. ** Died at 34 weeks. 
CHAPTER 8 THERAPY TRIAL Page 211 
TABLE 8.3.24.2. FOLLOW UP RATE : 
================================================ 
CASES CONTROLS TOTALS 
================================================ 
ORIGINAL No. 
SEEN AT 1 YEAR 











There was no significant difference in the proportions 
of cases and controls that were lost to the trial. Chi 
square= 1.14 DF=l. 
All the data that follows relates to the 88 patients who 
were sucessfully followed to 1 year of age. 
8.3.5.1. Age at Follow up Visits. 
The numbers of infants seen, and the mean ages in weeks 
at the various follow-up visits are set out in Table 
8.3.25. 
TABLE 8.3.25. AGE AT FOLLOW UP VISITS. 
========================================================= 
CASES CONTROLS t - TEST 
========================================================= 
VISIT . MEAN SD N MEAN SD N t VAL. Tot SIGN. 
========================================================= 
6 WEEKS 6.8 1. 4 46 7. 1 1. 5 38 1.136 84 NS 
3 MONTHS 13.3 1. 7 49 13.3 1. 5 35 0. 113 84 NS 
6 MONTHS 26.8 1. 9 48 25.9 1. 5 33 2.08 81 <0.05 
9 MONTHS 39.7 2.3 42 39.3 2.8 31 0~662 73 NS 
12 MONTHS 54.6 7. 1 51 52.9 3.2 37 1.380 88 NS 
========================================================= 
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8.3.5.2. Developmental Scores. 
The mean percentage scores in the Denver Developmental 
Screening Test at the various follow-up visits are set 
out in Table 8.3.26. 
TABLE 8.3.26. DEVELOPMENTAL SCORES AT FOLLOW-UP. 
========================================================== 
CASES CONTROLS t - TEST 
========================================================== 
VISIT MEAN SD N MEAN SD N t VAL. Tot SGN 
========================================================== 
6 WEEKS 80.7 14.3 46 82.3 12.9 38 0.515 84 NS 
3 MONTHS 88.3 10.5 49 86.9 13.3 34 0.540 83 NS 
6 MONTHS 69.5 16. 1 47 72.7 13. 1 32 0.845 79 NS 
9 MONTHS 80.7 15.3 42 81. 6 13. 1 30 0.256 72 NS 
12 MONTHS 77.8 21. 3 49 76.8 22.6 37 0.211 86* NS 
========================================================== 
* = 2 cases were too old for the test items at 12 months. 
No significant differences are demonstrated. 
At the 12 month visit the number of items scheduled for 
testing in the Denver Developmental Screening Test was 
12. The mean number tested (+-S.D.) was as follows: 
Cases 11. 79 ( +-0. 49) 
Controls 11.59 (+-0.68) 
t = 1.576 No significant difference. 
Analysis of the numbers of completed items of the test 
at all the follow-up ages are given in Appendix VII. 
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8.3.5.3. Weight. 
The mean weights in grams of the babies at the various 
follow-up visits are set out in Table 8.3.27. 
TABLE 8.3.27. WEIGHT AT FOLLOW UP VISITS 
========================================================== 
CASES CONTROLS t - TEST 
========================================================== 
VISIT MEAN SD N MEAN SD N t VAL. Tot SGN 
========================================================== 
6 WEEKS 4762 890 44 5027 817 37 1.370 81 NS 
3 MONTH 6072 1158 48 6171 950 34 0.407 82 NS 
6 MONTH 7929 1251 47 7930 1464 33 0.0006 80 NS 
9 MONTH 9135 1667 41 9008 1316 29 0.343 70 NS 
12 MONTH 10176 1647 49 9763 1567 36 1.165 85* NS 
========================================================== 
* = 2 cases were too old to include their weights in the 
comparison. In one control the data were missing. 
No significant differences were demonstrated. 
8.3.5.4. Head Circumference. 
The mean head circumferences in centimetres of the 
babies at the various follow-up visits are set out in 
Table 8.3.28. 
TABLE 8.3.28. HEAD CIRCUMFERENCE AT FOLLOW UP. 
========================================================= 
CASES CONTROLS t - TEST 
========================================================= 
VISIT MEAN SD N MEAN SD N t VAL. Tot SGN 
========================================~================ 
6 WEEKS 38.7 2.2 45 39.5 1. 6 38 1. 711 83 NS 
3 MONTH 41. 3 1.6 47 41. 6 1. 6 34 0.852 81 NS 
6 MONTH 44. 1 1. 8 46 44.3 1. 9 33 0.289 79 NS 
9 MONTH 45.7 1. 9 39 46. 1 1. 8 29 0.343 68 NS 
12 MONTH 46.9 1. 7 49 46.8 1. 9 37 0. 101 86* NS 
========================================================= 
* = 2 cases were too old as explained in Table 8.3.27. 
No significant differences were demonstrated. 
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8.3.6. FINAL OUTCOMES AT 12 MONTHS. 
The outcomes at 12 months for developmental score, 
·weight and head circumference have been given above. No 
significant differences were demonstrated in any of 
these parameters. Other aspects of final outcome will be 
given below. 
8.3.6.1. Neurolological and developmental Outcome. 
Outcome is considered in terms of both neurology and 
development. In some cases both were abnorma!, whil~ in 
others only one was· abnormal. These results are set out 
in Table 8.3.29. for cases, Table 8.3.30. for controls 
and in Table 8.3.31. for both combined. 
















TOTALS 8 43 51 
====================================================== 
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27 29 ======================================================= TOTALS 4 33 37 ======================================================= 
TABLE 8.3.31. ALL PATIENTS NEUROLOGICAL AND 
DEVELOPMENTAL OUTCOME. 
====================================================== 
NEUROLOGICAL STATUS : 








67 73 ==========================================£=========== TOTALS 12 76 88 ====================================================== 
The identity of the patients in these tables is given in 
Appendix IV Tables. AX.IV.1 and 2. 
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8.3.6.2. Comparison of neurological and developmental outcomes. 
Table 8.3.32. compares the neurological outcome of 
cases and controls. 
TABLE 8.3.32. NEUROLOGICAL OUTCOMES. 
============================================ 
CASES CONTROLS TOTALS <X> 
============================================ 
ABNORMAL 8 4 12 (13.6) 
NORMAL 43 33 76 (86.4) 
============================================ 
TOTALS 51 37 88 (100) 
============================================ 
There was no significant difference between cases and 
controls in regard to neurological outcome. <Chi 
squared with Yates' correction= 0.117 DF = 1). 
Table 8.3.33. compares the developmental butcomes of 
cases and controls. 
TABLE 8.3.33. DEVELOPMENTAL OUTCOMES. 
============================================ 
CASES CONTROLS TOTALS <X> 
============================================ 
ABNORMAL 7 8 15 (17.4) 
NORMAL 29 71 (82.6) 
============================================ 
TOTALS 49 37 86 (100) 
============================================ 
Key : * = 2 cases were too old for the test items at 12 
months. 
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There was no significant difference between cases and 
controls in regard to developmental outcome. <Chi 
squared with Yates' correction= 0.360 OF= 1). 
Table 8.3.34. compares the neurodevelopmental outcome of 
cases and controls. 
TABLE 8.3.34. ALL NEUROOEVELOPMENTAL OUTCOMES. 
=============================================== 
CASES CONTROLS TOTALS 
=============================================== 
ABNORMAL 11 10 21 (23.8) 
NORMAL 40 27 67 (76.2} 
=============================================== 
TOTALS 51 37 88 000) 
=============================================== 
There was no significant difference between cases and 
controls in regard to any abnormal neurodevelopmental 
outcome. ( Chi square = 0. 351 OF= 1} . 
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8.3.6.3. Types of neurological abnormality. 
The types of abnormal neurological outcome are set out 
in Table 8.3.35. 
TABLE 8.3.35. DETAILS OF PATIENTS WITH ABNORMAL 
NEUROLOGICAL OUTCOME AT 12 MONTHS. 
=================================================== 




026 Moderately severe spastic quadri-
paresi s. Deaf. 
036 Moderately severe quadriparesis. 
054 Mild spastic quadriparesis. 
079 Very mild hemiparesis 
068 Squint 
097 Mild spatic quadriparesis 
116 Abnormally brisk arm and leg tendon 
reflexes. 











030 Microcephalic, severe spastic quadriparesis 
0/12 
088 Moderately severe spastic quadriparesis 0/12 
008 Abnormally brisk arm tendon reflexes. 8/10 
059 Mild spastic quadriparesis. 10/11 
================================================== 
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8.3.6.4. Hearing. 
The details of hearing at the final examination is shown 
in Table 8.3.36.1. 
TABLE 8. 3. 36. 1. HEARING AT 1 YEAR. 
================================================= 




















TOTALS 51 37 88 
TABLE 8.3.36.2. HEARING AT 1 YEAR - PERCENTAGES. 
================================================= 




















TOTALS 100.0 100.0 100.0 
No significant differences could be demonstrated. 
Fisher's exact probability= 1.33. 
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8.3.6.5. Seizures over Follow-up Period. 
The details of the occurence of seizures over the whole 
12 month follow-up period are shown in Table 8.3.37.1. 
TABLE 8.3.37.1. SEIZURES AT 1 YEAR. 











2 ================================================= TOTALS 51 37 88 
TABLE 8.3.37.2. SEIZURES AT 1 YEAR - PERCENTAGES. 











2.3 ================================================= TOTALS 100.0 100.0 100.0 
No significant differences could be demonstrated. 
Fisher's exact probability= 0.760. 
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8.4. DISCUSSION. 
8.4.1. PATIENTS AND METHODS 
8.4.1.1. Criteria for entry into the trial : 
The literature review on criteria of asphyxia revealed 
a wide lack of uniformity. Apgar scores, placental 
acid-base, time to spontaneous respiration as well as 
the occurence and severity of encephalopathy have all 
been used. It is clear that no one criterion will be 
adequate and the newer combination schemes of Low et al 
(1983) and Rothberg et al (1986) take this into 
account. The use in this trial of a combination of 
biochemical and clinical criteria was in response to 
this newer and more rational view of asphyxia which 
goes beyond a low Apgar score at the time of birth and 
tries to detect inf ants who have experienced 
significant intrauterine hypoxia. The choice 0£ the ·~ 
placental arterial base excess as the biochemical 
criterion was because it has been used in a number of 
previous studies as described in Chapter 3, and it was 
easily available in the working environment. The 5 
minute Apgar and evidence of fetal distress are 
similarly well documented criteria. 
De Sousa et al (1983) reported that the combination of 
a low umbilical venous pH and low Apgar Score was able 
to predict infants who would be abnormal neurologically 
in the neonatal period very much better than either 
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criterion taken alone. A similar combination of 
criteria was used here in order to select infants with 
a significant metabolic acidosis plus either depression 
at birth or evidence of fetal distress. The fact that. 
only 20 - 30 Y. of the controls were neurologically 
abnormal at 48-72 hours indicates that a group of 
relatively mildly affected infants were selected. In a 
sense one would have liked to have chosen only those 
who were going to develop overt encephalopathy but to 
wait until the infant shows signs of encephalopathy 
before giving the protective agent is to negate its 
possible protective role. Equally in the routine 
situation one has to start treatment for asphyxia 
immediately after birth on the basis of some objective 
criteria rather than wait for the onset of seizures or 
other indication of encephalopathy. 
8.4.1.2. Dosage regimens. 
The literature review of dosage of phenobarbitone 
indicated that authors such as Jalling <1975), Lockman 
et al (1979) and Donn et al (1985) have found that a 
loading dose of 15mg/kg given intravenously will 
produce a peak level of about 195 mmol/l within a few 
minutes of administration and be well sustained for 24 
hours at least. The finding in this study of a mean 
phenobarbitone level of 130 mmol/l at a mean sampling 
time of 73.1 hours fits in well with these previous 
findings. It is of note that no previous study has 
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related a barbiturate blood level to its protective 
effect after asphyxia either in human or experimental 
animal work. ·The blood levels achieved here are in the 
range found to be anticonvulsant but what relationship 
that level has to brain protective levels is not known. 
The literature review also showed that the dose of 
dexamethasone used in this study (2 mg/Kg/24hrs> is 
relatively small when compared to the doses that have 
been used in this situation in experimental animals. 
The Manchester group of Desousa and Dobbing (1973) used 
20-40mg/Kg in rats. The human infant has however been 
shown to respond to a dose of 4 mg with reduction in 
measured intracranial pressure by Levene and Evans 
(1985>. 
8.4.1.3. Use of Placental ehorionie arterial sampling for 
fetal acid-base status : 
The use of placental arterial sampling to assess fetal 
acid base status has been reported by Rothberg et al 
<1986) and Bolton (1985>. Sykes et al <1982) in their 
very large study on neonatal acid- base status used the 
arterial side of umbilical cord segments. Furthermore 
it appears to be in order to sample from the placental 
vessels for a period after delivery. Woods et al 
(1986> have shown that the acid base values in 
placental arterial samples are well preserved for up to 
10 minutes after normal delivery of the placenta. 
' 
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8.4.1.4. Neurodevelopmental Evaluation. 
The method chosen to evaluate the neurological status 
of the infants at 48-72 hours of age was that of 
Prechtl <Prechtl 1977). This is a detailed neurological 
assessment taking about 30 minutes to carry out, but is 
useful for two main reasons. Firstly it has a large 
number of test items and secondly it takes into account 
the state of arousal of the infant in that he/she must 
be in the correct state for each item. Test schemes 
without these 2 features can easily provide a false 
picture of a newborn infant's neurological state. This 
requirement inevitably means that not every item can be 
carried out on every inf ant. Nevertheless the large 
number of related test items provides enough testable 
items to obtain a reliable assessment. The main purpose 
of the test in this trial was to compare the 
neurological state of the 2 groups rather than to 
document the absolute condition of each infant. The 
scoring system devised for use in this trial was 
intended to provide a means of expressing the 
neurological state numerically and is not part of 
Precht.l's original scheme. It showed that there was no 
difference in the number of test items completed in the 
two groups but that there was a significant difference 
in the neurological state as measured by the test items. 
For the follow-up visits and the final assessment at 12 
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months of age the Denver Developmental Screening Test 
<Frankenburg and Dodds 1967) was used. It was chosen 
because it is a relatively simple scheme which could 
easily be taught to the nursing staff who made the home 
visits. Furthermore the author, who is a general, 
rather than a neurodevelopmental, paediatrician felt 
that it was more appropriate to his level of skill than 
more specialised schemes. The method of expressing the 
scores for this test needs some comment. The orthodox 
method would have been to use the whole test at each 
follow visit and express the result up as a 
developmental quotient. This was difficult for 
practical reasons. The often crowded and noisy home 
situation, both in township and rural areas usually did 
not lend itself to the performance of an "all item" 
test. Therefore a form containing all the items 
relevant to the age of the visit was used. The score 
for each visit was taken as the number of items passed, 
divided by the number of items tested, expressed as a 
percentage. This was an adaptation of the test to the 
local practical sittiation. 
The decision to follow up for only 1 year was taken 
mainly for practical reasons. Amiel-Tison and Ellison 
<1986) reviewing the age of appearance of handicap 
after perinatal asphyxia, conclude that very few new 
cases of major neurological deficit will be found after 
the first year of life, although lesser degrees of 
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handicap will continue to be found with increasing age. 
This is relevant to the decision to follow up for 1 
year which period was chosen as a compromise between 
practicality and sensitivity. 
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8.4.2. RESULTS 
8.4.2.1. Comparability. 
This set of comparisons of cases and controls serves to 
show that in all respects, other than the use of 
phenobarbitone and dexamethasone, the cases and 
controls were highly comparable. These included : 
* Maternal age 
* Gravidity and Parity 
* Antenatal care useage 
* Complications of pregnancy 
* Presentation 
* Occurence of fetal distress 
* Complications of labour 
* Duration of the first stage of labour 
* Method of delivery 
* Indications for operative delivery 
* Placental weight 
* Maternal sedation 
* Obstetricians designated cause of asphyxia 
* Birth weight 
* Resuscitation 
* Placental arterial acid base values. 
8.4.2.2. Phenobarbitone levels 
These refer to cases only. As explained in the results 
section, 25 specimens were lost in a power failure. 
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Nevertheless but it is felt reasonable to assume that 
this was a random event and that the surviving 
specimens are as representative as those that were 
lost. 
There was quite a wide range of phenobarbitone levels 
obtained with a range of 21 to 378 mmol/l resulting 
from the same dosage. This is in agreement with Jalling 
(1975) who found marked patient to patient variability 
in the half life of phenobarbitone and furthermore 
that this varied from day to day in the same patient. 
It may be that in further studies more frequent 
phenobarbitone levels would need to be done to document 
therapeutic levels in each patient. Nevertheless levels 
thought to be anticonvulsant were achieved in most 
cases. 
8.4.3. NEONATAL OUTCOMES 
In the period of stay in the nursery a number of 
significant differences were found between the cases 
and controls. These were: 
* Mortality - Untreated higher. 
* Prechtl test at 48-72 hours 
- Treated more depressed. 
* Neurological evaluation at 48-72 hours 
- Treated more abnormal 
* Occurence of neonatal jaundice - Treated less 
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* Biochemical values - Sodium 
Urea 
- Treated lower 
- Treated higher 
In the nursery other outcomes were no different. These 
were : 
* Occurence of other illnesses in the nursery 
period. 
* Occurence of seizures. 
* The age at independent feeding. 
* The age at discharge from the nursery. 
* Biochemical values - Potassium 
- Creatinine 
A similar reduction in neonatal mortality was seen in 
the study of Svenningsen et al (1982) which was a 
prospective trial of an intensive care package which 
included vigourous ventilation, phenobarbitone, 
dexamethasone and lasix given to cases as compared to 
the routine supportive care given to controls. The 
infants were very much more severely asphyxiated than 
those in the present study in that they were chosen by 
their failure to establish regular respiration at 30 
minutes. They found a neonatal mortality reduction in 
that 0/14 of the treated cases died as compared to 5/16 
in controls. This is a similar effect to that seen in 
this trial but there were additional items of treatment 
in their regimen and so direct comparisons are 
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difficult. These differences have been discussed in 
Chapter 7. 
The reduction in immediate mortality with no difference 
in the long term neurological deficits in survivors 
found in the trial was interestingly similar to the 
experimental work in adult cats by Todd et al (1982) 
discussed in section 7.4.1.5. 
The difference both in the Prechtl and in the 
conventional neurological state at 48-72 hours is not 
surprising in view of the presence of therapeutic blood 
levels of phenobarbitone. Some degree of depression is 
to be expected. 
Similarly to be expected was the fact that there were 
fewer cases of significant jaundice among the treated 
inf ants considering the well known effect of 
phenobarbitone in inducing the liver enzyme glucuronyl 
transferase <Conney 1967 & Trolle 1968). 
The effect of treatment upon the serum sodium and urea 
is less easy to explain. One might speculate that the 
steroid effects of dexamethasone may have increased the 
intravascular volume leading to a minor reduction in 
serum sodium as was seen. Also that by increasing body 
catabolism the blood urea may have been raised. 
There were proprtionately fewer cases of seizures among 
the treated infants but the difference was small and 
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did not reach statistical significance. This effect may 
well have been real as even though the number of 
patients having seizures was small the trend was 
visible. The low incidence of fits in such a group of 
infants is surprising. A possible explanation for this 
is that the selection criteria defined a very mildly 
affected group. However the 23.SX incidence of 
neurodevelopmental abnormality found at 1 year for the 
group as a whole would not support this. A real 
possibility also exists that in an often crowded and 
busy neonatal unit such as ours, subtle neonatal 
seizures might be missed by mothers and staff and that 
the true incidence is higher than recorded here. 
8.4.4. LATER FOLLOW UP. 
At the final 12 month visit 88 <75.9X) out of the 
original 116 patients were examined . As stated in the 
results section there was no difference in the numbers 
lost between the two groups. It is a possibility that 
at least some of the infants who were lost to follow 
up, died. It must be emphasised that in that case, they 
must have first moved away from their last address 
without our knowlege as deaths at known addresses were 
all accounted for. 
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At 12 months there were no significant differences 
between the two groups in respect of : 
* Death 
* Developmental scores at all follow-up stages 
* Growth parameters - Weight 
Head circumference 
* Neurological status 
* Hearing status 
* Occurence of seizures 
The lack of difference in the long term outcome between 
these two groups is perhaps suprising in view of the 
differences seen in the neonatal period. The 
possibility exists that an effect of the regimen was 
present but could not be demonstrated for methodological 
reasons. There are three obvious variables which 
might have made a difference : 
Ca> Dose of agents. The dose of phenobarbitone chosen 
in this study was that conventionally used for stopping 
seizures in the human neonate. It is possible that one 
might need to use much higher doses of the agent to 
achieve protection. In animal exerimental work 
pentobarbitone rather than phenobarbitone has been used 
in doses of 20mg/Kg. Unfortunately no animal study has 
included blood levels of barbiturate but protective 
benefits have been demonstrated at these doses. 
Guidance from human studies is also very scanty. The 
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only other prospective study of the use of 
phenobarbitone in the asphyxiated human term infant is 
that of Svenningsen et al 1982 who used a loading dose 
of lOmg/Kg IV of phenobarbitone and lOmg/Kg daily 
thereafter. This regimen produced peak levels of 150-
350mmol I 1 at 48-72 hours aft.er deli very and the authors 
demonstrated a protective effect for phenobarbitone in 
combination 
treatments. 
with a number of other agents and 
The dose of dexamethasone used by Svenningsen et al 
1982 was 2mg IV 6 hourly. This is very similar to the 
0.5 mg/kg IV 6 hourly in the present study. 
Cb) Severity of asphyxia : The protective effect of an 
agent in a mild insult will clearly be more difficult 
to document than in a more severe one. The patients 
selected into this trial were much less severely 
affected than were those of Svenningsen et 
who chose patients who had failed to 
al ( 1982) 
establish 
spontaneous respiration by 30 minutes. The severity in 
that trial was reflected by a mortality of 30% at 1 
year as compared to 5% in this trial. It is possible 
that if the selection criteria had been more severe an 
effect may have been shown. 
(c) Length of follow-up. Patients were only followed 
for 1 year and it is likely that a longer follow up 
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period would allow more subtle developmental defects to 
become detectable. Measurable differences between the 
groups might then appear. 
8.4.5. OUTCOME OF GROUP AS A WHOLE 
Although it was·not one of the original aims of this 
study, it is of interest to summarise the outcome of a 
group of 116 infants selected as being asphyxiated by 
these criteria in terms of mortality and neurological 
outcome at 1 year. 
The neonatal mortality was 4 out of 116 infants (3.4X>. 
It is interesting to compare this mortality to figures 
from other follow-up studies of asphyxia as reviewed in 
Chapter 4 Table 4.3.1. The report of Nelson and 
Ellenberg (1981> is from the large and authoritative 
"Collaborative Study of Cerebral Palsy, Mental 
Retardation and other Neurological 
Disorders of Infancy and Childhood " 
National Institute Of Neurological and 
and Sensory 
from the US 
Communicative 
Disorders and Stroke. The collaborative study looked at 
the outcome of a complete grid of possible Apgar 
scores. Scores of 0-3 at 1 minute were associated with 
a 1 st year mortality of 5.6X which was very similar to 
that in this study. Most of the other studies included 
in Table 4.3.1. show very much higher mortalities. 
Typical of this pattern is the st~dy from Cape Town of 
Molteno (1976) who used a selection criterion of Apgar 
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score at 1 minute of 3 or less and found a mortality of 
131.. 
In the pr~sent study, at 1 year the neurological 
abnormality picture was that 3 (3.4/.) infants had 
severe neurological disorders and 9 <10.2/.) had milder 
neurological deficits. A further 9 (10.2/.) had abnormal 
developmental scores but no hard neurological findings. 
Overall therefore 23.81. had some degree of 
neurodevelopmental abnormality. 
Again it is interesting to compare the outcome in terms 
of the rate of severe neurological deficit. Reference 
to Table 4.3.1. will show that Nelson and Ellenberg 
(1981) from the collaborative study give a figure of 
1.5/. associated with the Apgar 0-3 at 1 minute. Molteno 
(1976) gives a figure of 5.51. with similar sefection 
criteria to Nelson and Ellenberg. The present study 
found a rate of 3.41.. Many other studies have given 
figures of that order. 
It seems that in comparison to many of the reported 
follow up studies of asphyxia neonatorum, this study 
gives a very similar rate of severe neurological 
deficit but a much lower mortality. The main but 
important exception to these other studies is part of 
the collaborative study from the US. The reasons for 
this discrepancy are not clear but it must be restated 
that until more uniformity of selection criteria is 
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obtained it will remain very difficult to compare 
studies meaningfully. 
That asphyxia in the term infant leads mainly to 
spastic quadriparesis is supported by the findings in 
this study. Of the 12 infants with hard neurological 
deficits 9 had various degrees of spastic 
quadriparesis. Only 3 did not have this type of lesion. 
All 3 of the severly affected children had spastic 
quadriplegia, one of whom had associated microcephaly. 
A review of studies giving the types of cerebral palsy 
resulting from perinatal asphyxia is set out in Table 
2.4.2. The table shows that the commonest outcome was 
spastic quadriparesis varying from 20 to 70 /. of the 
total. The present study yielded 9/12 or 75/. spastic 
quadriparesis. 
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8.5. CONCLUSIONS 
8.5.1. A treatment regimen consisting of phenobarbitone and 
dexamethasone given to asphyxiated term neonates was 
shown to have the following effect 
* A significant reduction in neonatal mortality. 
* Neurological depression at 48-72 hours. 
* A significant reduction in neonatal jaundice. 
* Alteration in some biochemical values 
Serum sodium was reduced slightly. 
Blood urea was slightly raised. 
8.5.2. There were no differences between treated and control 
groups in respect of growth or development. 
8.5.3. At final evaluation at one year there was no 
significant difference between treated and control 
groups with respect to the occurence of objective 
neurological abnormality or developmental criteria. 
CHAPTER 8 THERAPY TRIAL Page 238 
8.5.4. The outcome of a group of term infants selected as 
being asphyxiated on the basis of a placental 
arterial base excess of >11 AND either an 5 minute 
Apgar score of <7 or objective signs of fetal 
distress was as follows 
8.5.5. 
Neonatal mortality 
1 year outcome 
Severe neurological deficits 
Minor neurological deficits 
Delayed development only 
All neurodevelopmental deficits 
- 4/116 (3.4i0 
3188 ( 3.4i0 
9188 ( 10. 2Y.) 
9188 (10.2Y.) 
- 21/88 (23.8Y.) 
The pattern of resulting abnormal neurological 
outcome was such that 9/12 <75Y.) had spastic 
quadriparesis. 
CHAPTER 9 FINAL CONCLUSIONS Page 239 
This final chapter reviews the extent to which the 
hypotheses advanced at the outset of this study can be 
accepted. It also makes some general conclusions and 
points out where the findings may lead in the future. 
9.1. FIRST HYPOTHESIS. 
"ASPHYXIA NEONATORUM IS THE LEADING ASCERTAINABLE CAUSE 
OF CEREBRAL PALSY AMONG HANDICAPPED CHILDREN IN 
DEVELOPING COMMUNITIES IN SOUTHERN AFRICA." 
For the area of the Ciskei studied, the leading 
ascertainable cause of cerebral palsy was asphyxia and 
so this hypothesis is accepted. How far it is true for 
similar communities is less certain but the scanty 
literature from similar areas suggests that a similar 
situation exists there too. 
The severity of the difficulties faced by the parents 
of a handicapped child in the urban areas of the 
developing world cannot be overemphasised. Community 
faciliies for managing the problems of the handicapped 
are very inadequate. The much vaunted "extended family 
network" which is said to look after these children, is 
largely a myth in the urban situation. 
The literature shows that spastic quadriparesis is the 
leading form of cerebral palsy following hypoxic 
ischaemic encephalopathy. This is bourne out in the 
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present study. It seems reasonable to assume that in a 
community in which spastic quadriparesis is the 
dominant form of cerebral palsy, one may be reasonably 
confident that asphyxia is unduely prevalent and that 
active steps to prevent it should be taken. 
9.2. SECOND HYPOTHESIS . 
"DATA ON THE EPIDEMIOLOGY OF ASPHYXIA NEONATORUM WILL 
BE HELPFUL IN LIMITING THE UNDUELY HARMFUL EFFECTS 
WHICH THIS CONDITION IS HAVING IN DEVELOPING 
COMMUNITIES AT PRESENT.•• 
A number of faritors in the antenatal and intrapartum 
periods have been shown to be significantly associated 
with asphyxia. In that a number of these are amenable 
to intervention, this hypothesis is accepted. 
The importance of antenatal care was highlighted as was 
the particularly vulnerable position of the primiparous 
woman. The antenatal detection of cephalopelvic 
disproportion and of disorders associated with utero-
placental dysfunction is particularly important. D~ring 
labour the early detection and active management of 
fetal distress is crucial. It is likely that the 
association of prolonged first stage of labour and 
operative delivery with asphyxia was due to the 
consequences of cephalopelvic disproportion and 
placental disorders. 
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All of the above factors are amenable to good obstetric 
care presently available in theory if not in practice. 
The challenge is to make such care easily available to 
as many women as possible and to get them to make use 
of such services. This involves the planning and 
creation of appropriate obstetric services, 
particularly at primary care level and the training of 
medical and midwifery staff. During this training 
particular emphasis needs to be laid on the disorders 
associated with asphyxia. 
The occurence of a sizable group of cases of asphyxia 
in which no clear cause could be found by the attending 
obstetrician, leads to speculation as to the existence 
of a group of disorders, presumably utero-placental, 
that are as yet unrecognized. This surely represents a 
great investigational challenge for the disipline of 
obstetrics. 
The fact that the quality of obstetric care is 
traditionally measured only in terms of mortality has 
resulted in a relative insensitvity of obstetricians 
and midwives to outcomes of pregnancy that may be more 
disastrous than perinatal death, namely the survival of 
severely physically and mentally handicapped children. 
It is suggested that the routine use of an index 
involving the incidence of perinatal asphyxia would 
provide an ongoing assessment of this problem. Such 
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monitoring might lead to a more active approach to this 
disastrous disorder. 
9.3. THIRD HYPOTHESIS. 
ON THE EFFICACY OF TREATMENT REGIMENS FOR 
ASPHYXIA NEONATORUM WILL BE HELPFUL IN LIMITING THE 
UNDUELY HARMFUL EFFECTS THAT THIS CONDITION IS HAVING 
IN DEVELOPING COMMUNITIES AT PRESENT". 
The treatment regimen used in the therapy trial did not 
make a significant difference to the long term 
neurodevelopmental outcome of survivors. In view of 
this the hypothesis cannot be accepted. However it is 
possible that with higher dosages of phenobarbitone a 
protective effect may be demonstrated in future trials. 
Work that has been published since this study was 
undertaken has indeed proceeded along these lines. 
Other protective agents may emerge in future and that 
some form of therapeutic intervention may be found to 
be beneficial remains a strong and desirable 
possibility. 
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APPENDIX I SCHEMES FOR GRADING 
ENCEPHALOPATHY. 
HYPOXIC-ISCHAEMIC 
TABLE AX.I.1. SARNAT SCHEME FOR GRADING ENCEPHALOPATHY. 
--------------------------------------------------------------------------------------------------------------------------
ITEM STAGE 1 STAGE 2 STAGE 3 
--------------------------------------------------------------------------------------------------------------------------

















Hyperalert Lethargic Stuporose 
Normal Mild hypotonia Flaccid 
Mild distal Strong distal Intermit. 





++++ - or absent 
Weak or abs Absent 
Weak Absent 
++++ Weak or 
absent 
Slight Strong Absent 
Generalized Generalized Both 
sympathetic Parasymp. depressed 



























From Sarnat and Sarnat (1976), 
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Amiel-Tison and Ellison (1986) propose a scheme with 3 
stages of severity each with a subdivision. 
Stage I Characterized by hyperexcitability and mild 
of abnormalities of tone. Subdivision is by duration 
symptoms for more or less than 7 days. 
Stage II 
or light coma. 
Deepening CNS depression defined as lethargy 
Subdivision is on the occurrence of seizures. 
Stage III Deep coma. Subdivision is by presence of 
brain stem signs especially the occulovestibular response. 
The authors also classify the special investigations usually 
asociated with the vaious degrees of encephalopathy : 







Key : NMR 
BAER 
Abn 
Stage I Stage II Stage III 
a b a b a b 
N ? Ahn ? Ahn Ahn Mod to sev Abn. 
N Ahn Mod to sev Ahn. 
N Abn Mod to sev Abn. 
N Mild Abn Severe Abn. 
N N N Abn 
Nuclear magnetic resonance. 
Brainstem auditory evoked response. 
Abnormal. 
APPENDICES Page 272 





Minor disturbances of tone, hyperalertness, 
and slight feeding difficulties recovering 
by 48 hours after birth. 
L~thargy, more pronounced abnormalities of 
tone, poor feeding and convulsions with 
signs of recovery by 7 days. 
Coma, failure to maintain adequate 
ventilation, profound hypotonia and 
seizures. 
============================================================ 
From Fenichiel (1983). 
TABLE AX.I.4. BROWN SCHEME FOR GRADING ENCEPHALOPATHY. 
============================================================ 
Brown used a large number of neurological and other 
parameters to characterise degrees of encephalopathy. In 
relating outcome to severity of encephalopathy he used 
patterns of muscle tone as follows : 
Flexor extensor - extensor/hypotonia hypotonia. 
============================================================ 
From Brown et al (1974>. 
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APPENDIX II COMBINATION SCHEMES FOR DEFINITION OF 
ASPHYXIA. 
TABLE AX.II.1. LOW'S COMBINATION SCHEME FOR DEFINING 
ASPHYXIA. 
Stage lA : Fetal metabloic acidosis. 
Children with evidence of fetal metabolic acidosis of 
a significant degree (umbilical artery buffer base of 
<34 mEq/L) and duration as defined by intrapartum 
acid-base measures. The diagnosis of fetal metabolic 
acidosis may be supported by evidence of hypoxemia, 
hypercarbia, and hyperlactemia with an increased 
lactate-pyruvate ratio. 
Stage 18 : Fetal metabolic acidosis plus newborn depression. 
Stage 
Children with evidence of significant fetal metabolic 
acidosis with evidence of fetal depression as 
expressed by an Apgar score at 1 minute <3 and at 5 
minutes <7 and/or respiratory delay >5 minutes 
requiring assisted ventilation. 
2 Fetal metabolic acidosis 
encephalopathy. 
plus neonatal 
Children with evidence of significant fetal metabolic 
acidosis and neonatal encephalopathy as expressed by 
abnormal neurological signs in respect to 
consciousness, tone, seizures, primitive reflexes and 
autonomic nervous system function. 
From Low et al (1983). 
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TABLE AX. I I. 2. ROTHBERG'S COMBINATION SCHEME FOR DEFINING 
ASPHYXIA. 
============================================================= 





TSR<5 min +- brief !PPR 
TSR>5 min requiring IPPR 
+- cardiac support and 
resusc. medications. 
TSR> 5 min, continued 
!PPR +- cardiac support 
and resusc medications. 
1 min <4 and/or 5 min <7 
1 min <4 and/or 5 min <7 
rapid recovery - 7-10 @ 
> 15 min. 
1 min <4 and/or 5 min <7 
and/or persistently 
low scores - <7 @ >15 
min. 
Grade 4 Above plus neonatal As for Grade 3. 
encephalopathy 




* This scheme takes note of the fact that Acid-base 




Time to sustained respiration 
Intermittent positive pressure ventilation. 
From Rothberg et al <1986). 
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APPENDIX III - CRITERIA FOR REFERRAL OF OBSTETRIC PATIENTS 
FOR HOSPITAL DELIVERY. 
REFERRAL CRITERIA 
1. AT BOOKING 






1.2. OBSTETRIC INDICATIONS 
Previous caesarian section 
Previous stillbirth 
Previous neonatal death 
Previous instrumental delivery 
Previous congenital abnormality 
Previous premature delivery 
Previous pre-eclampsia/eclampsia 
Previous baby >4 Kg 
Family history of diabetes 
Palpation/dates discrepancy 
2. FROM ANTENATAL CLINIC 
If any of above conditions present 
Glycosuria on 2 occasions 
Hypertension with or without proteinuria 
Proteinuria <2+) with or without 
hypertension 
A.P.H. 
Abnormal lie at 36 weeks 
Rhesus or ABO antibodies 
Anaemia - Hb =< 8 GI. 
Hb =< 9 GI. if no response to 
iron 
Rupture of membranes 
Multiple pregnancy at 28 weeks 
APPENDICES 
3. . IN LABOUR 
Primigravida 
Multigravida (G4 and above) 










All patients seen . in hospital during 
antenatal clinic and assessed for hospital 
delivery. 
Note : The above are ref erred only if the 
clinic is sure that the patient will not 
deliver before arrival in hospital. 
From Dr.R.Jones Department of Obstetrics - Cecilia Makiwane 
Hospital. 
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APPENDIX IV - IDENTITY OF PATIENTS WITH ABNORMAL 
NEURODEVELOPMENTAL OUTCOMES AT 12 MONTHS. 
TABLE AX IV.1. CASES ABNORMAL NEUROLOGICAL AND/OR 






















TOTALS 8 3 11 
========================================================== 
TABLE AX IV.2. CONTROLS ABNORMAL NEUROLOGICAL AND/OR 




ABNORMAL NORMAL TOTALS 
========================================================== DEVELOPMENTAL PROBABLY 030 007 8 





NORMAL 008 2 
059 
========================================================== 
TOTALS 4 6 10 ----------------------------------------------------------
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APPENDIX V COMPOSITION OF "NEONATALYTE - SABAX" 
Neonatalyte is an intravenous fluid preparation intended 
for use in the neonatal period. Its composition is as 















In addition it contains dextrose, 100gm per litre ClOX>. 
Manufactured by SABAX Johannesburg. 
APPENDICES 
APPENDIX VI RANGES OF DATA IN THERAPY TRIAL 





NUMBER OF VISITS 








(see TABLE 8.3.3.> 






BIRTH WEIGHT - Gms. 1970-4430 
GESTATIONAL AGE - Wks. 38-43 
2400-4600 
38-42 
================================================== (see TABLE 8.3.14.) 
TABLE AX.VI.3. RANGES FOR PLACENTAL CHORIONIC 
ARTERIAL BLOOD GAS DETERMINATIONS. 
================================================= 
CASES CONTROLS --------------------------------------------------------------------------------------------------pH 
BASE EXCESS 
pC02 
6.69 - 7.225 
11.10 - 25.9 
4.06 - 19.67 
6.827 - 7.24 
11. 3 - 29. 3 
3.82 - 13.11 
================================================= (see TABLE 8.3.15.) 
TABLE AX. VI. 4. RANGES FOR PRECHTL TEST SCORES. 
================================================== 





43 - 120 
23.7 - 99.0 
22.0 - 99.0 
40 - 120 
26.3 - 84.0 
22.2 90.0 
================================================== (see TABLE 8.3.17.) 
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35 - 184 
124 - 145 
3.3 - 9.4 
1.3 - 14.7 
38 - 130 
43 - 168 
131 - 148 
3.1 - 7.9 
1.2 - 20.8 
55 - 161 
================================================== 
(see TABLE 8.3.19.> 










4 - 11 
10 - 19 
25 - 35 
35 - 48 
47 - 65 
5 - 13 
9 - 18 
24 - 32 
36 - 45 
47 - 63 
================================================== 
(see TABLE 8.3.25. > 










7.0 - 100.0 
53.8 100.0 
20.0 - 93.3 
23.0 - 100.0 
0.0 - 100.0 
40.0 - 100.0 
61.5 100.0 
43.3 - 93.3 
0.0 - 100.0 
0.0 - 100.0 
================================================== 
<see TABLE 8.3.26.> 
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TABLE AX. VI. 8. RANGES FOR WEIGHT AT FOLLOW UP 









2750 - 6500 
3600 - 8600 
5500 - 11000 
5500 - 14400 
6000 - 14500 
3400 - 7000 
4000 - 8120 
5200 - 10900 
6000 - 12000 
6200 - 14000 
================================================== 
<see TABLE 8.3.27.> 
TABLE AX. VI. 9. RANGES FOR HEAD CIRCUMFERENCE 




6 WEEKS 32.0 - 45.0 36.0 - 42.0 
3 MONTHS 37.0 - 45.0 39.0 - 45.0 
6 MONTHS 40.0 - 48.5 39.0 - 48.0 
9 MONTHS 43.0 - 51. 0 42.0 - 50.0 
12 MONTHS 43.5 - 51. 5 42.0 - 50.0 
================================================== 
<see TABLE 8.3.28.) 
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APPENDIX VII TEST ITEMS COMPLETED AT FOLLOW-UP VISITS 
The number of items tested at each visit are as 
follows 
6 weeks 7 
3 months 13 
6 months 15 
9 months 13 
12 months 12 
The nature of the items may be seen in Fig.1 and in the 
proformas included in Appendix IX. 
The degree to which each patient. was assesed on 
the full set of items at each age is set out in Tables 
AX.VII 1-7. 
TABLE AX.VII.1 SIX WEEKS FOLLOW-UP : 
TEST ITEMS COMPLETED 
================================================ 













TOTALS 2 2 17 62 
TABLE AX.VII.2 THREE MONTHS FOLLOW-UP 
TEST ITEMS COMPLETED 
83 
=============================================== 













TOTALS 1 8 7 67 83 
APPENDICES 
TABLE AX.VII.3 SIX MONTHS FOLLOW-UP 
TEST ITEMS COMPLETED 
=============================================== 















TOTALS 1 1 3 18 57 
TABLE AX.VII.4 NINE MONTHS FOLLOW-UP 
TEST ITEMS COMPLETED 
80 
----------------------------------------------------------------------------------------------









TOTALS 1 1 2 69 
TABLE AX.VII.5 TWELVE MONTHS FOLLOW-UP 
TEST ITEMS COMPLETED 
----------------------------------------













TOTALS 6 12 70 88 
73 
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APPENDIX VIII PROFORMAS FOR NURSERY. 
These proformas are copies of the forms used in the 
gathering of data in the labour ward and nursery. 
gcILIA MAKIWANE HOSPITAL · 
~ARTMENT OF PAEDIATRICS 
.ASPHYXIA RESEARCH PROFORMA. 
• ~USCITATION OF INFANT 
1. Case Number 
~~~~~~~~~-
Mother 's Name 
2. M~ther's Folder No. 
nate Of Delivery --------
Time of Delivery --------
3~ METHOD OF RESUSCITATION (Tick) 
Nene 
Face Mask 02 alone 
Fae e Mask IPPV 














---8 6. Apgar Scores: 1 min. 5 mins. 10 mins. 15 mins. 
INTRA VENOUS MEDIC.A TION 
7. Sodium Bicar~onate 8% 
8. Dextrose 50% 










o. Time to sustained spontaneous respiration -...__-;i-i. I I 
i • ASTRUP POST DELIVERY 
minjp=J 
1. Time taken poat delivery~~~~~~ min. 11r=o 
2/ ••.•.••••• 
- 2 -
A. 12.• SITE FROM WHICH TAKEN (Tick) I OFFICE USE 
·o Zg>b. Placental Artery 




,---.__ ., ' 
...___~--....._...--~ 
Result 130 PH---- 14 .. PC2 ___ -+ 1 I D 
15ft pc0z ___ 16e BE_~~[ 
1 
]~] 
·17.. SB I 
-- 1i[ 11_J 
1~ Ll I_ I 
1111 I ] J 
Details Recorded By 
1 sl 1-t-·*' I 
Date 
Please now take the next envelop in the Seriesi 9lc=J. 
Is tbiSbaby to be a case nr a control? ! 
I! 
1: 
· If a case please pl1.e::;i6.blbe the Anti Cerebral i 
oedema measures as soon as possible and on any \ [IJ·· . 
20 i 
case before 6hrs. of age. \ · 
I 
.... .. •· ........... 
' ' CECTLIA MAKIWANE IDSP!TAL Office use 
DEPARIMENr OF PAEDIATRICS 
ASPHYXIA.RESEARCH PPDFORMA 
~gq.. 
y ' ! B. I.AEOUR AND PRE'.CNANCY 1....._____.,..._ ' 
I ,, 
I Case nunber 
' M::>ther's name 
1: 
25. Mother's address 2s4 1 I I f I I • I , ' 
i 26. Mother's folder nunber 26l I I. f I ( ( ·~ 'I 
Cl 27. Baby's folder number 271 , l 1 f I I I LABOUR 
28. , Duration of 1st stage of labour rours. 28.0J 
29. Duration of 2rrl stage of labour mins. 29.j I j i i 
30. In which stage of labour did the mother arrive 30.0 at Cecilia Makiwane Ibspital? (Circle) 
, 
. Before lal:x:mr ( 
1st stage 
2nd stage 
Did the mother receive any of the following 
sa:lative ma:lications in the 72 hours prior t6 
delivery (circle and st~te date and time of last 
dose for each) 
31. Valiun last dose at 
31rn 
32. Pethicline. last dose at 32.[]J 
33. Magnesiun Sulphate last dose at 133.rn 
34. Other (specify 
: 34.0 last dose at . , . 
35. Were any complications of lalx:>Ur detected? 1 YES/NO 
35m If YES, please circle: I 




Cord ai:ound infant's neck 
Other (specify) 
I 
36. Presentation (circle) 











Other (si:ecify) ___ ~~~--~-~ 
Off ice Use 
.....-........ ____ . 
38. Indications for assisted delive:ry -------138.ITJ 
Lo 39. Was any evidence of fetal distress detected? 
YFS/Noj 
40. M=conium stained liqw1 YFS I NO j 
41~ Was any fetal heart abnormality found on 
auscultation? J YES I ID J 
42. Was canliotachograph recording carried out 
during lal:our? r YES I 4 
43. If yes, did it show evidence of fetal 
distress? 
44. Was fetal scalp sampling cfuri.Ed out? 
1YF1> /NOi 
45. If yes, give result of test rearest to 
delive:ry. · 
PH __ ro2 __ FC02__ BE SB ---
46. What is obstetrician 1s assessment of cause of 
47. Weight of placenta. -------
' 








,- ~-- ·------ -~ 
49. Mother's age years 
' ; m'--_J 
149 :t 
50. Gravida• .50.[[] 
51. Parity 51.[[J 
52. On lrM many occasions did the mother attend A. N. c. )2.ITJ 
in this pregnancy? 
53. At what stage did she first attend A.N.C.? ~3.ITJ 
weeks. 
54. lbw long before delivery was the last A.N.c. 54.ITJ 
visit? weeks. 
... 
55. Were any of the following a::xnplications of ss.IT:] 
JYFS1roj pregnancy detected? 
If yes, please circle. 
Pregnancy irtluced hypertension 
F.clampsia 





56. Were any special investigations carried out in 1~6rn 
pregnancy? 'YES/NOJ If yes, please tick. I 
i 
Ultra sound. Once only I 
Serial ultra sound : 
Fetal rrovement m:mitoring ,I Ir 
I 
NorH!tress c. T. test 
Stress C.T. test 
Other (specify) 
' 
Details of a}:x)ve tests done r 





Other (specify) -------------+ 
58. Reason for referral 
-----------~ 
Off ice use 
.570 
sa.·DJ 















Babies Folder Number 
Birth Weight ----kg,, 
·sex --------·-
·--- Cm,. at Birth 
weeks 
Head C ircu.mf er enc e 
Gestational Age (Scored) -----
Classif'ication (tick) AG.A 
SGA 
LG.A 
Respiratory Distress Since Birth YES/NO 
If yes Diagnosis -----
Scalp Bleeding Tick YES/NO --·If ''Yee;~; Circle 
C epbalhemat oma 
Sub~aponeunotic hai.6morrhage 
Oth:Br ( Spec if y) 
Now Carry out Neurological Assessment __ _ 
(Proforma D) • 
Date oo.d T~.m.e c:f I::;awi.ng 











76 Details Recordecl By 
~--~~~~~~--
Date of Recording ----------
60 I l 
610 
62 [ J 




69 f I 
70 c l 
71 I I 
72 












CECILIA MAKIWANE HOSPITAL 
DEPAR'!MENT OF PAEDIATRICS 
AsPHYXIA RESEARCH P:OOFORMA 
D. NEUROLOOICAL ASSESSMENT 
Baby's Folder Number 
~--~~~~-------~-~ 
91. Baby's age 6.n hours) (Give in days if 
7 days or more) 
•c. 92. Weight today Axillary Temp. -------
93. Time since last feerl hrs. 
Stool consistency -----
94. If j aundi ca:1 - TSB .,, mm 
95. PCV % 
95. -----
96. Methcrl of feEding today (circle) 
Nil per mouth 
Nasogastric 
Fully by breast or lx>ttle 




98. Have there been seizures sine~ tlle last neurological 
assessment? j YFS/NO ( 
99. lbw long after birth did they begin hrs. ----
100. lbw long is it since the last seizure ----
Please give results of invE)5tigations carried out at 
the time of onset of seizures. 
Office use 
91·-rn 



















EXAMINATION (Circle where appropriate) 
Heart rate 





~: Now carry out examination and fill in 
Prechtl profo:r:ma before filling in below. 
==~ynmetrical ~ 
Opisthotonus; No, Slight, Marked. 
Frog Position: t YFS/NO I 
105. Limb Posture - anns and legs - predaninantly 
f lexion, semi flexion, extension 
Motility 










absent, slight, marked 
Incidence: -. +, ++. 
Frequency: absent, lCM, high 
Amplitude: absent, low, high 
Motor Systan 
Hypertonia: -, +. ++ 
Hypotonia : -, +, ++. 
Thresh:>ld Responses 
Average thresh:::>ld: low, mediun, high 
Tendon Reflexes 
Intensity: -, +, ++, +++, ++++ 
Thresoold: lCM mediun, high 
Mom Resp:?nse 
112. Average Intensity : lCM, medium high 
Thresoold: low, medium high 
State 
113. Initial 
114. ~ --- (highest state reached) 















115. Type : nomial, grunt, high pitched 
Intensity low, medium, high 
116. Hemi .syndrome (asymmetry) 
p:>sture Ann: - +, ++ 
leg: - +, ++ 
notility Ann: - , +, ++ 
leg: - , +, ++ 
motor system: Ann: - , +, ++ 
leg: - +,. ++ 
asynmetry in resp:>nses: ann•-. , +, ++ 
leg:-, +, ++ 
117. Syndromes of abno.nnal reactivity 
absent f YES7No J 
hyperexcitable - +, ++ 
apathetic 




For Of £ice Canpletion 
120. Brown State 
Hyp:>tonia, H;yp:>-ext, Extension/Flexion 
121. Sarnat Stage 









? q f' 
\--- -~ 
E. 
cmn.'tA ~- Jaf.n'I'AL 
DEPARI'MENT OF PAEDIATRICS 
ASPHYXIA RESEA.OCH PROFORMA 
DISCHARGE DEI'AILS 
Case number -
Baby's Fblder no. _____ ........,.. ______ __,. 
24D-Age_ days 240~ ·l I I 
241. Weight: kg. 
242.. --1-ead _circunfereme an. 
243. P.C,V. % 
Mdress to which baby is procealing ------i 
Other aJ.dress (es) which may be useftil in keeping 
_contact with the baby 
~~-~-~~---~ 
241 ·I i I ! ! -. 
242.[J] 
243.[J] 
_244. Outa::me of mother after delivery (circle): Alive --2.44. 0 
Dead 
245. Is the baby being discharged with its rrother 245. 0 
j YES/NO.I If "NO", Why not? -------~ 
Name and address of person taking 
the baby out of hospital -----
\. 
Date of discharge 
------------~~~----i 
Note: Carry out a neurological assessment - -
(Pmfonna D) mless one has been perfonned 
within the previous 4 days. 
( 
_246. -Details recorded by ------~------t 246.o. 
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APPENDIX IX PROFORMAS FOR FOLLOW UP. 
These proformas are copies of the forms used at the 
various stages of follow up. 
CECILIA MAKIWANE HOSPITAL 
DEPARTMENT OF PAEDIATRICS 
ASPHYXIA RESEARCH PROFORMA 
F. FOLLOW UP HEADER SHEET : FILL IN AT FIRST VISIT AND AGAIN IF 
THE CARETAKER OR THE ADRESS CHANGES. 
1. CASE NUMBER·-----·--·-·-·· 2. BABY'S FOLDER NO 
3. MOTHER'S NAME 
4. DATE OF BIRTH ____ / ___ ......... 1 ..... ---·-· 5. DATE DF DISCHARGE I I 
6. KNOWN HOME ADRESS 
7. OTHER ADRESS A. 
8. OTHER ADRESS B. 
9. CARETAKER :WHO COTHER THAN A NANNY l ~S RESDNSIBLE FOR THE DAY 
TO DAY CARE OF THE BABY ? 
* MOTHER * FATHER'S MOTHER *MOTHER'S MOTHER 
* OTHER RELATIVE ii· DTHE:R PERSON <SPECIFY)-·-------·--
10. DOES THE ABOVE PERSON HAVE A REGULAR JOB AT PRESENT ? 
YES /ND 
11. IF YES : WHO CARES FOR THE CHIL.D DUFHNG THE DAYTIME ? 
* RELATIVE * PAID NANNY * OTHER <SPECIFY> 
12 DOES THE CARETAKER RECIEVE REGULAR FINANCIAL SUPPORT ? YES/NO 
1~5. IF Y~.$.. : WHO FROM ? 
14. IF THE MOTHER IS NOT THE CARE TAKER ; WHY NOT ? 
15. DOES THE MOTHER <WHEf-iEVER SHE IS ) Hf.WE A REGULAR JOB YES/NO 
16. WHAT IS/WAS THE MOTHER'S FATHER'S OCCUPATION ? 
17. WHAT IS THE CHILD'S FATHER'S OCCUPATION ? 
18. IS THE CHILD'S FATHER : * LIVING IN THE CHILD'S HOME ? 
* LIVING ELSEWHERE BUT IN REGULAR CONTACT ? 
* A MIGRANT WORKER ? * NOT IN ANY CONTACT ? 
19. DOES THE CHILD'S FATHER SUPPORT ? YES./ NO 
20. WHAT TYPE OF HOUSE IS THE BABY LIVING IN ? 
* TOWNSHIP HOUSE * SHACK * TRADITIONAL HUT 
* 0 THER ( SPEC I FY ) ...................... ·-··-·-····-·-·-.. ·-·-······---· .. ---·---·--··-····· .. -·---·-----·------·--·-----
21. HOW MANY ROOMS DOES IT HAVE <EXCLUDING KITCHEN AND BATHROOM) 
22. HOW MANY PEOPLE <ADULTS PLUS CHILDREN> SLEEP IN THE HOUSE 
EACH NIGHT ? 
23. DOES IT HAVE RUNNING t>Jr:YrER I.!::L~L!J)_~_ THE HOUSE ? YES I NO 
VISIT CONDUCTED BY DATE .............. _I ·--·-·-I 
14/11/83 
CECILIA MAKIWANE HOSPITAL 
DEPARTMENT OF PAEDIATRICS 
ASPHYXIA RESEARCH PROFORMA 
G. INTERVIEW SHEET FILL IN AT EACH VISIT. 
WHICH VISIT ? <CIRCLE) 3M 6M 9M 12M 
1. CASE NUMBER 2. BABY'S FOLDER NO 
3. MOTHER 'S NAME : -··-----···-···-· ...................... -·--···-·--·····-··-··-·-· .. ···-······---· .. -·······-····-·-·······-·-·-·-·------------
4. AD RESS FOR VISIT : ________ ..................................... -.. -...................... -........................................ -... ··--·-···--·-··· .. ··-·-··--···-·-··-···--------·-·---·-.. 
.. --·---------····-----.. ·--··········---· .. -·-· .. .;.. ............................................................................................................................... -. .. ~------.. --···-· .. --·---.. ----···---····-·--
5. DATE OF I NT ERV I EW _, ___ / __ ,, ...... ../ ............. . 6. BABY'S AGE IN WEEKS 
7. STATUS OF BABY ALIVE I DEAD I LOST TO FOLLOW UP. 
IF DEAD : DATE OF DEATH I I PLEASE GIVE DETAILS. 
8. HAS THE BABY BEEN ADMITTED TO HOSPITAL SINCE THE LAST VISIT ? 
YES I NO IF YJ:::s, DATE OF ADM I SS I 01\I ..... _ ... __ / ·-·-·---1 __ 
HOSP I Tr:.:11_ ........... ·---·---.. ·-·---...... -.... --·----· WARD 
REASON FOR ADMISSION 
9. ANY FITS SINCE DISCHARGE DR LAST VISIT ? YES I NO 
IF Y~~- GIVE AGE AT FIRST FIT .......................................... MONTHS 
ALSO APROX. NUMBER IN SAME PREIOD 
10. HAVE THERE BEEN ANY OTHER MAJOR PROBLEMS SINCE THE LAST VISIT 
OR DISCHARGE FROM WARD 17. 
YES I NO 
IF J::.f.:..§. PLEASE GI VE DETAILS 
11. HAS THE CARETAKER OR HER ADRESS CHANGED SINCE THE LAST VISIT ? 
YES /NO IF yg_$.. PLEtiE1E FI LL IN ti NEW 
FORM II F : FOLLOW UP HE.Ci DER SHEET. II 
12. WILL THE CARETAKER BE CHANGING HER ADRESS BEFORE THE NEXT VISIT? 
YES /NO IF YE;,~ ENTEf-=< THE NEl.J {-1DF\ESS ON FORM F. 
13. NOW PLEASE FILL IN THE FOLLOW UP SHEET FOR THE CORRECT AGE. 
VISIT CONDUCTED BY 
14/11/83 
D?1TE I I 
-,;. 
]Oo 
CECILIA MAKIWANE HOSPITAL 
DEPARTMENT OF PAEDIATRICS 
ASPHYXIA RESEARCH PROFORMA 
H: 6 WEEK FOLLOW UP . CPiSE NO. 
8_!_ pi SK THE r;.B.R. E T.81~~11 J H.F.~. l:J.J..h-J,,,_QJ~JJ..~L~. Q.!J.t;.JiTJ._QI~!.§. 
1. IS THE BABY FEEDING WELL ? YES /NO IFl::!_QGIVE DET?,ILS 
2. IS THE BABY CONTENT OR RESTLESS ? 
IF RESTLESS - GIVE DETAILS 
3. HOW IS THE BABY FEEDING ? BREAST ONLY /BOTTLE ONLY /MIXED 
4. DOES HE GET ANY SOLID FOOD YET ? YES /NO 
IFYE§_DOES HE HAVE DIFFICULTY TAI< ING IT ? YES /NO 
5. DOES THE BABY QUIETEN AND PAY ATTENTION WHEN YOU SPEAK TO 
HIM/HER ? YES /NO/ NOT SURE 
6. DOES HE/SHE WATCH YOU WITH HIS/HER EYES WHEN YOU FEED 
OR TALK TO HIM/HER ? 
YES/ NO/ NOT SURE 
7. HAS HE /SHE BEGUN TO SMILE BACK AT YOU WHEN YOU TALK TO HIM ? 
YES/NO/ DON'T KNOW 
?· EXflMINAT_I_ON OF ~rHE ~-(:)_~~Y. : UNDF~ESS THE BABY INCLUDING 
NAPKIN AND LIE HIM/HER ON THE BACK. 
8. DOES HE SHE MOVE ALL 4 LIMBS EQUALLY ? YES/NO/NOT SURE 
9. PULL THE BABY TO SIT i;JH I CH CW THESE IS MOST APPLICABLE ? 
~ 
- ( __ ) 
10. PLACE THE BABY ON THE ABDOMEN :OBSERVE THE HIPS IN THE AWAKE 







11.HOLD THE BABY UNDER THE ABDOMEN AND OBSERVE THE HEAD AND 
LIMBS. WHICH OF THESE IS .MOST APPLICABLE ? 
(-) 
12. WEIGHT __ _/ ___ KG. 13. HEr-~D CI RC. , ____ CM 
14. LENGTH ...... CM 
15. IF THERE ARE ANY OTHER PROBLEMS WITH THE BABY PLEASE RECORD 
THEM HERE : --·-·---···--·----·----· .. ·--·--··-···-·--··-· .... -····-·--.... --.. ---·--··----------·-·-·------
16. CONCLUSION : * NORMAL BABY * ABNORMAL BABY FOR REFERRAL 
DATE OF APPT: .. ! .. ! .. 
VISIT CARRIED OUT BY DATE I I 
***************************************************************** 
OFFICE USE ONLY : 
RESULT 
30/11/83 
NORMAL -·-·-· .. -·-···-······-··-· .. -· ... -·--- ( 1) 
ABNORMALITY 1 
ABNORMAL I TY 2 --.. ---------·- < ........ _ .. __ 
ABNORMALITY 3 C 
1:f FOLL.UPbl-'j 
I 
CECILIA MAKIWANE HOSPITAL 
DEPARTMENT OF PAEDIATRICS 
ASPHYXIA RESEARCH PROFORMA 
I: 3 MONTH FOLLOW UP . CASE NO. 
1. IS THE BABY FEEDING WELL ? YES /l\HJ IF NQ GIVE DETAILS 
2. IS THE BABY CONTENT OR RESTLESS ? 
IF RESTLESS - GIVE DETAILS 
3. HOW IS THE BABY FEEDING ? (CIRCLE> 
BREAST ONLY /BOTTLE ONLY /MIXED 
4. DOES HE GET ANY SOLID FOOD YET ? YES /NO 
IF YES. DOES HE HAVE DIFFICULTY TA~<ING IT ? YES /NO 
5. DOES THE BABY QUIETEN AND PAY ATTENTION WHEN YOU SPEAK TO 
HIM/HER ? YES /NO/ NOT SURE 
CARETAKER I l\ITERV I EWER 
6. DOES THE BABY SMILE AT YOU NOl,<J ? -·----·- YES/NO YES/NO 
7. DOES HE SOMETIMES PUT ·HIS H(-~NDS 
TOGETHER? ------ YES/NO YES/NO 
8. DOES HE/SHE SOMETIMES REACH OUT TO 
TAKE AN OBJECT '? ------ YES/NO YES/NO 
9. DOES HE/SHE LAUGH ? ----- YES/NO YES/NO 
1 o. DOES HE/SHE SOMETIMES l:'.(OLL.. O\JER?----- YES/NO YES/NO 
EXAMINATIQN. OF JHE;_ ~AB'( -·· UNDF~ESS THE BABY INCLUDING THE NAPPY 
AND LIE HIM/HER ON A BED OR OTHER SURFACE. 
INTERVIEWER'S OBSERVATION 
11. DOES HE GRASP A RATTLE r? YES/NO 
12. DOES HE LOOK AT A SMP1L_L OBJECT r? YES/NO 
1.::. THROUGH vJHAT ANGLE WIL.L HE FCJLLOW ?~ WOOL BALL ? 0--90 DEG 
90-180 DEG 
IWlll! ... ,•-.. -·•:----• 
303 
14. NOW PULL THE BABY TO SIT ~WHICH OF THE FOLLOWING DIAGRAMS IS 
MOST APPLICABLE ? 
15. NOW SIT THE BABY UP HOLDING HIM/HER UNDER THE ARMS 
DOES HE/SHE HOLD THE STEADY ? YES/NO 
16. NOW TURN THE BABY OVER TO LIE ON HIS/HER STOMACH 
OBSERVE THE POSITION OF THE HEAD: · 
DOES HE/SHE HOLD IT UP TO AN ANGLE OF: <A> 0-45 DEGREES 
<B> 45-90 DEGREES 
17. DOES HE/SHE SUPPORT HIS/HER CHEST OFF THE BED WITH THE 
FOREARMS ? 
YES/NO 
18. ARE THERE ANY OTHER MAJOR HEALTH PROBLEMS ? YES/NO 
IF YES PLEASE GIVE MORE DETAILS : 
1. 9 . WE I G HT -----··. ·--·-··-_..!< G 20. LENGTH ................... -.......... CM 
21 • HEAD CIRCUMFERENCE -·-.. --.......................... CM. 
22. IF THERE ARE ANY OTHER PROBLEMS WITH THE BABY PLEASE RECORD 
THEM HERE : 
·--------·-----·-·-·----.................. _ ............... -··-··--··· .. ··-.. -·--·-·--·-··----·-·-·-····----·--·--.. ----·------·-·------
23. CONCLUSION BY INTERVIEWER <CIRCLE * 
* NORMAL BABY 
* ABNORMAL BABY - FOR REFERRAL. 
V I S I T CARR I ED OUT BY : ---·--·---·---·-·----.. -··· .. ·-·-····--·-·-·----·------·-·-,DATE ··-··" .. --/ _, ___ / __ _ 
***************************************************************** 
OFFICE USE ONLY : 
RESULT NORMAL ••.....•..... Cl) 
ABNORMALITY 1 ...... -.. ~ ( .... ) 
ABNORMAL I TY' 2 a a n n 11 If a ( n a u 11 ) 
ABNORM?iL I TY :::;: ....... < .... ) 
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CECILIA MAKIWANE HOSPITAL 
DEPARTMENT OF PAEDIATRICS 
ASPHYXIA RESEARCH PROFORMA 
J~ 6 MONTH FOLLOW UP . Cf'..iSE NO. 
f:.GH..J.JE'..!JJ;JAI. N.f:~~LDJ~J!.. :: T CJ V CJ F~ P 1J M ·····PU M :: i;<JO DD EN CUBE ~ :::; C PiL E ~ 
MEASURING FRAME : TAPE MEASURE 
t} .!!.. fi.f!L. It:!£ CD.EJ:'.J::.O.!::J~E. I!::!J:i~ E:J:JJ,J,JIHJJ"JQ. U.l)LTLLl: .. QJ:X;;; .L 
1. CAN THE BABY GET HIMSELF UP TO SITTING FROM LYING DOWN ? 
YES/NO/? 
2. CAN CStHE PULL HIMSELF UP TD STANDING ? YES/NO/? 
3. CAN CS>HE STAND UP HOLDING ON TD THE FURNITURE ? YES/NO/? 
4. CAN <S>HE FEED HIMSELF A BISCUIT DR OTHER PIECE OF FOOD ? 
YES/J\ID/? 
5. IS CS>HE SHY WITH STRANGERS ~ YES/NO/? 
6. DOES CS>HE MAKE A QUITE A FEW DIFFERENT SOUNDS ? YES/NO/? 
B : ~J..!iI.2.!i~S~?.. I.!::IL. f!.O .. ~.Y. (_:_::.QtJL:.L:LJ::.L.L.Y. (\UP. CJ:::/).\:~.!~::. !:::LJ.tJ .I.N. ·r·1:::1.1::.;. ~3..J..I.:LIJ::l.Q. 
f::.Q.~~-I.I.1.Qli JE. i:.::.Q .. sLl,jJ..f.lJ:J;=;. Q[J f:J..IJ:.ff:;_i:::yJJ .. '.:.ff::. l::::.Y . .IJ':!n. P.H. t::lI§. 
~l-::.f:!l.::!J.5..1;;.I Q.!::l 0. ~:'.!EX~ QB O.N I.t::IJ;.:. L:.LP.P.!3 .. :! ... 
!}.0.GL. DJ.~. fJ 
NQ.t~. C.t.~J:;;.r-::;,y QJJ..I. I!::!.~::. i:.=:pJ::,.L,_Q~:l . .I.NP. IIEJ::l.f.~. P.!:=::. 1;;:.>.:;.f::1tJ..I.N6.I.I.P.U L 
7. GIVE HIM A TOY. WHEN HE IS PLAYING WITH IT TRY GEJ\ITLY TO 
REMOVE IT FROM HIM. 
DOES CS>HE RESIST YOU ? YES/J\10/NOT SURE 
8. PUT THE TOY JUST OUT OF HIS REACH -- DOES CS>HE TRY TO GET TO 
THE TOY? YES/NO /NOT SURE 
9. II\! THE SITTING POSITION : DROP THE TOY OUT OF HIS SIGHT 
DOES <S>HE TRY TD LUOK WHERE IT WENT ? YES/NO/NOT SURE 
10. PLACE A WOODEN CUBE IN ONE HAND -- DOES <S>HE PASS IT TO THE 
OTHER Hf-)ND ? YES/ l\iO/ 1-...!0T :;:;LJRE 
11. CAN <S>HE HOLD A WOODEN CUBE IN EACH HAND AT THE SAME TIME ? 
YES/NO/J\IOT SURE 
12. WITH THE BABY LYING ON HIS BACK PULL HIM TO SITTING. 
WHICH OF THE FOLLOWING DIAGRAMS IS MOST APP~ICABLE ? 
2. 
13. IS THE BABY ABLE TO SIT SECURELY WITHOUT SUPPORT ? YES/NO/? 
14. CAN CS>HE TAKE SOME WEIGHT ON HIS LEGS WHEN HELD IN 1HE 
STANDING POSITION ? YES/NO/NOT SURE 
15. PERFORM THE HEARING TEST USING YOUR VOICE AS THE TEST NOISE. 
DOES CS>HE TURN TD THE SOUND ON THE L~~f: YES/NO/NOT SURE 
EI.U!:::!I.:: YEE; I NO I NOT Sl..JF{E 
1 f:.i: ~~EIGHT _ ........................... • ............... KG l 7. LENGTH ...................... CM 
18. HEAD CIRCUMFERENCE CM 
19. ARE THERE ANY OTHER MAJOR HEALTH PROBLEMS PRESENT ? YES/NO 
,., .-. 
.i:..l_l 
IF Y.~.~~. GI\JE DETP1IL.b 
•••••••••••• .. •0•••<•••••'•'''''''"'"''-''"''''MOo0•"'''''''''''''"''''''00o•••<•oOooOooOoooooooooo•OHOOOHOOOOnOOOO"O"-O"oooO_ ....... MO• .. OO .. oMoo .. o• .. •OO .. O"""'MOMOOO"M•OOooo,.ooooo .. OM""''''M'°'°-''""'-''' 
·--.. ·•-OM ... OMMOO-ooo,. ... ,,_,,, .. ,, .. , .... ,_OOOOoO•OOM•Mo•ooo-•OOO--•OoOOM-OoOoooooooo ''''''''"""''''••••-••••••'"''''"''''"''"'••••••'•••••••••••••o•••••o••-••<"'''''''''•••••••••"··-··········-·••••<•HOM•OO••OOO•H•O .. OOo•OOO••••·--··-•-•OO<H-.. ••• .. •••••••"OHOOH•-"'''"''"'''"'••M-•••"MMOO-•O•-•••M••» 
·--.. -··--·-··--...................................................... -........................... . ................................................................................................................................................................................. _, __ .......................... ,_ ........................ .. 
CONCLUSION BY INTERVIEWER 
VISIT 
D(-%TE 
* i\lDRMf~L. BPiBY 





OFFICE USE CJl\ILY 
1::;:EBUL.T NDRMAL. --------------, 
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P1 E: N Cl R l''i (i L. I T ''{ 2 ........ - -·- ·-· -- -.. C ............................ . 
ABNORMALITY 3 -------( 
.. ·· 
3o 1-
CECILIA MAKIWANE HG3PITAL 
DEPARTMENT OF PAEDIATRICS 
ASPHYXIA RESEARCH PROFORMA 
l<: 9 MONTH FCJLl .... 01 ... \i UP .. 
LQUJ.L:t:lfJ'fL tJl;::J~J)J;J)~ TD\' Uh' F'Di"f·····F>C::i! 1i :: '.? i. 1JDODEN CUElES ................ , .... ri :::.»L·!-·:11....t::. :: 
MEP1~:::uR I l\IG FF~(d·'iE :: T(·:,r::·c !'iE(·,::::;ui:::.·c :: DU TOTT RP1TTL.1::::" 
1. CAN THE BABY GET HIMSELF TO SITTING FROM LYING DOWN ? 
v1:::s / N1::::i .1 
CAN HE PULL HIMSELF TO STANDING Y"ES / f\.iD / .-' 
J\ID / ':.' 
4. "'/EB /hiU / ·· 
t... IS HE SHY AT FIRST WITH STRANGERS ? 
!H!H ·· ZlG ANYONE)? YES / NO / ~ 
9. IF HE IS HOLDING AN OBJECT IN EACH HAND DOES HE SOMETIMES 
1. (i. 
BANG THEM TOGETHER ~ 
s IT T!Jr~:. I}()}}'( PJJ (\ 
Cf\UE(( UJ.L:r:. JJ:IL~ C.PL:i. Q\il 
GIVE 
PUL..l .... 
HI l""'i p, TCJY,, V.iHEl\i 
IT rit-·Jr,·y- FhUl'i ii Ii'"!" 
HE IS PLAYING WITH IT,GENTLY TFY TD 
l\i!J / :-.· 
:10 .. TRY Pl....P1\,..ING F'E:Ei<·····P,·-C;UU VJITH THE: F:t):H\i,, (F'L..(iCE \'DUR~::;Ei .... F UUT DF 
THE BABY'S VISION AND THEN SUDDENL REAPPEAR WITH A CRY.> 
DOES HE PL.AV THE GAME WITH YUU ? YES / NO /? 
JO~ 
11. PLACE A SMALL ROUND OBJECT EG. A SMALL PELLET OF PAPER ABOUT 
THE SIZE OF A PEA, ON THE FLOOR I BED IN FRONT OF THE 
BABY AND BRING HIS ATTENTION TO IT. WATCH HOW HE PICKS IT 
UP. REPEAT THIS SEVERAL TIMES AND OBSERVE HIS PERFORMANCE 
WITH EITHER HAND. 
WAS THE OBJECT PICKED LIP 
A BETWEEN THUMB AND SIDE OF HAND 
B BETl/-JF.~E~l\I THUMB r'.)1\ID §..!..PJ:~. OF. FDF;:E FINGER 
c BET i/.JE EN T.I.E.'.. PE I.t:!JJtrn. O.NP I..u::. ~~~L . f:.ClEEE:.IN.GEE~ 
12. PERFORM THE HEARING TEST USING THE DU TOIT RATTLE AS THE TEST 
SOUND. DOES HE TURN TO THE SOUND ON THE : 
L::.f:EI: YES I NO / '::·· 
RIGHT: YES / ··-··-·---r·-·-· NO / '? 
WILL HE LOOK UP OR DOWN AT THE SOUND WHEN OFFERED ABOVE OR 
BELOW HIS EAR LEVEL ? 
YEE.: / ND I ? 
:i. ::~:. ~\IE I GHT : -········-······--····---· ···-·--·-·-·-·i<G. l Lj. n LENGTH ·-··········-··-·················-··Cl.,1 n 
1 1:::· , dn HEf.)D CI Fd::UMFEF:El\iCE : ·-·-····-·-.. --.-....... CM. 
16. ARE THERE ANY OTHER MAJOR HEALTH PROBLEMS PRESENT? YES / NO 
IF YES PLEASE GIVE DETAILS: 
.. , ... ·-·-·-·- .. --·-·-·-·-··· .. ··-···-····-·····-·-·--·-·······-··-····-·----···----·--·-·····-··········----·-·-··--··--··-----· 
···-·-····-· .. ··-··-···-····-·--········-··--.. -·······-·--·--·····--··-----······----.. ··-·-.. -----·--·-·-·-----···-····-····-·· .. ·-·-··-··--·----···-··-·-··-·--····-·········---··-····--------···--·-·----·-·--·· 
-···-··-····-··········-········-··········· .. ·······-··--·-·-·-·---·· .. -·--·-·-·-···--·--·-·--·-·········-·--··-·-·····---·-·--·-·-··--·-···-·-----·-····-·---··-·--·-·------·-······-···-·-·--·-···--·---·---·-··· 
•••-·•-O-OMOMo-OOO"•••••••··-· .. ····-••••• .. -••••-·-·-·•-•<H< .. _M•M•O-·-·----· .... ·----···-·-·-·-·-·-•"OOOO-.. OM--o-•o• .. ,ooooo•-·----···----·-·-•••M••MO•OO ... o00M•M0M-•0 .. 0M•oMoooo·-·--....... _, _____ ,_,_•••-•-.. O-OO .. -•--
17. CONCLUSION BY INTERVIEWER 
·*- NORMr'..)L Bf'.'-iBY. 
* ABNORMAL BABY - FOR REFERRAL. 
V I S I T C r'..":iR!=~ I ED OUT BY -···-·-····-··-.. ··--·-···-·····-······--······-·--·--·---·-· .. -··-····--··-·-·······-·····-······-··-·-····-·-··· .. -· 
D?)TE ~ / / 
***************************************************************** 
OFFICE USE ONLY : 
F~ESUL T ~ NOG:MAL 
~)BNORMf-H ... I TY 1 
?'-iBNORMf-iL I TY 2 
ABNORMf.1L I TY 3 
( 
CECILIA MAKIWANE HOSPITAL 
DEPARTMENT OF PAEDIATRICS 
ASPHYXIA RESEARCH PROFORMA 
L: 12 MONTH FOLLOW UP. 
N{.:iME: ··-·--···········--······--··-··-·-······-·········-··············-·· .............. -·· ····-··-·············· FCJL.DER NO. 
CQl).:1:r·ttLL:i.I Uf:J:::P_EP: BtiLL :: ~=:;r'IP-11....L. OB.J ECT ~ DI (:,f3N0'.:3T Jc~ f:)ET : :3PP1 TULP1 
HAEMOGLOBINOMETER :PATELLA HAMMER :SCALE : TAPE MEASURE :DU TOIT 
F;:t'..~1 TTLE ~ 
1. CAN THE CHJL..D SHOW YOU WHAT HE WANTS, OTHER THAN BY CRYING ? 
YE:3/i\IQ/·:.' 
DE T p, I LS ~ ··-··-···-·-·····-·-····-·-·············-···-·······-·--· .. ··-···-·-·······-········-······· .. ······-·--·-····-··--················-·······-··········-·-··-----·······-··---···-·-····-·-·-··-·······-···-·--
CAN HE DRINK FROM A CUP ? YE'.3/NC.l/? 
3. DOES HE BANG AN OBJECT IN EACH HAND TOGETHER ? YES/NO/? 
4. DDE'.3 HE USE THE fAJCli~?DS ''MPiMMf.~'' (.11\ID ''Tt:iTf.-~'' hlITH THE CORRECT 
MEANING ? YES/NO/? 
DE T (.'.i I LS : --· -···-······-··················-·-·······-········--····-······-·······-········· ·-···················-·-······ ·--·········--··--··················-···-·······-·-·-·--············ ... ---·····--···-········-··-···-·-· 
6. CAN HE STAND ALONE FOR A SHORT TIME ? YES/NO/? 
7 .. CAN. HE STAND ALONE WELL ? YE'.3/ND/? 
8. CPiN HE ~lD.b:.L. HOLDING ONTO THE FURf\iITUPE ? YES/NO/? 
9. .CAN HE BEND OVER AND STAND UP STRAIGHT AGAIN? YES/NO/? 
10. CAN HE WALK WELL ? YES/NCJ/? 
DETf.HLS · 
fl ·-··--·--········--·-·-·--·-·-·--·····-····-··--··--···-.. ··-·······--·-··· .. ··-··-·················-· .. ·-·----············-·· .. -········-·······-·-·······-··-··--··---·-··-·---······-··-·-·-·-·--·-· 
B: HAVE THE BABY DRESSED SITTING COMFORTABLY ON A LEVEL SURFACE 
11. PLACE A SMALL OBJECT <THE SIZE OF A RAISIN> ON THE SURFACE 
IN FRONT OF THE CHILD. BRING HIS ATTENTION TO IT AND OBSERVE 
HOW HE GRASPS THE OBJECT WITH EACH HA~D SEVERAL TIMES. 
WAS THE OBJECT PICKED UP : <CIRCLE) 
A~ BETWEEN THE THUMB AND SIDE OF THE HAND ? 
B: BEH1JEEN THE THUMB f-1ND $.JJ)_~_. OF FDFi'.EF INGER ? 
C ~ HE Tl•JE EN THE IJE. (:V:::. I.H.UUJ}. ~;NP LU::. QE. F Qfff;;EI.t!§.f:~f:(? 
D: OTHER C SPEC I FY) : ········-············--··-·········-·····-····--·---··---··----··-······--·--··------·----·-··-····-····-··-···-·--·-·-
12. OBSERVE THE CHILD PLAYING WITH A BALL.DOES HE PLAY 
COOPERATIVELY WITH YOU ? YES/NO/? 
DE T Pi I L. S : -····-·--····---·--·-·-·-·····----··--·······-·-·-···--······-·-··-·-·-···-··--·····-······----···-·-·-·--··---··-··-·--·-·---·-·--·-··-·-··--·---
3to 
C: GENERAL PHYSICAL EXAMINATION : 
tlBDU 
Ei\IT 
····-·······-···--·--·········--················-·········-.. ···············-·····--················-....................... _, _______ ,,,,,_,,, ................ _ ....................................... , ___________ , ···········-·········· .. ···-··· .. ·················· 
......... , ... _,_, .... ,,_,.,, ...................................................... ___ ,,, .................................. ··-··----......... _._,,, .. ___ ,,,., ........................................................................................... _, _________ , ___ .. __ ,, 
.................... ,, _____ , ____ .,, ................................................. ,._._ ... , ___ .,,. .... _ .............................. _,._ .. _ ·······-················ .. ··· .. ·······"·······,,··············-······-·--··-· .. ···· .... ·--.. ······-··················"·· ......... .. 
._, ............................ _ .. _,., ........................... _ ................ , __ ., ___ , .............. _ ......................... _,. ____ ···-·····• .. ••• .............................. _ ............................... -............. -.. -................... -··-····-·-·---··· 
...................... - .. -.......................... -..................................... ,_ ........................................... __ ,. __ ., ............................................. _ ....................... _., .... - ..................................... ___ ..................... . 
i'-
1
i U ~3 CUL U .. _SI< EL ET P1 L. : . -·· -·-··-······· _ .... - .... -.. ... ... .. ··--··· .... --···-····· ··--· ·-·· .. ·-················---···- ·-·-·-·····-··-·-····--···-·········. ····-·····-·····-····-··--· ··-· 
DETAILS OF ANY ABNORMALITIES: 
.................................................................................................. -............................. _ ................................... . 
.... --· .... _ ........................... -···· -· ... .. ......... ....... ...... .. ...................................................................... ·-......................................................................................... ., ................................ " ............................................................. ·-·---·-· 
.............................................................. . ....................................................................................... __ .,., ____ , ............................ ____ . .,., ............. _ ............. _ ......................................... ,_.,,,, ....................... ,_ ... ,. _____ ,,.,_._., ....... _ ... 
.................... -..................................................... _ ........................................................................ _,,_,.,,.,,_ ........................................................................................................ _ .. ,, ...... _,_,., ............................................................. .. 
·····-···-·· .. -...................... -............. _._., .................................................................. -.................... -........... ;:. ............ , ................................................... _ .................................................................... ,_, ______ ............. , ___ ,._. _________ . 
........... _ ................................................................................... -................................ -.............................. -........................................................................................................................................... ,_ ........................... - .... _,,, __ ,,, 
D: CNS EXAMINATION : 
HE:r-iD 
E:VES 
; ..................... ,_ ....................... _ .................................. _, ................ -.. -................ -.. -........................................................................................................... _, __ ,._ .............................. . 
..................... - .............................................. ., .. ____ ,,, __ ._,, ......... ___ .. _ ... , ...... , _______ ... _.,,., .. , ................................................... ,_ ................ _ .................. - ............................. - ........... .. 
i.; I E> I D N ~ -········--··-··········--···· --·-···-···········-·-·······-····· ·-·-··-·······-·-······················-············· -··-·········-···-··-·--··-····················-··········-··········-······-··· 
HE{.'.iF I NU :: < R?) TTLE TEST) F: ·--···-··-·-··-········-··-·---·-·-···-···- L : -·····-···--···-··-········-····--······-·-··-···-···-····--·--·--···-·····--·--· 
(OTHER TE:f:>"T') R: ............ ·-·········-······----····-·····-············ !.. .. :: ........................... -.... -........................................... _ ..................... . 
PCE.:;TUPE 
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t .. ,J E I G HT : ··········--···-····-·---·--··___!< G • LENGTH: CM .. 
HErrn c I 1:~CUMFERENCE: -·-··············-·······-·CM" HP1EMCJGL.CJB IN: -·······-·-·····-·····GM. 
F: CONCLUSIONS : 
6 FEB 1989 
31 f 
1. ARE THERE ANY HEALTH PROBLEMS PRESENT OTHER THAN THOSE OF 
THE CNS ? YES/Nb/? 
I ;.::· 'lE :::.; ;::; F' EC I FY : ··-···--······-·-·······---·····-····-·-··-·-··--·--··--········-·--··-····-······-··········-·····-··-·····-········-····-···--·-·--··-····-··-·--······--··--··--··-·-······-··· 
ARE THRE ANY NEUROLOGICAL PROBLEMS PRESENT 7 YES/NO/'::> 
I r:· 'l c· f::. f.J F' EC I FY ~ .. ··-·-·--··-····-···-··-······-···········-····-·--··-·-······ .. ·-······-······-··-·······-····-· -·····-········-··-··· ·······-··--·-··-·-··-·-·-··-·-·-·········-··-········---·-·····-···· 
3. CLASSIFICATION 
* GENERAL ABNORMALITY ; CNS NORMAL 
* GENERAL ABNORMALITY ; CNS ABNORMAL 
* GENERAL NORMAL ; CNS ABNORMAL 
EXAMINATION CARRIED OUT BY 
T"I. ,., ··1 .. r-
... h-1 I J::. ~ 
**********************************************************f ***** 
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